BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy15052
(422 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 144 bits (363), Expect = 9e-35, Method: Compositional matrix adjust.
Identities = 76/186 (40%), Positives = 110/186 (59%), Gaps = 7/186 (3%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
+Q +G +D S+ P QER + + + HP +N FT++YD+AL+ LE P E++ +
Sbjct: 56 TQWTAFLGLHDQSQRSAP-GVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVR 114
Query: 243 PICLPGSDDLL-IGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
PICLP + + G+ VTGWG GG+ +LQK + +++ C ++ +
Sbjct: 115 PICLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQ----- 169
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I+ MC GF +GG DSCQGDSGGPL DGR F AG++SWG GCA+ N PGV TR+
Sbjct: 170 ITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLP 229
Query: 362 KFVPWV 367
F W+
Sbjct: 230 LFRDWI 235
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 144 bits (363), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 76/186 (40%), Positives = 109/186 (58%), Gaps = 7/186 (3%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
+Q +G +D S+ P QER + + + HP +N FT++YD+AL+ LE P E++ +
Sbjct: 56 TQWTAFLGLHDQSQRSAP-GVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVR 114
Query: 243 PICLPGSDDLL-IGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
PICLP + + G+ VTGWG GG+ +LQK + ++ C ++ +
Sbjct: 115 PICLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVIQQTTCENLLPQQ----- 169
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I+ MC GF +GG DSCQGDSGGPL DGR F AG++SWG GCA+ N PGV TR+
Sbjct: 170 ITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLP 229
Query: 362 KFVPWV 367
F W+
Sbjct: 230 LFRDWI 235
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 142 bits (358), Expect = 3e-34, Method: Compositional matrix adjust.
Identities = 81/185 (43%), Positives = 108/185 (58%), Gaps = 8/185 (4%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S ++I GE D S E Q V K ++H +++ + D++L++L + F N+
Sbjct: 56 SGLQIVAGELDMSVNEGSE--QIITVSKIILHENFDYNLLDNDISLLKLSGSLTFNDNVA 113
Query: 243 PICLPGSDDLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFI 302
PI LP G+ VTGWG SEGG+ P VLQKVTVP+VS+E CR+ + G E +
Sbjct: 114 PIALPEQGHTATGD-VIVTGWGTTSEGGNTPDVLQKVTVPLVSDEDCRADY---GADEIL 169
Query: 303 SDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISK 362
D +CAG GG+DSCQGDSGGPL G +LAGI+SWG GCA PGV T +S
Sbjct: 170 -DSMICAGVPEGGKDSCQGDSGGPLAAS-DTGSTYLAGIVSWGYGCARPGYPGVYTEVSY 227
Query: 363 FVPWV 367
V W+
Sbjct: 228 HVDWI 232
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 140 bits (354), Expect = 9e-34, Method: Compositional matrix adjust.
Identities = 75/186 (40%), Positives = 109/186 (58%), Gaps = 7/186 (3%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
+Q +G +D S+ P QER + + + HP +N FT++YD+AL+ LE P E++ +
Sbjct: 56 TQWTAFLGLHDQSQRSAP-GVQERRLKRIISHPFFNDFTFDYDIALLELEKPAEYSSMVR 114
Query: 243 PICLPGSDDLL-IGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
PI LP + + G+ VTGWG GG+ +LQK + +++ C ++ +
Sbjct: 115 PISLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENLLPQQ----- 169
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I+ MC GF +GG DSCQGDSGGPL DGR F AG++SWG GCA+ N PGV TR+
Sbjct: 170 ITPRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLP 229
Query: 362 KFVPWV 367
F W+
Sbjct: 230 LFRDWI 235
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 132 bits (331), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 111/189 (58%), Gaps = 8/189 (4%)
Query: 186 KIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPIC 245
+I G + S + + P+ + + + ++H Y +D+AL++L+ P+E+ PI
Sbjct: 56 RIYSGILELSDITKDTPFSQ--IKEIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPIS 113
Query: 246 LPGSDDL-LIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISD 304
LP D I N VTGWG E G + +LQKV +P+V+NE+C+ R Y+ I+
Sbjct: 114 LPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQK---RYQDYK-ITQ 169
Query: 305 IFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFV 364
+CAG+ GG+D+C+GDSGGPL K +G + L GI SWG GCA PGV T++++++
Sbjct: 170 RMVCAGYKEGGKDACKGDSGGPLVCK-HNGMWRLVGITSWGEGCARREQPGVYTKVAEYM 228
Query: 365 PWVLDTGDS 373
W+L+ S
Sbjct: 229 DWILEKTQS 237
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 130 bits (328), Expect = 1e-30, Method: Compositional matrix adjust.
Identities = 66/164 (40%), Positives = 99/164 (60%), Gaps = 6/164 (3%)
Query: 207 GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDL-LIGENATVTGWGR 265
GV + ++H +Y YD+AL++LET V +A + PICLP D +I + VTGWG
Sbjct: 75 GVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDRNVIYTDCWVTGWGY 134
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ + LQK +P+V+NE+C+ + R I+ +CAG+ GG+D+C+GDSGG
Sbjct: 135 RALRDKIQNTLQKAKIPLVTNEECQKRY----RGHKITHKMICAGYREGGKDACKGDSGG 190
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLD 369
PL K + + L GI SWG GCA+ PGV T + ++V W+L+
Sbjct: 191 PLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 130 bits (327), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 66/164 (40%), Positives = 98/164 (59%), Gaps = 6/164 (3%)
Query: 207 GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDL-LIGENATVTGWGR 265
GV + ++H +Y YD+AL++LET V +A + PICLP D +I + VTGWG
Sbjct: 75 GVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDRNVIYTDCWVTGWGY 134
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ LQK +P+V+NE+C+ + R I+ +CAG+ GG+D+C+GDSGG
Sbjct: 135 RKLRDKIQNTLQKAKIPLVTNEECQKRY----RGHKITHKMICAGYREGGKDACKGDSGG 190
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLD 369
PL K + + L GI SWG GCA+ PGV T + ++V W+L+
Sbjct: 191 PLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 130 bits (326), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 66/164 (40%), Positives = 98/164 (59%), Gaps = 6/164 (3%)
Query: 207 GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDL-LIGENATVTGWGR 265
GV + ++H +Y YD+AL++LET V +A + PICLP D +I + VTGWG
Sbjct: 75 GVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPICLPSKGDRNVIYTDCWVTGWGY 134
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ LQK +P+V+NE+C+ + R I+ +CAG+ GG+D+C+GDSGG
Sbjct: 135 RKLRDKIQNTLQKAKIPLVTNEECQKRY----RGHKITHKMICAGYREGGKDACKGDSGG 190
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLD 369
PL K + + L GI SWG GCA+ PGV T + ++V W+L+
Sbjct: 191 PLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 130 bits (326), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 69/189 (36%), Positives = 110/189 (58%), Gaps = 8/189 (4%)
Query: 186 KIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPIC 245
+I G + S + + P+ + + + ++H Y +D+AL++L+ P+ + PI
Sbjct: 56 RIYSGILNLSDITKDTPFSQ--IKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPIS 113
Query: 246 LPGSDDL-LIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISD 304
LP D I N VTGWG E G + +LQKV +P+V+NE+C+ R Y+ I+
Sbjct: 114 LPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQK---RYQDYK-ITQ 169
Query: 305 IFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFV 364
+CAG+ GG+D+C+GDSGGPL K +G + L GI SWG GCA PGV T++++++
Sbjct: 170 RMVCAGYKEGGKDACKGDSGGPLVCK-HNGMWRLVGITSWGEGCARREQPGVYTKVAEYM 228
Query: 365 PWVLDTGDS 373
W+L+ S
Sbjct: 229 DWILEKTQS 237
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 128 bits (322), Expect = 5e-30, Method: Compositional matrix adjust.
Identities = 65/164 (39%), Positives = 97/164 (59%), Gaps = 6/164 (3%)
Query: 207 GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDL-LIGENATVTGWGR 265
GV + ++H +Y YD+AL++LET V + + PICLP D +I + VTGWG
Sbjct: 75 GVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGY 134
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ LQK +P+V+NE+C+ + R I+ +CAG+ GG+D+C+GDSGG
Sbjct: 135 RKLRDKIQNTLQKAKIPLVTNEECQKRY----RGHKITHKMICAGYREGGKDACKGDSGG 190
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLD 369
PL K + + L GI SWG GCA+ PGV T + ++V W+L+
Sbjct: 191 PLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 128 bits (321), Expect = 7e-30, Method: Compositional matrix adjust.
Identities = 68/186 (36%), Positives = 108/186 (58%), Gaps = 8/186 (4%)
Query: 185 IKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPI 244
+++ G + S+++E + GV + ++H +Y YD+AL++LET V + + PI
Sbjct: 442 LRVYSGILNQSEIKEDTSF--FGVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPI 499
Query: 245 CLPGSDDL-LIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFIS 303
CLP D +I + VTGWG + LQK +P+V+NE+C+ + R I+
Sbjct: 500 CLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRY----RGHKIT 555
Query: 304 DIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKF 363
+CAG+ GG+D+C+GDSGGPL K + + L GI SWG GCA+ PGV T + ++
Sbjct: 556 HKMICAGYREGGKDACKGDSGGPLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEY 614
Query: 364 VPWVLD 369
V W+L+
Sbjct: 615 VDWILE 620
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 127 bits (319), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 72/189 (38%), Positives = 106/189 (56%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN TY D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFIS--ASKSIVHPSYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG----QI 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 126 bits (317), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 65/164 (39%), Positives = 97/164 (59%), Gaps = 6/164 (3%)
Query: 207 GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDL-LIGENATVTGWGR 265
GV + ++H +Y YD+AL++LET V +A + PI LP D +I + VTGWG
Sbjct: 75 GVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGY 134
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ LQK +P+V+NE+C+ + R I+ +CAG+ GG+D+C+GDSGG
Sbjct: 135 RKLRDKIQNTLQKAKIPLVTNEECQKRY----RGHKITHKMICAGYREGGKDACKGDSGG 190
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLD 369
PL K + + L GI SWG GCA+ PGV T + ++V W+L+
Sbjct: 191 PLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 126 bits (317), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 65/164 (39%), Positives = 97/164 (59%), Gaps = 6/164 (3%)
Query: 207 GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDL-LIGENATVTGWGR 265
GV + ++H +Y YD+AL++LET V +A + PI LP D +I + VTGWG
Sbjct: 75 GVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGY 134
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ LQK +P+V+NE+C+ + R I+ +CAG+ GG+D+C+GDSGG
Sbjct: 135 RKLRDKIQNTLQKAKIPLVTNEECQKRY----RGHKITHKMICAGYREGGKDACKGDSGG 190
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLD 369
PL K + + L GI SWG GCA+ PGV T + ++V W+L+
Sbjct: 191 PLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 126 bits (317), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 65/164 (39%), Positives = 97/164 (59%), Gaps = 6/164 (3%)
Query: 207 GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDL-LIGENATVTGWGR 265
GV + ++H +Y YD+AL++LET V +A + PI LP D +I + VTGWG
Sbjct: 75 GVQEIIIHDQYKMAESGYDIALLKLETTVNYADSQRPISLPSKGDRNVIYTDCWVTGWGY 134
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ LQK +P+V+NE+C+ + R I+ +CAG+ GG+D+C+GDSGG
Sbjct: 135 RKLRDKIQNTLQKAKIPLVTNEECQKRY----RGHKITHKMICAGYREGGKDACKGDSGG 190
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLD 369
PL K + + L GI SWG GCA+ PGV T + ++V W+L+
Sbjct: 191 PLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 126 bits (317), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 69/189 (36%), Positives = 105/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S+I++R+GE++ LE + K + HP +N T + D+ L++L +P +
Sbjct: 44 SRIQVRLGEHNIDVLEGNEQFIN--AAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
+ LP S G ++GWG S G S P +LQ + P++SN C+S + G+
Sbjct: 102 TVSLPRSC-AAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSNSSCKSSY--PGQ--- 155
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I+ +C GF GG+DSCQGDSGGP+ G+ L GI+SWG GCA+ N PGV T++
Sbjct: 156 ITGNMICVGFLQGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVNWIQQT 219
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 125 bits (314), Expect = 5e-29, Method: Compositional matrix adjust.
Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 15/229 (6%)
Query: 146 RPYVKPLKESLGRPVNVYSNNEKVDDFSTESVNSLLTSQIKIRV--GEYDFSKLEEPYPY 203
+P P + L V+ + V++ + + + +KI V GE++ + E +
Sbjct: 8 KPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETE--HTE 65
Query: 204 QERGVVKKMVHPKYN--FFTYEYDLALVRLETPVEFAPNIVPICLPG---SDDLLIGENA 258
Q+R V++ + H YN TY +D+AL+ L+ P+ + PIC+ ++ L +
Sbjct: 66 QKRNVIRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSG 125
Query: 259 TVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDS 318
V+GWGR+ G VLQ + VP+V C LR+ ++ +++F CAGF GGRDS
Sbjct: 126 YVSGWGRVFHKGRSALVLQYLRVPLVDRATC----LRSTKFTITNNMF-CAGFHEGGRDS 180
Query: 319 CQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
CQGDSGGP V +G FL GIISWG CA G+ T++S++V W+
Sbjct: 181 CQGDSGGP-HVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWI 228
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 125 bits (313), Expect = 6e-29, Method: Compositional matrix adjust.
Identities = 64/164 (39%), Positives = 96/164 (58%), Gaps = 6/164 (3%)
Query: 207 GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDL-LIGENATVTGWGR 265
GV + ++H +Y YD+AL++LET V + + PI LP D +I + VTGWG
Sbjct: 75 GVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGY 134
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ LQK +P+V+NE+C+ + R I+ +CAG+ GG+D+C+GDSGG
Sbjct: 135 RKLRDKIQNTLQKAKIPLVTNEECQKRY----RGHKITHKMICAGYREGGKDACKGDSGG 190
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLD 369
PL K + + L GI SWG GCA+ PGV T + ++V W+L+
Sbjct: 191 PLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 125 bits (313), Expect = 6e-29, Method: Compositional matrix adjust.
Identities = 71/189 (37%), Positives = 105/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFIS--ASKSIVHPSYNSNTLNNDIMLIKLKSAASLXSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG----QI 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 125 bits (313), Expect = 6e-29, Method: Compositional matrix adjust.
Identities = 64/164 (39%), Positives = 96/164 (58%), Gaps = 6/164 (3%)
Query: 207 GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDL-LIGENATVTGWGR 265
GV + ++H +Y YD+AL++LET V + + PI LP D +I + VTGWG
Sbjct: 75 GVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTGWGY 134
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ LQK +P+V+NE+C+ + R I+ +CAG+ GG+D+C+GDSGG
Sbjct: 135 RKLRDKIQNTLQKAKIPLVTNEECQKRY----RGHKITHKMICAGYREGGKDACKGDSGG 190
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLD 369
PL K + + L GI SWG GCA+ PGV T + ++V W+L+
Sbjct: 191 PLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 125 bits (313), Expect = 6e-29, Method: Compositional matrix adjust.
Identities = 69/190 (36%), Positives = 104/190 (54%), Gaps = 16/190 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVP 243
+ K+RVG+ + + E E VV K H ++ TY++D+A++RL+TP+ F N+ P
Sbjct: 64 RFKVRVGDRNTEQEEGGEAVHEVEVVIK--HNRFTKETYDFDIAVLRLKTPITFRMNVAP 121
Query: 244 ICLPGSD----DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR--SMFLRAG 297
CLP D L+ + V+G+GR E G L+ + VP V C+ S F+
Sbjct: 122 ACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI--- 178
Query: 298 RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
I+ CAG+D D+CQGDSGGP + KD YF+ GI+SWG GCA G+
Sbjct: 179 ----ITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIY 233
Query: 358 TRISKFVPWV 367
T+++ F+ W+
Sbjct: 234 TKVTAFLKWI 243
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 124 bits (312), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 69/190 (36%), Positives = 104/190 (54%), Gaps = 16/190 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVP 243
+ K+RVG+ + + E E VV K H ++ TY++D+A++RL+TP+ F N+ P
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIK--HNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
Query: 244 ICLPGSD----DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR--SMFLRAG 297
CLP D L+ + V+G+GR E G L+ + VP V C+ S F+
Sbjct: 107 ACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFI--- 163
Query: 298 RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
I+ CAG+D D+CQGDSGGP + KD YF+ GI+SWG GCA G+
Sbjct: 164 ----ITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIY 218
Query: 358 TRISKFVPWV 367
T+++ F+ W+
Sbjct: 219 TKVTAFLKWI 228
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 124 bits (312), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 69/190 (36%), Positives = 104/190 (54%), Gaps = 16/190 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVP 243
+ K+RVG+ + + E E VV K H ++ TY++D+A++RL+TP+ F N+ P
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIK--HNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
Query: 244 ICLPGSD----DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR--SMFLRAG 297
CLP D L+ + V+G+GR E G L+ + VP V C+ S F+
Sbjct: 107 ACLPERDWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSFI--- 163
Query: 298 RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
I+ CAG+D D+CQGDSGGP + KD YF+ GI+SWG GCA G+
Sbjct: 164 ----ITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIY 218
Query: 358 TRISKFVPWV 367
T+++ F+ W+
Sbjct: 219 TKVTAFLKWI 228
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 124 bits (312), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 69/190 (36%), Positives = 104/190 (54%), Gaps = 16/190 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVP 243
+ K+RVG+ + + E E VV K H ++ TY++D+A++RL+TP+ F N+ P
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIK--HNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
Query: 244 ICLPGSD----DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR--SMFLRAG 297
CLP D L+ + V+G+GR E G L+ + VP V C+ S F+
Sbjct: 107 ACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI--- 163
Query: 298 RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
I+ CAG+D D+CQGDSGGP + KD YF+ GI+SWG GCA G+
Sbjct: 164 ----ITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIY 218
Query: 358 TRISKFVPWV 367
T+++ F+ W+
Sbjct: 219 TKVTAFLKWI 228
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 124 bits (312), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 69/190 (36%), Positives = 104/190 (54%), Gaps = 16/190 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVP 243
+ K+RVG+ + + E E VV K H ++ TY++D+A++RL+TP+ F N+ P
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIK--HNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
Query: 244 ICLPGSD----DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR--SMFLRAG 297
CLP D L+ + V+G+GR E G L+ + VP V C+ S F+
Sbjct: 107 ACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI--- 163
Query: 298 RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
I+ CAG+D D+CQGDSGGP + KD YF+ GI+SWG GCA G+
Sbjct: 164 ----ITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIY 218
Query: 358 TRISKFVPWV 367
T+++ F+ W+
Sbjct: 219 TKVTAFLKWI 228
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 124 bits (312), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 69/190 (36%), Positives = 104/190 (54%), Gaps = 16/190 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVP 243
+ K+RVG+ + + E E VV K H ++ TY++D+A++RL+TP+ F N+ P
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIK--HNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
Query: 244 ICLPGSD----DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR--SMFLRAG 297
CLP D L+ + V+G+GR E G L+ + VP V C+ S F+
Sbjct: 107 ACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI--- 163
Query: 298 RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
I+ CAG+D D+CQGDSGGP + KD YF+ GI+SWG GCA G+
Sbjct: 164 ----ITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIY 218
Query: 358 TRISKFVPWV 367
T+++ F+ W+
Sbjct: 219 TKVTAFLKWI 228
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 124 bits (312), Expect = 7e-29, Method: Compositional matrix adjust.
Identities = 71/189 (37%), Positives = 105/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFIS--ASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG----QI 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 124 bits (312), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 69/190 (36%), Positives = 104/190 (54%), Gaps = 16/190 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVP 243
+ K+RVG+ + + E E VV K H ++ TY++D+A++RL+TP+ F N+ P
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIK--HNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
Query: 244 ICLPGSD----DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR--SMFLRAG 297
CLP D L+ + V+G+GR E G L+ + VP V C+ S F+
Sbjct: 107 ACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI--- 163
Query: 298 RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
I+ CAG+D D+CQGDSGGP + KD YF+ GI+SWG GCA G+
Sbjct: 164 ----ITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIY 218
Query: 358 TRISKFVPWV 367
T+++ F+ W+
Sbjct: 219 TKVTAFLKWI 228
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 124 bits (312), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 68/189 (35%), Positives = 105/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S+I++R+GE++ LE + K + HP +N T + D+ L++L +P +
Sbjct: 44 SRIQVRLGEHNIDVLEGNEQFIN--AAKIITHPNFNGNTLDNDIMLIKLSSPATLXSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
+ LP S G ++GWG S G S P +LQ + P++S+ C+S + G+
Sbjct: 102 TVSLPRSC-AAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSY--PGQ--- 155
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I+ +C GF GG+DSCQGDSGGP+ G+ L GI+SWG GCA+ N PGV T++
Sbjct: 156 ITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVNWIQQT 219
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 124 bits (312), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 71/189 (37%), Positives = 105/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 50 SGIQVRLGEDNINVVEGNEQFIS--ASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 107
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 108 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG----QI 162
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 163 TSNMF-CAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 216
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 217 NYVSWIKQT 225
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 124 bits (312), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 69/190 (36%), Positives = 104/190 (54%), Gaps = 16/190 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVP 243
+ K+RVG+ + + E E VV K H ++ TY++D+A++RL+TP+ F N+ P
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIK--HNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
Query: 244 ICLPGSD----DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR--SMFLRAG 297
CLP D L+ + V+G+GR E G L+ + VP V C+ S F+
Sbjct: 107 ACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI--- 163
Query: 298 RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
I+ CAG+D D+CQGDSGGP + KD YF+ GI+SWG GCA G+
Sbjct: 164 ----ITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIY 218
Query: 358 TRISKFVPWV 367
T+++ F+ W+
Sbjct: 219 TKVTAFLKWI 228
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 124 bits (312), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 77/229 (33%), Positives = 123/229 (53%), Gaps = 15/229 (6%)
Query: 146 RPYVKPLKESLGRPVNVYSNNEKVDDFSTESVNSLLTSQIKIRV--GEYDFSKLEEPYPY 203
+P P + L V+ + V++ + + + +KI V GE++ + E +
Sbjct: 8 KPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETE--HTE 65
Query: 204 QERGVVKKMVHPKYN--FFTYEYDLALVRLETPVEFAPNIVPICLPG---SDDLLIGENA 258
Q+R V++ + H +N TY +D+AL+ L+ P+ + PIC+ ++ L +
Sbjct: 66 QKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSG 125
Query: 259 TVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDS 318
V+GWGR+ G VLQ + VP+V C LR+ ++ +++F CAGF GGRDS
Sbjct: 126 YVSGWGRVFHKGRAALVLQYLRVPLVDRATC----LRSTKFTITNNMF-CAGFHEGGRDS 180
Query: 319 CQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
CQGDSGGP V +G FL GIISWG CA G+ T++S++V W+
Sbjct: 181 CQGDSGGP-HVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWI 228
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 124 bits (312), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 69/190 (36%), Positives = 104/190 (54%), Gaps = 16/190 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVP 243
+ K+RVG+ + + E E VV K H ++ TY++D+A++RL+TP+ F N+ P
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIK--HNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
Query: 244 ICLPGSD----DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR--SMFLRAG 297
CLP D L+ + V+G+GR E G L+ + VP V C+ S F+
Sbjct: 107 ACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI--- 163
Query: 298 RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
I+ CAG+D D+CQGDSGGP + KD YF+ GI+SWG GCA G+
Sbjct: 164 ----ITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIY 218
Query: 358 TRISKFVPWV 367
T+++ F+ W+
Sbjct: 219 TKVTAFLKWI 228
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 124 bits (312), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 71/189 (37%), Positives = 105/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 49 SGIQVRLGEDNINVVEGNEQFIS--ASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 106
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 107 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG----QI 161
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 162 TSNMF-CAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 215
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 216 NYVSWIKQT 224
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 124 bits (312), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 71/189 (37%), Positives = 105/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFIS--ASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG----QI 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 124 bits (312), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 69/190 (36%), Positives = 104/190 (54%), Gaps = 16/190 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVP 243
+ K+RVG+ + + E E VV K H ++ TY++D+A++RL+TP+ F N+ P
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIK--HNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
Query: 244 ICLPGSD----DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR--SMFLRAG 297
CLP D L+ + V+G+GR E G L+ + VP V C+ S F+
Sbjct: 107 ACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI--- 163
Query: 298 RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
I+ CAG+D D+CQGDSGGP + KD YF+ GI+SWG GCA G+
Sbjct: 164 ----ITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIY 218
Query: 358 TRISKFVPWV 367
T+++ F+ W+
Sbjct: 219 TKVTAFLKWI 228
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 124 bits (312), Expect = 9e-29, Method: Compositional matrix adjust.
Identities = 68/189 (35%), Positives = 105/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S+I++R+GE++ LE + K + HP +N T + D+ L++L +P +
Sbjct: 44 SRIQVRLGEHNIDVLEGNEQFIN--AAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
+ LP S G ++GWG S G S P +LQ + P++S+ C+S + G+
Sbjct: 102 TVSLPRSC-AAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSAY--PGQ--- 155
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I+ +C GF GG+DSCQGDSGGP+ G+ L GI+SWG GCA+ N PGV T++
Sbjct: 156 ITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVNWIQQT 219
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 124 bits (311), Expect = 9e-29, Method: Compositional matrix adjust.
Identities = 69/190 (36%), Positives = 104/190 (54%), Gaps = 16/190 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVP 243
+ K+RVG+ + + E E VV K H ++ TY++D+A++RL+TP+ F N+ P
Sbjct: 49 RFKVRVGDRNTAAEEGGEAVHEVEVVIK--HNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
Query: 244 ICLPGSD----DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR--SMFLRAG 297
CLP D L+ + V+G+GR E G L+ + VP V C+ S F+
Sbjct: 107 ACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI--- 163
Query: 298 RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
I+ CAG+D D+CQGDSGGP + KD YF+ GI+SWG GCA G+
Sbjct: 164 ----ITQNMFCAGYDTKQEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIY 218
Query: 358 TRISKFVPWV 367
T+++ F+ W+
Sbjct: 219 TKVTAFLKWI 228
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 124 bits (311), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 104/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFIS--ASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP + G ++GWG S G S P VL+ + PI+S C+S + +
Sbjct: 102 SISLP-TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSTSSCKSAYPG----QI 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 124 bits (311), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 68/189 (35%), Positives = 105/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S+I++R+GE++ LE + K + HP +N T + D+ L++L +P +
Sbjct: 44 SRIQVRLGEHNIDVLEGNEQFIN--AAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
+ LP S G ++GWG S G S P +LQ + P++S+ C+S + G+
Sbjct: 102 TVSLPRSC-AAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSY--PGQ--- 155
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I+ +C GF GG+DSCQGDSGGP+ G+ L GI+SWG GCA+ N PGV T++
Sbjct: 156 ITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVNWIQQT 219
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 124 bits (311), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 68/189 (35%), Positives = 105/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S+I++R+GE++ LE + K + HP +N T + D+ L++L +P +
Sbjct: 44 SRIQVRLGEHNIDVLEGNEQFIN--AAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
+ LP S G ++GWG S G S P +LQ + P++S+ C+S + G+
Sbjct: 102 TVSLPRSC-AAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSY--PGQ--- 155
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I+ +C GF GG+DSCQGDSGGP+ G+ L GI+SWG GCA+ N PGV T++
Sbjct: 156 ITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVNWIQQT 219
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 124 bits (311), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 70/186 (37%), Positives = 105/186 (56%), Gaps = 7/186 (3%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S+ K +G + S L P + R + + +++P YN D+A++ LE V + I
Sbjct: 51 SKWKAVLGLHMASNLTSP-QIETRLIDQIVINPHYNKRRKNNDIAMMHLEMKVNYTDYIQ 109
Query: 243 PICLPGSDDLLI-GENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
PICLP + + G ++ GWG L GS VLQ+ VP++SNEKC+
Sbjct: 110 PICLPEENQVFPPGRICSIAGWGALIYQGSTADVLQEADVPLLSNEKCQQQMPEYN---- 165
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I++ +CAG++ GG DSCQGDSGGPL + ++ R+ LAG+ S+G CA N PGV R+
Sbjct: 166 ITENMVCAGYEAGGVDSCQGDSGGPLMCQ-ENNRWLLAGVTSFGYQCALPNRPGVYARVP 224
Query: 362 KFVPWV 367
+F W+
Sbjct: 225 RFTEWI 230
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 124 bits (311), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 71/189 (37%), Positives = 105/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 58 SGIQVRLGEDNINVVEGNEQFIS--ASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 115
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 116 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG----QI 170
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 171 TSNMF-CAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 224
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 225 NYVSWIKQT 233
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 124 bits (310), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 105/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFIS--ASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
+ LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 102 SVSLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG----QI 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGYLEGGKDSCQGDSGGPVVCAGK-----LQGIVSWGSGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 124 bits (310), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 71/189 (37%), Positives = 105/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 64 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 121
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 122 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG----QI 176
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 177 TSNMF-CAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 230
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 231 NYVSWIKQT 239
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 124 bits (310), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 70/188 (37%), Positives = 106/188 (56%), Gaps = 14/188 (7%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVP 243
+ K+RVG+ + + E E VV K H ++ TY++D+A++RL+TP+ F N+ P
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIK--HNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
Query: 244 ICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFI 302
LP + G ++GWG S G P LQ + P++S KC + + G+ I
Sbjct: 107 ASLPTAPPA-TGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASY--PGK---I 160
Query: 303 SDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISK 362
+ C GF GG+DSCQGDSGGP+ G+ L G++SWG GCA+ N PGV T++
Sbjct: 161 TSNMFCVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGVVSWGDGCAQKNKPGVYTKVYN 215
Query: 363 FVPWVLDT 370
+V W+ +T
Sbjct: 216 YVKWIKNT 223
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 124 bits (310), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 67/189 (35%), Positives = 103/189 (54%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S+I++R+GE++ LE + K + HP +N T + D+ L++L +P +
Sbjct: 52 SRIQVRLGEHNIDVLEGNEQFIN--AAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVA 109
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
+ LP S G ++GWG S G S P +LQ + P++S+ C+S +
Sbjct: 110 TVSLPRSC-AAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQ----- 163
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I+ +C GF GG+DSCQGDSGGP+ G+ L GI+SWG GCA+ N PGV T++
Sbjct: 164 ITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGIVSWGYGCAQKNKPGVYTKVC 218
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 219 NYVNWIQQT 227
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 124 bits (310), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 77/229 (33%), Positives = 123/229 (53%), Gaps = 15/229 (6%)
Query: 146 RPYVKPLKESLGRPVNVYSNNEKVDDFSTESVNSLLTSQIKIRV--GEYDFSKLEEPYPY 203
+P P + L V+ + V++ + + + +KI V GE++ + E +
Sbjct: 8 KPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETE--HTE 65
Query: 204 QERGVVKKMVHPKYN--FFTYEYDLALVRLETPVEFAPNIVPICLPG---SDDLLIGENA 258
Q+R V++ + H +N TY +D+AL+ L+ P+ + PIC+ ++ L +
Sbjct: 66 QKRNVIRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSG 125
Query: 259 TVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDS 318
V+GWGR+ G VLQ + VP+V C LR+ ++ +++F CAGF GGRDS
Sbjct: 126 YVSGWGRVFHKGRSALVLQYLRVPLVDRATC----LRSTKFTITNNMF-CAGFHEGGRDS 180
Query: 319 CQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
CQGDSGGP V +G FL GIISWG CA G+ T++S++V W+
Sbjct: 181 CQGDSGGP-HVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWI 228
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 123 bits (309), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 68/190 (35%), Positives = 104/190 (54%), Gaps = 16/190 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVP 243
+ K+RVG+ + + E E VV K H ++ TY++D+A++RL+TP+ F N+ P
Sbjct: 49 RFKVRVGDRNTEQEEGGEAVHEVEVVIK--HNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
Query: 244 ICLPGSD----DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR--SMFLRAG 297
CLP D L+ + V+G+GR E G L+ + VP V C+ S F+
Sbjct: 107 ACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFI--- 163
Query: 298 RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
I+ CAG+D D+CQGD+GGP + KD YF+ GI+SWG GCA G+
Sbjct: 164 ----ITQNMFCAGYDTKQEDACQGDAGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIY 218
Query: 358 TRISKFVPWV 367
T+++ F+ W+
Sbjct: 219 TKVTAFLKWI 228
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 123 bits (309), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 63/164 (38%), Positives = 96/164 (58%), Gaps = 6/164 (3%)
Query: 207 GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDL-LIGENATVTGWGR 265
GV + ++H +Y YD+AL++LET V + + PI LP + +I + VTGWG
Sbjct: 75 GVQEIIIHDQYKMAESGYDIALLKLETTVNYTDSQRPISLPSKGERNVIYTDCWVTGWGY 134
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ LQK +P+V+NE+C+ + R I+ +CAG+ GG+D+C+GDSGG
Sbjct: 135 RKLRDKIQNTLQKAKIPLVTNEECQKRY----RGHKITHKMICAGYREGGKDACKGDSGG 190
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLD 369
PL K + + L GI SWG GCA+ PGV T + ++V W+L+
Sbjct: 191 PLSCKHNE-VWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILE 233
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 123 bits (308), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 105/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 64 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 121
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 122 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG----QI 176
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGD+GGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 177 TSNMF-CAGYLEGGKDSCQGDAGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 230
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 231 NYVSWIKQT 239
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 123 bits (308), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 104/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFIS--ASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG----QI 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGD GGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGYLEGGKDSCQGDXGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 123 bits (308), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 71/189 (37%), Positives = 104/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFIS--ASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSXPDVLKCLKAPILSDSSCKSAYPG----QI 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGXLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 123 bits (308), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 62/163 (38%), Positives = 98/163 (60%), Gaps = 6/163 (3%)
Query: 206 RGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLI-GENATVTGWG 264
R + + +++P YN + D+A++ LE V + I PI LP + + G N ++ GWG
Sbjct: 73 RLIDEIVINPHYNRRRKDNDIAMMHLEFKVNYTDYIQPISLPEENQVFPPGRNCSIAGWG 132
Query: 265 RLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSG 324
+ G+ +LQ+ VP++SNE+C+ I++ +CAG++ GG DSCQGDSG
Sbjct: 133 TVVYQGTTADILQEADVPLLSNERCQQQMPEYN----ITENMICAGYEEGGIDSCQGDSG 188
Query: 325 GPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GPL + ++ R+FLAG+ S+G CA N PGV R+S+F W+
Sbjct: 189 GPLMCQ-ENNRWFLAGVTSFGYECALPNRPGVYARVSRFTEWI 230
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 122 bits (307), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 77/229 (33%), Positives = 122/229 (53%), Gaps = 15/229 (6%)
Query: 146 RPYVKPLKESLGRPVNVYSNNEKVDDFSTESVNSLLTSQIKIRV--GEYDFSKLEEPYPY 203
+P P + L V+ + V++ + + + +KI V GE++ + E +
Sbjct: 8 KPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETE--HTE 65
Query: 204 QERGVVKKMVHPKYN--FFTYEYDLALVRLETPVEFAPNIVPICLPG---SDDLLIGENA 258
Q+R V++ + H YN Y +D+AL+ L+ P+ + PIC+ ++ L +
Sbjct: 66 QKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSG 125
Query: 259 TVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDS 318
V+GWGR+ G VLQ + VP+V C LR+ ++ +++F CAGF GGRDS
Sbjct: 126 YVSGWGRVFHKGRSALVLQYLRVPLVDRATC----LRSTKFTIYNNMF-CAGFHEGGRDS 180
Query: 319 CQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
CQGDSGGP V +G FL GIISWG CA G+ T++S++V W+
Sbjct: 181 CQGDSGGP-HVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWI 228
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 122 bits (306), Expect = 4e-28, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 105/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP Y+ T D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFIS--ASKSIVHPSYDSNTLNNDIMLIKLKSAASLDSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG----QI 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 122 bits (305), Expect = 5e-28, Method: Compositional matrix adjust.
Identities = 76/229 (33%), Positives = 122/229 (53%), Gaps = 15/229 (6%)
Query: 146 RPYVKPLKESLGRPVNVYSNNEKVDDFSTESVNSLLTSQIKIRV--GEYDFSKLEEPYPY 203
+P P + L V+ + V++ + + + +KI V GE++ + E +
Sbjct: 8 KPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETE--HTE 65
Query: 204 QERGVVKKMVHPKYN--FFTYEYDLALVRLETPVEFAPNIVPICLPG---SDDLLIGENA 258
Q+R V++ + H YN Y +D+AL+ L+ P+ + PIC+ ++ L +
Sbjct: 66 QKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSG 125
Query: 259 TVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDS 318
V+GWGR+ G VLQ + VP+V C LR+ ++ +++F CAGF GGRDS
Sbjct: 126 YVSGWGRVFHKGRSALVLQYLRVPLVDRATC----LRSTKFTIYNNMF-CAGFHEGGRDS 180
Query: 319 CQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
CQGD+GGP V +G FL GIISWG CA G+ T++S++V W+
Sbjct: 181 CQGDAGGP-HVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWI 228
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 122 bits (305), Expect = 5e-28, Method: Compositional matrix adjust.
Identities = 72/192 (37%), Positives = 107/192 (55%), Gaps = 15/192 (7%)
Query: 184 QIKIRVGEYDFSKLEEPYPY-QERGVVKKMVHPKYNFFT--YEYDLALVRLETPVEFAPN 240
+I + GEY+ EE P Q R V++ + H YN Y +D+AL+ L+ P+
Sbjct: 48 KITVVAGEYN---TEETEPTEQRRNVIRAIPHHSYNATVNKYSHDIALLELDEPLTLNSY 104
Query: 241 IVPICLPG---SDDLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAG 297
+ PIC+ ++ L + V+GWGR+ G +LQ + VP+V C LR+
Sbjct: 105 VTPICIADKEYTNIFLKFGSGYVSGWGRVFNRGRSATILQYLKVPLVDRATC----LRST 160
Query: 298 RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
++ S++F CAGF GG+DSCQGDSGGP V +G FL GIISWG CA G+
Sbjct: 161 KFTIYSNMF-CAGFHEGGKDSCQGDSGGP-HVTEVEGTSFLTGIISWGEECAVKGKYGIY 218
Query: 358 TRISKFVPWVLD 369
T++S++V W+ +
Sbjct: 219 TKVSRYVNWIKE 230
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 121 bits (304), Expect = 6e-28, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 104/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFIS--ASKSIVHPSYNKRRKNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG----QI 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 121 bits (303), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 66/183 (36%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 189 VGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLP- 247
+GE+D S E Q R V + ++ Y T +D+AL+RL PV ++VP+CLP
Sbjct: 56 LGEHDLS--EHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPE 113
Query: 248 ---GSDDLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISD 304
L + V+GWG+L + G+ VLQ + VP + + C + G I++
Sbjct: 114 RTFSERTLAFVRFSLVSGWGQLLDRGATALVLQVLNVPRLMTQDCLQQSRKVGDSPNITE 173
Query: 305 IFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFV 364
CAG+ +G +DSC+GDSGGP + G ++L GI+SWG GCA GV TR+S+++
Sbjct: 174 YMFCAGYSDGSKDSCKGDSGGPHATHYR-GTWYLTGIVSWGQGCATVGHFGVYTRVSQYI 232
Query: 365 PWV 367
W+
Sbjct: 233 EWL 235
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 121 bits (303), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 67/188 (35%), Positives = 103/188 (54%), Gaps = 12/188 (6%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVP 243
+ +RVG+ + + E E V + H ++ TY++D+A++RL+TP+ F N+ P
Sbjct: 49 RFTVRVGDRNTEQEEGNEMAHE--VEMTVKHSRFVKETYDFDIAVLRLKTPIRFRRNVAP 106
Query: 244 ICLPGSD----DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRY 299
CLP D L+ + V+G+GR E G L L+ + VP V C+ + +
Sbjct: 107 ACLPEKDWAEATLMTQKTGIVSGFGRTHEKGRLSSTLKMLEVPYVDRSTCK----LSSSF 162
Query: 300 EFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTR 359
++F CAG+D D+CQGDSGGP + KD YF+ GI+SWG GCA GV T+
Sbjct: 163 TITPNMF-CAGYDTQPEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKFGVYTK 220
Query: 360 ISKFVPWV 367
+S F+ W+
Sbjct: 221 VSNFLKWI 228
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 121 bits (303), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 70/203 (34%), Positives = 111/203 (54%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ TY D+ L
Sbjct: 30 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRETYNNDIML 87
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 88 IKLSSPVKLNARVATVALP-SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 146
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQGDSGGP+ G+ L GI+SWG G
Sbjct: 147 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 197 CALPDNPGVYTKVCNYVDWIQDT 219
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 120 bits (302), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 67/189 (35%), Positives = 100/189 (52%), Gaps = 7/189 (3%)
Query: 185 IKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPI 244
IKIR GE+D +E PYQER + + ++H +N T D+AL+ L+ P+ A NI I
Sbjct: 191 IKIRAGEWDTLTEKERLPYQERKIRQVIIHSNFNPKTVVNDVALLLLDRPLVQADNIGTI 250
Query: 245 CLPGSDDLLIGENATVTGWGRLSEGG--SLPPVLQKVTVPIVSNEKCRSMF--LRAGRYE 300
CLP + +GWG+ G +L+K+ +P V +KC++ R G
Sbjct: 251 CLPQQSQIFDSTECFASGWGKKEFGSRHRYSNILKKIQLPTVDRDKCQADLRNTRLGLKF 310
Query: 301 FISDIFMCAGFDNGGRDSCQGDSGGPLQVKG--KDGRYFLAGIISWGIGCAEANLPGVCT 358
+ F+CAG + G+D+C GD G PL RY GI++WGIGC + N+PGV
Sbjct: 311 VLDQTFVCAGGEQ-GKDTCTGDGGSPLFCPDPRNPSRYMQMGIVAWGIGCGDENVPGVYA 369
Query: 359 RISKFVPWV 367
++ F W+
Sbjct: 370 NVAHFRNWI 378
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 120 bits (302), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 71/190 (37%), Positives = 106/190 (55%), Gaps = 15/190 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPN-I 241
S I++R+GE + + +E + K +VHP YN T D+ L++L++ + +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFIS--ASKSIVHPSYNSNTLNNDIMLIKLKSAASLXDSRV 101
Query: 242 VPICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYE 300
I LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 102 ASISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG----Q 156
Query: 301 FISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRI 360
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 ITSNMF-CAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKV 210
Query: 361 SKFVPWVLDT 370
+V W+ T
Sbjct: 211 CNYVSWIKQT 220
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 120 bits (301), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 69/192 (35%), Positives = 106/192 (55%), Gaps = 14/192 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S+I++R+GE++ + E + + VK ++HP YN + D+ L++L P +
Sbjct: 44 SRIQVRLGEHNIAVNEGTEQFIDS--VKVIMHPSYNSRNLDNDIMLIKLSKPASLNSYVS 101
Query: 243 PICLPGSDDLLIGENATVTGWGRLSEGGS-LPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
+ LP S G V+GWG LS S P L+ + +PI+S+ C S + +
Sbjct: 102 TVALP-SSCASSGTRCLVSGWGNLSGSSSNYPDTLRCLDLPILSSSSCNSAYPG----QI 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAGF GG+DSCQGDSGGP+ G+ L G++SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGFMEGGKDSCQGDSGGPVVCNGQ-----LQGVVSWGYGCAQRNKPGVYTKVC 210
Query: 362 KFVPWVLDTGDS 373
+ W+ T S
Sbjct: 211 NYRSWISSTMSS 222
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 120 bits (301), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 69/203 (33%), Positives = 108/203 (53%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ TY D+ L
Sbjct: 30 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRETYNNDIML 87
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 88 IKLSSPVKLNARVATVALP-SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 146
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C A I+D +C GF GG+D+CQGDSGGP+ G+ L GI+SWG G
Sbjct: 147 DCE-----ASSSFIITDNMVCVGFLEGGKDACQGDSGGPVVCNGE-----LQGIVSWGYG 196
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 197 CALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 119 bits (298), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 70/203 (34%), Positives = 110/203 (54%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T D+ L
Sbjct: 30 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRKTLNNDIML 87
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + I LP S G ++GWG LS G + P +LQ + P++
Sbjct: 88 IKLSSPVKLNARVATIALP-SSCAPAGTQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQA 146
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQGDSGGP+ G+ L GI+SWG G
Sbjct: 147 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 197 CALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 119 bits (298), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 69/203 (33%), Positives = 110/203 (54%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T D+ L
Sbjct: 30 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDHKTLNNDIML 87
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 88 IKLSSPVKLNARVATVALP-SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 146
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQGDSGGP+ G+ L GI+SWG G
Sbjct: 147 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 197 CALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 119 bits (297), Expect = 4e-27, Method: Compositional matrix adjust.
Identities = 69/203 (33%), Positives = 110/203 (54%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T D+ L
Sbjct: 30 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRKTLNNDIML 87
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 88 IKLSSPVKLNARVATVALP-SSCAPAGTQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQA 146
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQGDSGGP+ G+ L GI+SWG G
Sbjct: 147 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 197 CALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 118 bits (296), Expect = 5e-27, Method: Compositional matrix adjust.
Identities = 69/203 (33%), Positives = 111/203 (54%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T D+ L
Sbjct: 52 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRKTLNNDIML 109
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ ++ + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 110 IKLSSPVKLNAHVATVALP-SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 168
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQGDSGGP+ G+ L GI+SWG G
Sbjct: 169 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 218
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 219 CALPDNPGVYTKVCNYVDWIQDT 241
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 118 bits (295), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 69/203 (33%), Positives = 110/203 (54%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T D+ L
Sbjct: 30 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRKTLNNDIML 87
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 88 IKLSSPVKLNARVATVALP-SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 146
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQGDSGGP+ G+ L GI+SWG G
Sbjct: 147 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 197 CALPDNPGVYTKVCNYVDWIQDT 219
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 118 bits (295), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 64/160 (40%), Positives = 93/160 (58%), Gaps = 7/160 (4%)
Query: 214 HPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSD-DLLIGENATVTGWGRLSEGGSL 272
HP Y + D+AL++L P+ F+ I PI LP + G + TVTGWG ++ SL
Sbjct: 79 HPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQASFPNGLHCTVTGWGHVAPSVSL 138
Query: 273 --PPVLQKVTVPIVSNEKCRSMFLRAGRYE---FISDIFMCAGFDNGGRDSCQGDSGGPL 327
P LQ++ VP++S E C S++ + E F+ + +CAG+ GG+D+CQGDSGGPL
Sbjct: 139 LTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPL 198
Query: 328 QVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
+G ++L GI+SWG C N PGV T S + W+
Sbjct: 199 SCP-VEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWI 237
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 118 bits (295), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 64/160 (40%), Positives = 93/160 (58%), Gaps = 7/160 (4%)
Query: 214 HPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSD-DLLIGENATVTGWGRLSEGGSL 272
HP Y + D+AL++L P+ F+ I PI LP + G + TVTGWG ++ SL
Sbjct: 79 HPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAAQASFPNGLHCTVTGWGHVAPSVSL 138
Query: 273 --PPVLQKVTVPIVSNEKCRSMFLRAGRYE---FISDIFMCAGFDNGGRDSCQGDSGGPL 327
P LQ++ VP++S E C S++ + E F+ + +CAG+ GG+D+CQGDSGGPL
Sbjct: 139 LTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPL 198
Query: 328 QVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
+G ++L GI+SWG C N PGV T S + W+
Sbjct: 199 SCP-VEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWI 237
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 117 bits (294), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 69/203 (33%), Positives = 110/203 (54%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T D+ L
Sbjct: 38 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRKTLNNDIML 95
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 96 IKLSSPVKLNARVATVALPSSC-APAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 154
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQGDSGGP+ G+ L GI+SWG G
Sbjct: 155 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 204
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 205 CALPDNPGVYTKVCNYVDWIQDT 227
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 117 bits (294), Expect = 9e-27, Method: Compositional matrix adjust.
Identities = 69/203 (33%), Positives = 110/203 (54%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T D+ L
Sbjct: 40 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRKTLNNDIML 97
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 98 IKLSSPVKLNARVATVALPSSC-APAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 156
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQGDSGGP+ G+ L GI+SWG G
Sbjct: 157 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 206
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 207 CALPDNPGVYTKVCNYVDWIQDT 229
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 117 bits (293), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 68/203 (33%), Positives = 110/203 (54%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T D+ L
Sbjct: 30 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRKTLNNDIML 87
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 88 IKLSSPVKLNARVATVALP-SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 146
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQGD+GGP+ G+ L GI+SWG G
Sbjct: 147 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGDAGGPVVCNGE-----LQGIVSWGYG 196
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 197 CALPDNPGVYTKVCNYVDWIQDT 219
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 117 bits (292), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 63/160 (39%), Positives = 94/160 (58%), Gaps = 7/160 (4%)
Query: 214 HPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSD-DLLIGENATVTGWGRLSEGGSL 272
HP Y + D+AL++L P+ F+ I PI LP ++ G + TVTGWG ++ SL
Sbjct: 79 HPSYLQEGSQGDIALLQLSRPITFSRYIRPISLPAANASFPNGLHCTVTGWGHVAPSVSL 138
Query: 273 --PPVLQKVTVPIVSNEKCRSMFLRAGRYE---FISDIFMCAGFDNGGRDSCQGDSGGPL 327
P LQ++ VP++S E C +++ + E F+ + +CAG+ GG+D+CQGDSGGPL
Sbjct: 139 LTPKPLQQLEVPLISRETCNALYNIDAKPEEPHFVQEDMVCAGYVEGGKDACQGDSGGPL 198
Query: 328 QVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
+G ++L GI+SWG C N PGV T S + W+
Sbjct: 199 SCP-VEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWI 237
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 117 bits (292), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 68/203 (33%), Positives = 110/203 (54%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T D+ L
Sbjct: 40 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRKTLNNDIML 97
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 98 IKLSSPVKLNARVATVALPSSC-APAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 156
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQGD+GGP+ G+ L GI+SWG G
Sbjct: 157 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGDAGGPVVCNGE-----LQGIVSWGYG 206
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 207 CALPDNPGVYTKVCNYVDWIQDT 229
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 116 bits (291), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 68/203 (33%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T D+ L
Sbjct: 30 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRKTLNNDIML 87
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 88 IKLSSPVKLNARVATVALP-SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 146
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQGDSGGP+ G+ L GI+ WG G
Sbjct: 147 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVEWGYG 196
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 197 CALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 116 bits (291), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 68/203 (33%), Positives = 110/203 (54%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T ++ L
Sbjct: 30 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGDEQFVNAAKIIK--HPNFDRKTLNNNIML 87
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 88 IKLSSPVKLNARVATVALP-SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 146
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQGDSGGP+ G+ L GI+SWG G
Sbjct: 147 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 197 CALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 116 bits (291), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 68/203 (33%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T D+ L
Sbjct: 30 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRKTLNNDIML 87
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 88 IKLSSPVKLNARVATVALP-SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 146
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQGDSGGP+ G+ L GI+ WG G
Sbjct: 147 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVKWGYG 196
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 197 CALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 116 bits (291), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 68/203 (33%), Positives = 110/203 (54%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T ++ L
Sbjct: 30 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRKTLNNNIML 87
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 88 IKLSSPVKLNARVATVALP-SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 146
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQGDSGGP+ G+ L GI+SWG G
Sbjct: 147 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 197 CALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 116 bits (291), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 68/203 (33%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T D+ L
Sbjct: 30 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRKTLNNDIML 87
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 88 IKLSSPVKLNARVATVALP-SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 146
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQGD GGP+ G+ L GI+SWG G
Sbjct: 147 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGDCGGPVVCNGE-----LQGIVSWGYG 196
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 197 CALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 116 bits (290), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 64/183 (34%), Positives = 99/183 (54%), Gaps = 7/183 (3%)
Query: 189 VGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLP- 247
+GE+D S E Q R V + ++ Y T +D+AL+RL PV ++VP+CLP
Sbjct: 56 LGEHDLS--EHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPE 113
Query: 248 ---GSDDLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISD 304
L + V+GWG+L + G+ L + VP + + C + G I++
Sbjct: 114 RTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITE 173
Query: 305 IFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFV 364
CAG+ +G +DSC+GDSGGP + G ++L GI+SWG GCA GV TR+S+++
Sbjct: 174 YMFCAGYSDGSKDSCKGDSGGPHATHYR-GTWYLTGIVSWGQGCATVGHFGVYTRVSQYI 232
Query: 365 PWV 367
W+
Sbjct: 233 EWL 235
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 116 bits (290), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 68/203 (33%), Positives = 110/203 (54%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T D+ L
Sbjct: 38 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRKTLNNDIML 95
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +L+ + P++
Sbjct: 96 IKLSSPVKLNARVATVALPSSC-APAGTQCLISGWGNTLSSGVNEPDLLKCLDAPLLPQA 154
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQGDSGGP+ G+ L GI+SWG G
Sbjct: 155 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE-----LQGIVSWGYG 204
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 205 CALPDNPGVYTKVCNYVDWIQDT 227
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 116 bits (290), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 68/203 (33%), Positives = 110/203 (54%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T D+ L
Sbjct: 38 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRKTLNNDIML 95
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 96 IKLSSPVKLNARVATVALP-SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 154
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+DSCQG+SGGP+ G+ L GI+SWG G
Sbjct: 155 DCEASY--PGK---ITDNMVCVGFLEGGKDSCQGNSGGPVVCNGE-----LQGIVSWGYG 204
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 205 CALPDNPGVYTKVCNYVDWIQDT 227
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 116 bits (290), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 102/189 (53%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP + G ++GWG S G S P VL+ + PI+S+ C+S R
Sbjct: 102 SISLP-TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSR-----I 155
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I+ CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 115 bits (289), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 68/203 (33%), Positives = 109/203 (53%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T D+ L
Sbjct: 30 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRKTLNNDIML 87
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 88 IKLSSPVKLNARVATVALP-SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 146
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+ SCQGDSGGP+ G+ L GI+SWG G
Sbjct: 147 DCEASY--PGK---ITDNMVCVGFLEGGKSSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + PGV T++ +V W+ DT
Sbjct: 197 CALPDNPGVYTKVCNYVDWIQDT 219
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 115 bits (288), Expect = 5e-26, Method: Compositional matrix adjust.
Identities = 71/189 (37%), Positives = 102/189 (53%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP + G ++GWG S G S P VL+ + PI+S S A Y
Sbjct: 102 SISLP-TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSYII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 115 bits (287), Expect = 5e-26, Method: Compositional matrix adjust.
Identities = 66/189 (34%), Positives = 105/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
++I++R+GE++ LE + VK + HPKYN T + D+ L++L +P +
Sbjct: 44 TRIQVRLGEHNIKVLEGNEQFIN--AVKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVS 101
Query: 243 PICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP + G ++GWG LS G P L+ + P+++ +C++ + G+
Sbjct: 102 TISLPTAPPAA-GTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASY--PGK--- 155
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I++ C GF GG+DSCQ DSGGP+ G+ L G++SWG GCA N PGV T++
Sbjct: 156 ITNSMFCVGFLEGGKDSCQRDSGGPVVCNGQ-----LQGVVSWGHGCAWKNRPGVYTKVY 210
Query: 362 KFVPWVLDT 370
+V W+ DT
Sbjct: 211 NYVDWIKDT 219
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 115 bits (287), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 103/189 (54%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN TY D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP + G ++GWG S G S P VL+ + PI+S S A +
Sbjct: 102 SISLP-TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSFII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+D+CQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 114 bits (286), Expect = 7e-26, Method: Compositional matrix adjust.
Identities = 71/189 (37%), Positives = 103/189 (54%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN TY D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S S A +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSFII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+D+CQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGEGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 114 bits (286), Expect = 7e-26, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 103/189 (54%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN TY D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S S A +
Sbjct: 102 SISLPTSCASA-GTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSFII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+D+CQGDSGGP+ GK L GI+SWG GCA+ N PG+ T++
Sbjct: 157 TSNMF-CAGYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGIYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 114 bits (286), Expect = 8e-26, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 103/189 (54%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN TY D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S S A +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSFII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+D+CQGDSGGP+ GK L GI+SWG GCA+ N PG+ T++
Sbjct: 157 TSNMF-CAGYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGIYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 114 bits (285), Expect = 9e-26, Method: Compositional matrix adjust.
Identities = 70/190 (36%), Positives = 102/190 (53%), Gaps = 12/190 (6%)
Query: 185 IKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPI 244
+ + VGE+D S Q V V+ Y+ T E D+++++ + F N+ PI
Sbjct: 53 VSLVVGEHDSSAASTVR--QTHDVDSIFVNENYDPATLENDVSVIKTAVAITFDINVGPI 110
Query: 245 CLPGSDDLLIGENATVTGWGRLSEGG-SLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFIS 303
C P + + + +GWG ++ GG P VL+ VT+ I +N C +++ + I
Sbjct: 111 CAPDPANDYVYRKSQCSGWGTINSGGVCCPAVLRYVTLNITTNAFCDAVYTS----DTIY 166
Query: 304 DIFMCAGFDNGG---RDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRI 360
D +CA DN G RDSCQGDSGGPL VK G + L GI+SWGIGCA + PGV +R+
Sbjct: 167 DDMICA-TDNTGMTDRDSCQGDSGGPLSVKDGSGIFSLVGIVSWGIGCA-SGYPGVYSRV 224
Query: 361 SKFVPWVLDT 370
W+ DT
Sbjct: 225 GFHAGWITDT 234
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 114 bits (285), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 103/189 (54%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN TY D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S S A +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSFII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+D+CQGDSGGP+ GK L GI+SWG GCA+ N PG+ T++
Sbjct: 157 TSNMF-CAGYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGEGCAQKNKPGIYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 114 bits (285), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 71/189 (37%), Positives = 102/189 (53%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN TY D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S S A +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSFII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PG T++
Sbjct: 157 TSNMF-CAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 114 bits (285), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 103/189 (54%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN TY D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S S A +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSFII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+D+CQGD+GGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGYLEGGKDACQGDAGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 114 bits (285), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 66/189 (34%), Positives = 98/189 (51%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP + G ++GWG S G S P VL+ + PI+ ++
Sbjct: 102 SISLP-TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPIL-----SDSSCKSASSAI 155
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I+ CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 114 bits (284), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 103/189 (54%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN TY D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S S A +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSFII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+D+CQGD+GGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGYLEGGKDACQGDAGGPVVCSGK-----LQGIVSWGEGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 113 bits (283), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 73/202 (36%), Positives = 108/202 (53%), Gaps = 23/202 (11%)
Query: 176 SVNSLLTSQIKIRVGEYDFSKLEEPYPYQER--GVVKKMVHPKYNFFTYEYDLALVRLET 233
V L T ++++R E+ YQ++ V + +VHP++ D+AL+ LE
Sbjct: 49 DVKDLATLRVQLR---------EQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEE 99
Query: 234 PVEFAPNIVPICLP-GSDDLLIGENATVTGWGRLSEGGSLPPV--LQKVTVPIVSNEKCR 290
PV + + + LP S+ G VTGWG + LPP L++V VPI+ N C
Sbjct: 100 PVNISSRVHTVMLPPASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICD 159
Query: 291 SMFLRAGRY-----EFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWG 345
+ + G Y I D +CAG N RDSCQGDSGGPL K +G + AG++SWG
Sbjct: 160 AKY-HLGAYTGDDVRIIRDDMLCAG--NSQRDSCQGDSGGPLVCK-VNGTWLQAGVVSWG 215
Query: 346 IGCAEANLPGVCTRISKFVPWV 367
GCA+ N PG+ TR++ ++ W+
Sbjct: 216 EGCAQPNRPGIYTRVTYYLDWI 237
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 113 bits (283), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 102/189 (53%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP + G ++GWG S G S P VL+ + PI+S S A +
Sbjct: 102 SISLP-TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSWII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 113 bits (282), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 71/189 (37%), Positives = 102/189 (53%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S S A +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSFII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGYLEGGKDSCQGDSGGPVVCSGK-----LQGIVSWGEGCAQKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 113 bits (282), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 103/189 (54%), Gaps = 17/189 (8%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFIS--ASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG----QI 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG + G DSCQGDSGGP+ GK L GI+SWG GCA+ N PGV T++
Sbjct: 157 TSNMF-CAGLEGG--DSCQGDSGGPVVCSGK-----LQGIVSWGSGCAK-NKPGVYTKVC 207
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 208 NYVSWIKQT 216
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 113 bits (282), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 64/189 (33%), Positives = 104/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
++I++R+GE++ LE + K + HPKYN T + D+ L++L +P +
Sbjct: 44 TRIQVRLGEHNIKVLEGNEQFIN--AAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVS 101
Query: 243 PICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP + G ++GWG LS G P L+ + P+++ +C++ + G+
Sbjct: 102 TISLPTAPPAA-GTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASY--PGK--- 155
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I++ C GF GG+DSCQ D+GGP+ G+ L G++SWG GCA N PGV T++
Sbjct: 156 ITNSMFCVGFLEGGKDSCQRDAGGPVVCNGQ-----LQGVVSWGHGCAWKNRPGVYTKVY 210
Query: 362 KFVPWVLDT 370
+V W+ DT
Sbjct: 211 NYVDWIKDT 219
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 113 bits (282), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 102/189 (53%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN TY D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S S A +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSFII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+D+CQGDSGGP+ GK L GI+SWG GCA+ N PG T++
Sbjct: 157 TSNMF-CAGYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 112 bits (281), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 64/189 (33%), Positives = 104/189 (55%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
++I++R+GE++ LE + K + HPKYN T + D+ L++L +P +
Sbjct: 44 TRIQVRLGEHNIKVLEGNEQFIN--AAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVS 101
Query: 243 PICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP + G ++GWG LS G P L+ + P+++ +C++ + G+
Sbjct: 102 TISLPTAPPAA-GTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASY--PGK--- 155
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I++ C GF GG+DSCQ D+GGP+ G+ L G++SWG GCA N PGV T++
Sbjct: 156 ITNSMFCVGFLEGGKDSCQRDAGGPVVCNGQ-----LQGVVSWGHGCAWKNRPGVYTKVY 210
Query: 362 KFVPWVLDT 370
+V W+ DT
Sbjct: 211 NYVDWIKDT 219
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 112 bits (281), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 62/150 (41%), Positives = 82/150 (54%), Gaps = 7/150 (4%)
Query: 225 DLALVRLETPVEFAPNIVPICLPGSDDLLI-GENATVTGWGRLSEGGSLPPVLQKVTVPI 283
D+ALV L +P+ I P+CLP + L+ G+ TVTGWG G VLQ+ VPI
Sbjct: 95 DIALVHLSSPLPLTEYIQPVCLPAAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPI 154
Query: 284 VSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVK---GKDGRYFLAG 340
+SN+ C + I CAG+ GG D+CQGDSGGP + + R+ L G
Sbjct: 155 ISNDVCNGADFYGNQ---IKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCG 211
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDT 370
I+SWG GCA A PGV T++S F W+
Sbjct: 212 IVSWGTGCALAQKPGVYTKVSDFREWIFQA 241
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 112 bits (281), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 66/196 (33%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 176 SVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPV 235
S S+I++R+GE++ LE + K + HP+Y+ T D+ L++L +
Sbjct: 37 SAGHCYKSRIQVRLGEHNIEVLEGNEQFIN--AAKIIRHPQYDRKTLNNDIMLIKLSSRA 94
Query: 236 EFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNEKCRSMFL 294
+ I LP + G ++GWG S G P LQ + P++S KC + +
Sbjct: 95 VINARVSTISLPTAPPA-TGTKCLISGWGNTASSGADXPDELQCLDAPVLSQAKCEASY- 152
Query: 295 RAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLP 354
G+ I+ C GF GG+DSCQGDSGGP+ G+ L G++SWG GCA+ N P
Sbjct: 153 -PGK---ITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQ-----LQGVVSWGDGCAQKNKP 203
Query: 355 GVCTRISKFVPWVLDT 370
GV T++ +V W+ +T
Sbjct: 204 GVYTKVYNYVKWIKNT 219
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 112 bits (281), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 67/203 (33%), Positives = 108/203 (53%), Gaps = 14/203 (6%)
Query: 169 VDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLAL 228
++D S S+I++R+GE++ + LE + + K HP ++ T D+ L
Sbjct: 30 INDQWVVSAAHCYKSRIQVRLGEHNINVLEGNEQFVNAAKIIK--HPNFDRKTLNNDIML 87
Query: 229 VRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNE 287
++L +PV+ + + LP S G ++GWG LS G + P +LQ + P++
Sbjct: 88 IKLSSPVKLNARVATVALP-SSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQA 146
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
C + + G+ I+D +C GF GG+ SCQGDSGGP+ G+ L GI+SWG G
Sbjct: 147 DCEASY--PGK---ITDNMVCVGFLEGGKGSCQGDSGGPVVCNGE-----LQGIVSWGYG 196
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA + P V T++ +V W+ DT
Sbjct: 197 CALPDNPDVYTKVCNYVDWIQDT 219
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 112 bits (281), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 62/150 (41%), Positives = 82/150 (54%), Gaps = 7/150 (4%)
Query: 225 DLALVRLETPVEFAPNIVPICLPGSDDLLI-GENATVTGWGRLSEGGSLPPVLQKVTVPI 283
D+ALV L +P+ I P+CLP + L+ G+ TVTGWG G VLQ+ VPI
Sbjct: 212 DIALVHLSSPLPLTEYIQPVCLPAAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPI 271
Query: 284 VSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVK---GKDGRYFLAG 340
+SN+ C + I CAG+ GG D+CQGDSGGP + + R+ L G
Sbjct: 272 ISNDVCNGADFYGNQ---IKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCG 328
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDT 370
I+SWG GCA A PGV T++S F W+
Sbjct: 329 IVSWGTGCALAQKPGVYTKVSDFREWIFQA 358
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 112 bits (281), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 70/189 (37%), Positives = 102/189 (53%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN TY D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S S A +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSFII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+D+CQGDSGGP+ GK L GI+SWG GCA+ N PG T++
Sbjct: 157 TSNMF-CAGYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKLC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 112 bits (281), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 62/150 (41%), Positives = 82/150 (54%), Gaps = 7/150 (4%)
Query: 225 DLALVRLETPVEFAPNIVPICLPGSDDLLI-GENATVTGWGRLSEGGSLPPVLQKVTVPI 283
D+ALV L +P+ I P+CLP + L+ G+ TVTGWG G VLQ+ VPI
Sbjct: 212 DIALVHLSSPLPLTEYIQPVCLPAAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPI 271
Query: 284 VSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVK---GKDGRYFLAG 340
+SN+ C + I CAG+ GG D+CQGDSGGP + + R+ L G
Sbjct: 272 ISNDVCNGADFYGNQ---IKPKMFCAGYPEGGIDACQGDSGGPFVCEDSISRTPRWRLCG 328
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDT 370
I+SWG GCA A PGV T++S F W+
Sbjct: 329 IVSWGTGCALAQKPGVYTKVSDFREWIFQA 358
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 112 bits (281), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 65/196 (33%), Positives = 103/196 (52%), Gaps = 14/196 (7%)
Query: 176 SVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPV 235
S S+I++R+GE++ LE + K + HP+Y+ T D+ L++L +
Sbjct: 37 SAGHCYKSRIQVRLGEHNIEVLEGNEQFIN--AAKIIRHPQYDRKTLNNDIMLIKLSSRA 94
Query: 236 EFAPNIVPICLPGSDDLLIGENATVTGWGR-LSEGGSLPPVLQKVTVPIVSNEKCRSMFL 294
++ I LP + G ++GWG S G P LQ + P++S KC + +
Sbjct: 95 VINAHVSTISLPTAPPA-TGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASY- 152
Query: 295 RAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLP 354
G+ I+ C GF GG+DSCQGD+GGP+ G+ L G++SWG GCA+ N P
Sbjct: 153 -PGK---ITSNMFCVGFLEGGKDSCQGDAGGPVVCNGQ-----LQGVVSWGDGCAQKNKP 203
Query: 355 GVCTRISKFVPWVLDT 370
GV T++ +V W+ +T
Sbjct: 204 GVYTKVYNYVKWIKNT 219
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 112 bits (280), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 14/225 (6%)
Query: 146 RPYVKPLKESLGRPVNVYSNNEKVDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQE 205
+PY +P + SL + + V++ S S++++R+GE++ E +
Sbjct: 8 KPYSQPHQVSLNSGYH-FCGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKVTEGSEQFIS 66
Query: 206 RGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR 265
V + HP Y+ + + D+ L++L P + P+ LP S G TV+GWG
Sbjct: 67 SSRVIR--HPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSC-APAGTMCTVSGWGN 123
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ LQ + +PI+S C + + I++ CAG+ GG+DSCQGDSGG
Sbjct: 124 TMSSTADSNKLQCLNIPILSYSDCNNSYPG-----MITNAMFCAGYLEGGKDSCQGDSGG 178
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDT 370
P+ G+ L G++SWG GCAE PGV ++ F W+ T
Sbjct: 179 PVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 218
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 112 bits (280), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 67/189 (35%), Positives = 99/189 (52%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN T D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFIS--ASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S+ C+S + +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG----QI 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F G + G DSCQGDSGGP+ GK L GI+SWG GC N PGV T++
Sbjct: 157 TSNMFCAYGLEGKG-DSCQGDSGGPVVCSGK-----LQGIVSWGSGCQAKNKPGVYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 112 bits (280), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 68/225 (30%), Positives = 110/225 (48%), Gaps = 14/225 (6%)
Query: 146 RPYVKPLKESLGRPVNVYSNNEKVDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQE 205
+PY +P + SL + + V++ S S++++R+GE++ E +
Sbjct: 28 KPYSQPHQVSLNSGYH-FCGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKVTEGSEQFIS 86
Query: 206 RGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR 265
V + HP Y+ + + D+ L++L P + P+ LP S G TV+GWG
Sbjct: 87 SSRVIR--HPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSC-APAGTMCTVSGWGN 143
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ LQ + +PI+S C + + I++ CAG+ GG+DSCQGDSGG
Sbjct: 144 TMSSTADSNKLQCLNIPILSYSDCNNSYPG-----MITNAMFCAGYLEGGKDSCQGDSGG 198
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDT 370
P+ G+ L G++SWG GCAE PGV ++ F W+ T
Sbjct: 199 PVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 238
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 112 bits (279), Expect = 5e-25, Method: Compositional matrix adjust.
Identities = 66/192 (34%), Positives = 94/192 (48%), Gaps = 12/192 (6%)
Query: 181 LTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPN 240
+T+ + GE+D E Q+ + K + KYN T D+ L++L T F+
Sbjct: 45 VTTSDVVVAGEFDQGSSSEKI--QKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQT 102
Query: 241 IVPICLP-GSDDLLIGENATVTGWGRLS-EGGSLPPVLQKVTVPIVSNEKCRSMFLRAGR 298
+ +CLP SDD G TGWG + P LQ+ ++P++SN C+ +
Sbjct: 103 VSAVCLPSASDDFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWGTK-- 160
Query: 299 YEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCT 358
I D +CAG G SC GDSGGPL K K+G + L GI+SWG + PGV
Sbjct: 161 ---IKDAMICAGAS--GVSSCMGDSGGPLVCK-KNGAWTLVGIVSWGSSTCSTSTPGVYA 214
Query: 359 RISKFVPWVLDT 370
R++ V WV T
Sbjct: 215 RVTALVNWVQQT 226
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 112 bits (279), Expect = 5e-25, Method: Compositional matrix adjust.
Identities = 69/189 (36%), Positives = 102/189 (53%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN TY D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S S A +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSFII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+D+CQGD+GGP+ GK L GI+SWG GCA+ N PG T++
Sbjct: 157 TSNMF-CAGYLEGGKDACQGDAGGPVVCSGK-----LQGIVSWGSGCAQKNKPGFYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 112 bits (279), Expect = 5e-25, Method: Compositional matrix adjust.
Identities = 72/202 (35%), Positives = 108/202 (53%), Gaps = 23/202 (11%)
Query: 176 SVNSLLTSQIKIRVGEYDFSKLEEPYPYQER--GVVKKMVHPKYNFFTYEYDLALVRLET 233
V L T ++++R E+ YQ++ V + +VHP++ D+AL+ LE
Sbjct: 49 DVKDLATLRVQLR---------EQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEE 99
Query: 234 PVEFAPNIVPICLP-GSDDLLIGENATVTGWGRLSEGGSLPPV--LQKVTVPIVSNEKCR 290
PV + + + LP S+ G VTGWG + LPP L++V VPI+ N C
Sbjct: 100 PVNISSRVHTVMLPPASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICD 159
Query: 291 SMFLRAGRY-----EFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWG 345
+ + G Y I D +CAG N RDSC+GDSGGPL K +G + AG++SWG
Sbjct: 160 AKY-HLGAYTGDDVRIIRDDMLCAG--NSQRDSCKGDSGGPLVCK-VNGTWLQAGVVSWG 215
Query: 346 IGCAEANLPGVCTRISKFVPWV 367
GCA+ N PG+ TR++ ++ W+
Sbjct: 216 EGCAQPNRPGIYTRVTYYLDWI 237
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 111 bits (278), Expect = 6e-25, Method: Compositional matrix adjust.
Identities = 66/192 (34%), Positives = 94/192 (48%), Gaps = 12/192 (6%)
Query: 181 LTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPN 240
+T+ + GE+D E Q+ + K + KYN T D+ L++L T F+
Sbjct: 60 VTTSDVVVAGEFDQGSSSEKI--QKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQT 117
Query: 241 IVPICLP-GSDDLLIGENATVTGWGRLS-EGGSLPPVLQKVTVPIVSNEKCRSMFLRAGR 298
+ +CLP SDD G TGWG + P LQ+ ++P++SN C+ +
Sbjct: 118 VSAVCLPSASDDFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWGTK-- 175
Query: 299 YEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCT 358
I D +CAG G SC GDSGGPL K K+G + L GI+SWG + PGV
Sbjct: 176 ---IKDAMICAGAS--GVSSCMGDSGGPLVCK-KNGAWTLVGIVSWGSSTCSTSTPGVYA 229
Query: 359 RISKFVPWVLDT 370
R++ V WV T
Sbjct: 230 RVTALVNWVQQT 241
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 111 bits (278), Expect = 7e-25, Method: Compositional matrix adjust.
Identities = 69/189 (36%), Positives = 102/189 (53%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN TY D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S S A +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSFII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F CAG+ GG+D+CQGD+GGP+ GK L GI+SWG GCA+ N PG T++
Sbjct: 157 TSNMF-CAGYLEGGKDACQGDAGGPVVCSGK-----LQGIVSWGEGCAQKNKPGFYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 111 bits (278), Expect = 7e-25, Method: Compositional matrix adjust.
Identities = 66/194 (34%), Positives = 110/194 (56%), Gaps = 16/194 (8%)
Query: 186 KIRVGEYDFSKLEEPY-------PYQ--ERGVVKKMVHPKYNFFTYE--YDLALVRLETP 234
K+R+GE++ + + Y P + + G+ + + HP Y + + +D+AL+RL
Sbjct: 83 KVRLGEWNTATDPDCYGAVRVCVPDKPIDLGIEETIQHPDYVDGSKDRYHDIALIRLNRQ 142
Query: 235 VEFAPNIVPICLPG-SDDLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMF 293
VEF I P+CLP ++++ +G+ TV GWGR +E G + QK+ VP+V E+C F
Sbjct: 143 VEFTNYIRPVCLPQPNEEVQVGQRLTVVGWGR-TETGQYSTIKQKLAVPVVHAEQCAKTF 201
Query: 294 LRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANL 353
AG + +CAG + +DSC GDSGGPL + + ++FL G++S+G C
Sbjct: 202 GAAGVR--VRSSQLCAGGEKA-KDSCGGDSGGPLLAERANQQFFLEGLVSFGATCGTEGW 258
Query: 354 PGVCTRISKFVPWV 367
PG+ T++ K+ W+
Sbjct: 259 PGIYTKVGKYRDWI 272
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 111 bits (278), Expect = 7e-25, Method: Compositional matrix adjust.
Identities = 69/192 (35%), Positives = 107/192 (55%), Gaps = 15/192 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S+I++R+GE++ LE + K + HP +N T + D+ L++L +P +
Sbjct: 47 SRIQVRLGEHNIDVLEGNEQFIN--AAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVA 104
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQ-KVTVPIVSNEKCRSMFLRAGRYE 300
+ LP S E + ++GWG S G S P +LQ + P++S+ C+S + G+
Sbjct: 105 TVSLPRSCAAAGTECSLISGWGNTKSSGSSYPSLLQCSLKAPVLSDSSCKSSY--PGQ-- 160
Query: 301 FISDIFMCAGFDNGGRDSC-QGDSGGPLQVKGKDGRYFLAGIISWGIGC-AEANLPGVCT 358
I+ +C GF GG+DSC QGDSGGP V +G+ L GI+SWG GC A+ N PGV T
Sbjct: 161 -ITGNMICVGFLEGGKDSCSQGDSGGP--VVCSNGQ--LQGIVSWGYGCSAQKNKPGVYT 215
Query: 359 RISKFVPWVLDT 370
++ +V W+ T
Sbjct: 216 KVCNYVNWIQQT 227
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 110 bits (276), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 69/189 (36%), Positives = 101/189 (53%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN TY D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSETYNNDIMLIKLKSAASLXSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S S A +
Sbjct: 102 SISLPTSCASA-GTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSFII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F C G+ GG+D+CQGDSGGP+ GK L GI+SWG GCA+ N PG T++
Sbjct: 157 TSNMF-CVGYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGEGCAQKNKPGFYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 110 bits (276), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 65/168 (38%), Positives = 96/168 (57%), Gaps = 12/168 (7%)
Query: 208 VVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLP-GSDDLLIGENATVTGWGRL 266
V + +VHP++ D+AL+ LE PV+ + ++ + LP S+ G VTGWG +
Sbjct: 74 VSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDV 133
Query: 267 SEGGSLPPV--LQKVTVPIVSNEKCRSMFLRAGRY-----EFISDIFMCAGFDNGGRDSC 319
LPP L++V VPI+ N C + + G Y + D +CAG N RDSC
Sbjct: 134 DNDERLPPPFPLKQVKVPIMENHICDAKY-HLGAYTGDDVRIVRDDMLCAG--NTRRDSC 190
Query: 320 QGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
QGDSGGPL K +G + AG++SWG GCA+ N PG+ TR++ ++ W+
Sbjct: 191 QGDSGGPLVCK-VNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWI 237
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 110 bits (276), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 69/189 (36%), Positives = 101/189 (53%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I++R+GE + + +E + K +VHP YN TY D+ L++L++ +
Sbjct: 44 SGIQVRLGEDNINVVEGNEQFISAS--KSIVHPSYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 243 PICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
I LP S G ++GWG S G S P VL+ + PI+S S A +
Sbjct: 102 SISLPTSC-ASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILS----DSSCKSASSFII 156
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
S++F C G+ GG+D+CQGDSGGP+ GK L GI+SWG GCA+ N PG T++
Sbjct: 157 TSNMF-CVGYLEGGKDACQGDSGGPVVCSGK-----LQGIVSWGEGCAQKNKPGFYTKVC 210
Query: 362 KFVPWVLDT 370
+V W+ T
Sbjct: 211 NYVSWIKQT 219
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 110 bits (276), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 65/168 (38%), Positives = 96/168 (57%), Gaps = 12/168 (7%)
Query: 208 VVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLP-GSDDLLIGENATVTGWGRL 266
V + +VHP++ D+AL+ LE PV+ + ++ + LP S+ G VTGWG +
Sbjct: 74 VSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDV 133
Query: 267 SEGGSLPPV--LQKVTVPIVSNEKCRSMFLRAGRY-----EFISDIFMCAGFDNGGRDSC 319
LPP L++V VPI+ N C + + G Y + D +CAG N RDSC
Sbjct: 134 DNDERLPPPFPLKQVKVPIMENHICDAKY-HLGAYTGDDVRIVRDDMLCAG--NTRRDSC 190
Query: 320 QGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
QGDSGGPL K +G + AG++SWG GCA+ N PG+ TR++ ++ W+
Sbjct: 191 QGDSGGPLVCK-VNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWI 237
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 110 bits (276), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 65/168 (38%), Positives = 96/168 (57%), Gaps = 12/168 (7%)
Query: 208 VVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLP-GSDDLLIGENATVTGWGRL 266
V + +VHP++ D+AL+ LE PV+ + ++ + LP S+ G VTGWG +
Sbjct: 74 VSRIIVHPQFYTAQIGADIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWGDV 133
Query: 267 SEGGSLPPV--LQKVTVPIVSNEKCRSMFLRAGRY-----EFISDIFMCAGFDNGGRDSC 319
LPP L++V VPI+ N C + + G Y + D +CAG N RDSC
Sbjct: 134 DNDERLPPPFPLKQVKVPIMENHICDAKY-HLGAYTGDDVRIVRDDMLCAG--NTRRDSC 190
Query: 320 QGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
QGDSGGPL K +G + AG++SWG GCA+ N PG+ TR++ ++ W+
Sbjct: 191 QGDSGGPLVCK-VNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWI 237
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 110 bits (275), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 67/225 (29%), Positives = 109/225 (48%), Gaps = 14/225 (6%)
Query: 146 RPYVKPLKESLGRPVNVYSNNEKVDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQE 205
+ Y +P + SL + + V++ S S++++R+GE++ E +
Sbjct: 8 KAYSQPHQVSLNSGYH-FCGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKVTEGSEQFIS 66
Query: 206 RGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR 265
V + HP Y+ + + D+ L++L P + P+ LP S G TV+GWG
Sbjct: 67 SSRVIR--HPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALP-SSCAPAGTMCTVSGWGN 123
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ LQ + +PI+S C + + I++ CAG+ GG+DSCQGDSGG
Sbjct: 124 TMSSTADKNKLQCLNIPILSYSDCNNSYPG-----MITNAMFCAGYLEGGKDSCQGDSGG 178
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDT 370
P+ G+ L G++SWG GCAE PGV ++ F W+ T
Sbjct: 179 PVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 218
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 110 bits (274), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 14/225 (6%)
Query: 146 RPYVKPLKESLGRPVNVYSNNEKVDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQE 205
+ Y +P + SL + + V++ S S++ +R+GE++ E +
Sbjct: 8 KAYSQPHQVSLNSGYH-FCGGSLVNENWVVSAAHCYKSRVAVRLGEHNIKVTEGSEQFIS 66
Query: 206 RGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR 265
V + HP Y+ + + D+ L++L P + P+ LP S G TV+GWG
Sbjct: 67 SSRVIR--HPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALP-SSCAPAGTMCTVSGWGN 123
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ LQ + +PI+S C + + I++ CAG+ GG+DSCQGDSGG
Sbjct: 124 TMSSTADGDKLQCLNIPILSYSDCNNSYPG-----MITNAMFCAGYLEGGKDSCQGDSGG 178
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDT 370
P+ G+ L G++SWG GCAE PGV ++ F W+ T
Sbjct: 179 PVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 218
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 109 bits (273), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 71/202 (35%), Positives = 107/202 (52%), Gaps = 23/202 (11%)
Query: 176 SVNSLLTSQIKIRVGEYDFSKLEEPYPYQER--GVVKKMVHPKYNFFTYEYDLALVRLET 233
V L T ++++R E+ YQ++ V + +VHP++ D+AL+ LE
Sbjct: 49 DVKDLATLRVQLR---------EQHLYYQDQLLPVSRIIVHPQFYIIQTGADIALLELEE 99
Query: 234 PVEFAPNIVPICLP-GSDDLLIGENATVTGWGRLSEGGSLPPV--LQKVTVPIVSNEKCR 290
PV + + + LP S+ G VTGWG + LPP L++V VPI+ N C
Sbjct: 100 PVNISSRVHTVMLPPASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICD 159
Query: 291 SMFLRAGRY-----EFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWG 345
+ + G Y I D +CAG N RDSC+GDSGGPL K +G + AG++SW
Sbjct: 160 AKY-HLGAYTGDDVRIIRDDMLCAG--NSQRDSCKGDSGGPLVCK-VNGTWLQAGVVSWD 215
Query: 346 IGCAEANLPGVCTRISKFVPWV 367
GCA+ N PG+ TR++ ++ W+
Sbjct: 216 EGCAQPNRPGIYTRVTYYLDWI 237
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 109 bits (273), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 67/225 (29%), Positives = 109/225 (48%), Gaps = 14/225 (6%)
Query: 146 RPYVKPLKESLGRPVNVYSNNEKVDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQE 205
+ Y +P + SL + + V++ S S++++R+GE++ E +
Sbjct: 8 KAYSQPHQVSLNSGYH-FCGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKVTEGSEQFIS 66
Query: 206 RGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR 265
V + HP Y+ + + D+ L++L P + P+ LP S G TV+GWG
Sbjct: 67 SSRVIR--HPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALPTSC-APAGTMCTVSGWGN 123
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ LQ + +PI+S C + + I++ CAG+ GG+DSCQGDSGG
Sbjct: 124 TMSSTADSNKLQCLNIPILSYSDCNNSYPG-----MITNAMFCAGYLEGGKDSCQGDSGG 178
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDT 370
P+ G+ L G++SWG GCAE PGV ++ F W+ T
Sbjct: 179 PVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 218
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 109 bits (272), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 66/225 (29%), Positives = 109/225 (48%), Gaps = 14/225 (6%)
Query: 146 RPYVKPLKESLGRPVNVYSNNEKVDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQE 205
+ Y +P + SL + + V++ S +++++R+GE++ E +
Sbjct: 8 KAYSQPHQVSLNSGYH-FCGGSLVNENWVVSAAHCYKTRVEVRLGEHNIKVTEGSEQFIS 66
Query: 206 RGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR 265
V + HP Y+ + + D+ L++L P + P+ LP S G TV+GWG
Sbjct: 67 SSRVIR--HPNYSSYNIDNDIMLIKLSKPATLNTYVQPVALP-SSCAPAGTMCTVSGWGN 123
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ LQ + +PI+S C + + I++ CAG+ GG+DSCQGDSGG
Sbjct: 124 TMSSTADKNKLQCLNIPILSYSDCNNSYPG-----MITNAMFCAGYLEGGKDSCQGDSGG 178
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDT 370
P+ G+ L G++SWG GCAE PGV ++ F W+ T
Sbjct: 179 PVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFNNWLTST 218
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 108 bits (271), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 63/196 (32%), Positives = 103/196 (52%), Gaps = 18/196 (9%)
Query: 182 TSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNI 241
+ ++ +R+GEYD + E+ + + + VHP Y+ T + D+AL+ L P + I
Sbjct: 47 SKKLLVRLGEYDLRRWEKWE--LDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTI 104
Query: 242 VPICLPGS-----DDLLIGENATVTGWGRLSEGGSLPP-----VLQKVTVPIVSNEKCRS 291
VPICLP S + G+ VTGWG S VL + +P+V + +C
Sbjct: 105 VPICLPDSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSE 164
Query: 292 MFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEA 351
+ +S+ +CAG +D+C+GDSGGP+ V G +FL G++SWG GC
Sbjct: 165 VM-----SNMVSENMLCAGILGDRQDACEGDSGGPM-VASFHGTWFLVGLVSWGEGCGLL 218
Query: 352 NLPGVCTRISKFVPWV 367
+ GV T++S+++ W+
Sbjct: 219 HNYGVYTKVSRYLDWI 234
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 108 bits (271), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 63/196 (32%), Positives = 103/196 (52%), Gaps = 18/196 (9%)
Query: 182 TSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNI 241
+ ++ +R+GEYD + E+ + + + VHP Y+ T + D+AL+ L P + I
Sbjct: 47 SKKLLVRLGEYDLRRWEKWE--LDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTI 104
Query: 242 VPICLPGS-----DDLLIGENATVTGWGRLSEGGSLPP-----VLQKVTVPIVSNEKCRS 291
VPICLP S + G+ VTGWG S VL + +P+V + +C
Sbjct: 105 VPICLPDSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSE 164
Query: 292 MFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEA 351
+ +S+ +CAG +D+C+GDSGGP+ V G +FL G++SWG GC
Sbjct: 165 VM-----SNMVSENMLCAGILGDRQDACEGDSGGPM-VASFHGTWFLVGLVSWGEGCGLL 218
Query: 352 NLPGVCTRISKFVPWV 367
+ GV T++S+++ W+
Sbjct: 219 HNYGVYTKVSRYLDWI 234
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 108 bits (271), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 61/188 (32%), Positives = 95/188 (50%), Gaps = 13/188 (6%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S++++R+GE++ E + V + HP Y+ + + D+ L++L P +
Sbjct: 44 SRVEVRLGEHNIKVTEGSEQFISSSRVIR--HPNYSSYNIDNDIMLIKLSKPATLNTYVQ 101
Query: 243 PICLPGSDDLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFI 302
P+ LP S G TV+GWG + LQ + +PI+S C + I
Sbjct: 102 PVALPTSC-APAGTMCTVSGWGNTMSSTADSDKLQCLNIPILSYSDCNDSYPG-----MI 155
Query: 303 SDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISK 362
++ CAG+ GG+DSCQGDSGGP+ G+ L G++SWG GCAE PGV ++
Sbjct: 156 TNAMFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCI 210
Query: 363 FVPWVLDT 370
F W+ T
Sbjct: 211 FSDWLTST 218
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 108 bits (270), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 68/190 (35%), Positives = 101/190 (53%), Gaps = 22/190 (11%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S K+ +G + LE P+ QE V + + P D+AL++L +P ++
Sbjct: 67 SSYKVILGAHQEVNLE-PH-VQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVI 118
Query: 243 PICLPGSDDLLIGENAT-VTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P CLP + ++ +TGWG ++G +L++ +P++ N+ C RYEF
Sbjct: 119 PACLPSPNYMVADRTECFITGWGE-TQGTFGAGLLKEAQLPVIENKVCN-------RYEF 170
Query: 302 ----ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
+ +CAG GG DSCQGDSGGPL KD +Y L G+ SWG+GCA N PGV
Sbjct: 171 LNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVY 229
Query: 358 TRISKFVPWV 367
R+S+FV W+
Sbjct: 230 VRVSRFVTWI 239
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 108 bits (270), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 61/188 (32%), Positives = 96/188 (51%), Gaps = 13/188 (6%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S++++R+GE++ E + V + HP Y+ + + D+ L++L P +
Sbjct: 59 SRVEVRLGEHNIKVTEGSEQFISSSRVIR--HPNYSSYNIDNDIMLIKLSKPATLNTYVQ 116
Query: 243 PICLPGSDDLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFI 302
P+ LP S G TV+GWG + LQ + +PI+S C + + I
Sbjct: 117 PVALPTSC-APAGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPG-----MI 170
Query: 303 SDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISK 362
++ CAG+ GG+DSCQGDSGGP+ G+ L G++SWG GCAE PGV ++
Sbjct: 171 TNAMFCAGYLEGGKDSCQGDSGGPVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCI 225
Query: 363 FVPWVLDT 370
F W+ T
Sbjct: 226 FNDWLTST 233
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 108 bits (270), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 70/209 (33%), Positives = 111/209 (53%), Gaps = 19/209 (9%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 52 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 109
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR- 290
F+ I P+CLP + L G VTGWG L E P VLQ V +PIV C+
Sbjct: 110 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWGQPSVLQVVNLPIVERPVCKD 169
Query: 291 SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGI 346
S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI+SWG
Sbjct: 170 STRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 223
Query: 347 GCAEANLPGVCTRISKFVPWVLDTGDSGG 375
GC G T + + W+ D G
Sbjct: 224 GCDRDGKYGFYTHVFRLKKWIQKVIDQFG 252
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 108 bits (270), Expect = 6e-24, Method: Compositional matrix adjust.
Identities = 72/215 (33%), Positives = 113/215 (52%), Gaps = 25/215 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 52 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 109
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 110 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 169
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ G
Sbjct: 170 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 223
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
I+SWG GC PG T + + W+ D G
Sbjct: 224 IVSWGEGCDRDGKPGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 108 bits (270), Expect = 6e-24, Method: Compositional matrix adjust.
Identities = 67/157 (42%), Positives = 85/157 (54%), Gaps = 12/157 (7%)
Query: 213 VHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGS-DDLLIGENATVTGWGRLSEGGS 271
VHP Y+ DLA+++L T + NI L S D + G +ATV GWG SEGGS
Sbjct: 74 VHPSYS--GNNNDLAILKLSTSIPSGGNIGYARLAASGSDPVAGSSATVAGWGATSEGGS 131
Query: 272 LPPV-LQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVK 330
PV L KVTVPIVS CR+ + I++ CAG +GG+DSCQGDSGGP+
Sbjct: 132 STPVNLLKVTVPIVSRATCRAQY----GTSAITNQMFCAGVSSGGKDSCQGDSGGPI--- 184
Query: 331 GKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
D L G +SWG GCA N GV + ++
Sbjct: 185 -VDSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 108 bits (270), Expect = 6e-24, Method: Compositional matrix adjust.
Identities = 67/157 (42%), Positives = 85/157 (54%), Gaps = 12/157 (7%)
Query: 213 VHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGS-DDLLIGENATVTGWGRLSEGGS 271
VHP Y+ DLA+++L T + NI L S D + G +ATV GWG SEGGS
Sbjct: 74 VHPSYS--GNNNDLAILKLSTSIPSGGNIGYARLAASGSDPVAGSSATVAGWGATSEGGS 131
Query: 272 LPPV-LQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVK 330
PV L KVTVPIVS CR+ + I++ CAG +GG+DSCQGDSGGP+
Sbjct: 132 STPVNLLKVTVPIVSRATCRAQY----GTSAITNQMFCAGVSSGGKDSCQGDSGGPI--- 184
Query: 331 GKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
D L G +SWG GCA N GV + ++
Sbjct: 185 -VDSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 108 bits (269), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 68/190 (35%), Positives = 101/190 (53%), Gaps = 22/190 (11%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S K+ +G + LE P+ QE V + + P D+AL++L +P ++
Sbjct: 71 SSYKVILGAHQEVNLE-PH-VQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVI 122
Query: 243 PICLPGSDDLLIGENAT-VTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P CLP + ++ +TGWG ++G +L++ +P++ N+ C RYEF
Sbjct: 123 PACLPSPNYVVADRTECFITGWGE-TQGTFGAGLLKEAQLPVIENKVCN-------RYEF 174
Query: 302 ----ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
+ +CAG GG DSCQGDSGGPL KD +Y L G+ SWG+GCA N PGV
Sbjct: 175 LNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVY 233
Query: 358 TRISKFVPWV 367
R+S+FV W+
Sbjct: 234 VRVSRFVTWI 243
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 108 bits (269), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 68/190 (35%), Positives = 101/190 (53%), Gaps = 22/190 (11%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S K+ +G + LE P+ QE V + + P D+AL++L +P ++
Sbjct: 68 SSYKVILGAHQEVNLE-PH-VQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVI 119
Query: 243 PICLPGSDDLLIGENAT-VTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P CLP + ++ +TGWG ++G +L++ +P++ N+ C RYEF
Sbjct: 120 PACLPSPNYVVADRTECFITGWGE-TQGTFGAGLLKEAQLPVIENKVCN-------RYEF 171
Query: 302 ----ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
+ +CAG GG DSCQGDSGGPL KD +Y L G+ SWG+GCA N PGV
Sbjct: 172 LNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVY 230
Query: 358 TRISKFVPWV 367
R+S+FV W+
Sbjct: 231 VRVSRFVTWI 240
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 107 bits (268), Expect = 9e-24, Method: Compositional matrix adjust.
Identities = 58/148 (39%), Positives = 85/148 (57%), Gaps = 14/148 (9%)
Query: 225 DLALVRLETPVEFAPNIVPICLPGSDDLLIGENAT-VTGWGRLSEGGSLPPVLQKVTVPI 283
D+AL++L +P ++P CLP + ++ +TGWG ++G +L++ +P+
Sbjct: 646 DIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGE-TQGTFGAGLLKEAQLPV 704
Query: 284 VSNEKCRSMFLRAGRYEF----ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLA 339
+ N+ C RYEF + +CAG GG DSCQGDSGGPL KD +Y L
Sbjct: 705 IENKVC-------NRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQ 756
Query: 340 GIISWGIGCAEANLPGVCTRISKFVPWV 367
G+ SWG+GCA N PGV R+S+FV W+
Sbjct: 757 GVTSWGLGCARPNKPGVYVRVSRFVTWI 784
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 107 bits (268), Expect = 9e-24, Method: Compositional matrix adjust.
Identities = 71/209 (33%), Positives = 112/209 (53%), Gaps = 20/209 (9%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 52 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 109
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR- 290
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV C+
Sbjct: 110 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKEKGQ-PSVLQVVNLPIVERPVCKD 168
Query: 291 SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGI 346
S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI+SWG
Sbjct: 169 STRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 222
Query: 347 GCAEANLPGVCTRISKFVPWVLDTGDSGG 375
GC G T + + W+ D G
Sbjct: 223 GCDRDGKYGFYTHVFRLKKWIQKVIDQFG 251
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 107 bits (268), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 68/190 (35%), Positives = 100/190 (52%), Gaps = 22/190 (11%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S K+ +G + LE P+ QE V + + P D+AL++L +P ++
Sbjct: 68 SSYKVILGAHQEVNLE-PH-VQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVI 119
Query: 243 PICLPGSDDLLIGENAT-VTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P CLP + ++ +TGWG ++G +L + +P++ N+ C RYEF
Sbjct: 120 PACLPSPNYVVADRTECFITGWGE-TQGTFGAGLLMEAQLPVIENKVCN-------RYEF 171
Query: 302 ----ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
+ +CAG GG DSCQGDSGGPL KD +Y L G+ SWG+GCA N PGV
Sbjct: 172 LNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVY 230
Query: 358 TRISKFVPWV 367
R+S+FV W+
Sbjct: 231 VRVSRFVTWI 240
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 107 bits (268), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 71/200 (35%), Positives = 109/200 (54%), Gaps = 20/200 (10%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR-SMFLRAGRY 299
CLP + L G VTGWG L E G P VLQ V +PIV C+ S +R
Sbjct: 119 CLPDRETAASLLQAGYKGRVTGWGNLKETGQ-PSVLQVVNLPIVERPVCKDSTRIR---- 173
Query: 300 EFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCAEANLPG 355
I+D CAG+ D G R D+C+GDSGGP +K + R++ GI+SWG GC G
Sbjct: 174 --ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYG 231
Query: 356 VCTRISKFVPWVLDTGDSGG 375
T + + W+ D G
Sbjct: 232 FYTHVFRLKKWIQKVIDQFG 251
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 107 bits (268), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 72/206 (34%), Positives = 110/206 (53%), Gaps = 25/206 (12%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSNEKCR-SMF 293
CLP + L G VTGWG L E G P VLQ V +PIV C+ S
Sbjct: 119 CLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTR 178
Query: 294 LRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCA 349
+R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI+SWG GCA
Sbjct: 179 IR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCA 232
Query: 350 EANLPGVCTRISKFVPWVLDTGDSGG 375
G T + + W+ D G
Sbjct: 233 RKGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 66/225 (29%), Positives = 108/225 (48%), Gaps = 14/225 (6%)
Query: 146 RPYVKPLKESLGRPVNVYSNNEKVDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQE 205
+ Y +P + SL + + V++ S S++++R+GE++ E +
Sbjct: 8 KAYSQPHQVSLNSGYH-FCGGSLVNENWVVSAAHCYKSRVEVRLGEHNIKVTEGSEQFIS 66
Query: 206 RGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGR 265
V + HP Y+ + + D+ L++L + P+ LP S G TV+GWG
Sbjct: 67 SSRVIR--HPNYSSYNIDNDIMLIKLSKSATLNTYVQPVALP-SSCAPAGTMCTVSGWGN 123
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ LQ + +PI+S C + + I++ CAG+ GG+DSCQGDSGG
Sbjct: 124 TMSSTADKNKLQCLNIPILSYSDCNNSYPG-----MITNAMFCAGYLEGGKDSCQGDSGG 178
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDT 370
P+ G+ L G++SWG GCAE PGV ++ F W+ T
Sbjct: 179 PVVCNGE-----LQGVVSWGYGCAEPGNPGVYAKVCIFNDWLTST 218
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 67/190 (35%), Positives = 101/190 (53%), Gaps = 22/190 (11%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S K+ +G + LE P+ QE V + + P D+AL++L +P ++
Sbjct: 71 SSYKVILGAHQEVNLE-PH-VQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVI 122
Query: 243 PICLPGSDDLLIGENAT-VTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P CLP + ++ +TGWG ++G +L++ +P++ N+ C RYEF
Sbjct: 123 PACLPSPNYVVADRTECFITGWGE-TQGTFGAGLLKEAQLPVIENKVCN-------RYEF 174
Query: 302 ----ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
+ +CAG GG DSCQGD+GGPL KD +Y L G+ SWG+GCA N PGV
Sbjct: 175 LNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVY 233
Query: 358 TRISKFVPWV 367
R+S+FV W+
Sbjct: 234 VRVSRFVTWI 243
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 67/190 (35%), Positives = 101/190 (53%), Gaps = 22/190 (11%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S K+ +G + LE P+ QE V + + P D+AL++L +P ++
Sbjct: 68 SSYKVILGAHQEVNLE-PH-VQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVI 119
Query: 243 PICLPGSDDLLIGENAT-VTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P CLP + ++ +TGWG ++G +L++ +P++ N+ C RYEF
Sbjct: 120 PACLPSPNYVVADRTECFITGWGE-TQGTFGAGLLKEAQLPVIENKVCN-------RYEF 171
Query: 302 ----ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
+ +CAG GG DSCQGD+GGPL KD +Y L G+ SWG+GCA N PGV
Sbjct: 172 LNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVY 230
Query: 358 TRISKFVPWV 367
R+S+FV W+
Sbjct: 231 VRVSRFVTWI 240
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 107 bits (267), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 67/190 (35%), Positives = 101/190 (53%), Gaps = 22/190 (11%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S K+ +G + LE P+ QE V + + P D+AL++L +P ++
Sbjct: 70 SSYKVILGAHQEVNLE-PH-VQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVI 121
Query: 243 PICLPGSDDLLIGENAT-VTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P CLP + ++ +TGWG ++G +L++ +P++ N+ C RYEF
Sbjct: 122 PACLPSPNYVVADRTECFITGWGE-TQGTFGAGLLKEAQLPVIENKVCN-------RYEF 173
Query: 302 ----ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
+ +CAG GG DSCQGD+GGPL KD +Y L G+ SWG+GCA N PGV
Sbjct: 174 LNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVY 232
Query: 358 TRISKFVPWV 367
R+S+FV W+
Sbjct: 233 VRVSRFVTWI 242
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 107 bits (266), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 67/190 (35%), Positives = 101/190 (53%), Gaps = 22/190 (11%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S K+ +G + LE P+ QE V + + P D+AL++L +P ++
Sbjct: 69 SSYKVILGAHQEVNLE-PH-VQEIEVSRLFLEPTRK------DIALLKLSSPAVITDKVI 120
Query: 243 PICLPGSDDLLIGENAT-VTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P CLP + ++ +TGWG ++G +L++ +P++ N+ C RYEF
Sbjct: 121 PACLPSPNYVVADRTECFITGWGE-TQGTFGAGLLKEAQLPVIENKVCN-------RYEF 172
Query: 302 ----ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
+ +CAG GG DSCQGD+GGPL KD +Y L G+ SWG+GCA N PGV
Sbjct: 173 LNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWGLGCARPNKPGVY 231
Query: 358 TRISKFVPWV 367
R+S+FV W+
Sbjct: 232 VRVSRFVTWI 241
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 106 bits (265), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 72/206 (34%), Positives = 109/206 (52%), Gaps = 25/206 (12%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSNEKCR-SMF 293
CLP + L G VTGWG L E G P VLQ V +PIV C+ S
Sbjct: 119 CLPDRETAASLLQAGYKGRVTGWGNLKETWTTNVGKGQPSVLQVVNLPIVERPVCKDSTR 178
Query: 294 LRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCA 349
+R I+D CAG+ D G R D+CQGDSGGP +K + R++ GI+SWG GC
Sbjct: 179 IR------ITDNMFCAGYKPDEGKRGDACQGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 350 EANLPGVCTRISKFVPWVLDTGDSGG 375
G T + + W+ D G
Sbjct: 233 RDGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 106 bits (265), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 66/157 (42%), Positives = 84/157 (53%), Gaps = 12/157 (7%)
Query: 213 VHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGS-DDLLIGENATVTGWGRLSEGGS 271
VHP Y+ DLA+++L T + NI L S D + G +ATV GWG SEGGS
Sbjct: 74 VHPSYS--GNNNDLAILKLSTSIPSGGNIGYARLAASGSDPVAGSSATVAGWGATSEGGS 131
Query: 272 LPPV-LQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVK 330
PV L KVTVPIVS CR+ + I++ CAG +GG+DSCQGD GGP+
Sbjct: 132 STPVNLLKVTVPIVSRATCRAQY----GTSAITNQMFCAGVSSGGKDSCQGDXGGPI--- 184
Query: 331 GKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
D L G +SWG GCA N GV + ++
Sbjct: 185 -VDSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 106 bits (264), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 113/215 (52%), Gaps = 25/215 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 52 KNFIENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 109
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 110 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 169
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ G
Sbjct: 170 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 223
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
I+SWG GC G T + + W+ D G
Sbjct: 224 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 105 bits (263), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 71/214 (33%), Positives = 113/214 (52%), Gaps = 25/214 (11%)
Query: 179 SLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVE 236
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 53 NFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 110
Query: 237 FAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSN 286
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 111 FSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVER 170
Query: 287 EKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGI 341
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI
Sbjct: 171 PVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGI 224
Query: 342 ISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
+SWG GC + G T + + W+ D G
Sbjct: 225 VSWGEGCRDDGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 105 bits (263), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 70/207 (33%), Positives = 110/207 (53%), Gaps = 20/207 (9%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ + E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 52 KNFTENDLLVRIGKHSRTAYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 109
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR- 290
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV C+
Sbjct: 110 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETGQ-PSVLQVVNLPIVERPVCKD 168
Query: 291 SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGI 346
S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI+SWG
Sbjct: 169 STRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 222
Query: 347 GCAEANLPGVCTRISKFVPWVLDTGDS 373
GC G T + + W+ D
Sbjct: 223 GCDRDGKYGFYTHVFRLKKWIQKVIDQ 249
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 105 bits (262), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 71/206 (34%), Positives = 109/206 (52%), Gaps = 25/206 (12%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSNEKCR-SMF 293
CLP + L G VTGWG L E G P VLQ V +PIV C+ S
Sbjct: 119 CLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTR 178
Query: 294 LRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCA 349
+R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI+SWG GC
Sbjct: 179 IR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGKGCD 232
Query: 350 EANLPGVCTRISKFVPWVLDTGDSGG 375
G T + + W+ D G
Sbjct: 233 RDGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 105 bits (261), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 65/170 (38%), Positives = 89/170 (52%), Gaps = 7/170 (4%)
Query: 202 PYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLP--GSDDLLIGENAT 259
P QER V + ++H KY D+AL+++ PV P I P CLP + +
Sbjct: 78 PLQERFVEEIIIHEKYVSGLEINDIALIKITPPVPCGPFIGPGCLPQFKAGPPRAPQTCW 137
Query: 260 VTGWGRLSEGG-SLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDS 318
VTGWG L E G P LQ+ V ++ E C S GR I +CAG+ G D+
Sbjct: 138 VTGWGYLKEKGPRTSPTLQEARVALIDLELCNSTRWYNGR---IRSTNVCAGYPRGKIDT 194
Query: 319 CQGDSGGPLQVKGK-DGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
CQGDSGGPL + + + + + GI SWG+GCA A PGV T ++ W+
Sbjct: 195 CQGDSGGPLMCRDRAENTFVVVGITSWGVGCARAKRPGVYTSTWPYLNWI 244
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 105 bits (261), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 67/181 (37%), Positives = 94/181 (51%), Gaps = 8/181 (4%)
Query: 191 EYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPG-- 248
E+ +K +P P QER V K ++H KY+ + D+AL+++ PV I P CLP
Sbjct: 68 EWGTNKPVKP-PLQERYVEKIIIHEKYSASSEANDIALMKITPPVTCGHFIGPGCLPQFR 126
Query: 249 SDDLLIGENATVTGWGRLSEGGS-LPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFM 307
+ + + V GWG L E P+LQ+ V ++ C S GR I +
Sbjct: 127 AGPPRVPQTCWVAGWGFLQENARRTSPMLQEARVDLIDLGLCNSTRWYNGR---IRSTNV 183
Query: 308 CAGFDNGGRDSCQGDSGGPLQVK-GKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPW 366
CAG+ G D+CQGDSGGPL K + Y + GI SWG+GCA A PGV T ++ W
Sbjct: 184 CAGYPEGKIDTCQGDSGGPLMCKDSAENSYVVVGITSWGVGCARAKRPGVYTSTWSYLNW 243
Query: 367 V 367
+
Sbjct: 244 I 244
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 105 bits (261), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 70/206 (33%), Positives = 107/206 (51%), Gaps = 25/206 (12%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSNEKCR-SMF 293
CLP + L G VTGWG L E G P VLQ V +PIV C+ S
Sbjct: 119 CLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTR 178
Query: 294 LRAGRYEFISDIFMCAGF---DNGGRDSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCA 349
+R I+D CAGF D D+C+GDSGGP +K + R++ GI+SWG GC
Sbjct: 179 IR------ITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 350 EANLPGVCTRISKFVPWVLDTGDSGG 375
G T + + W+ D G
Sbjct: 233 RKGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 105 bits (261), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 71/206 (34%), Positives = 109/206 (52%), Gaps = 25/206 (12%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSNEKCR-SMF 293
CLP + L G VTGWG L E G P VLQ V +PIV C+ S
Sbjct: 119 CLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTR 178
Query: 294 LRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCA 349
+R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI+SWG GC
Sbjct: 179 IR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 350 EANLPGVCTRISKFVPWVLDTGDSGG 375
G T + + W+ D G
Sbjct: 233 RDGKIGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 105 bits (261), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 71/214 (33%), Positives = 112/214 (52%), Gaps = 25/214 (11%)
Query: 179 SLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVE 236
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 53 NFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 110
Query: 237 FAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSN 286
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 111 FSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVER 170
Query: 287 EKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGI 341
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI
Sbjct: 171 PVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGI 224
Query: 342 ISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
+SWG GC G T + + W+ D G
Sbjct: 225 VSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 105 bits (261), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 71/206 (34%), Positives = 109/206 (52%), Gaps = 25/206 (12%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSNEKCR-SMF 293
CLP + L G VTGWG L E G P VLQ V +PIV C+ S
Sbjct: 119 CLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTR 178
Query: 294 LRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCA 349
+R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI+SWG GC
Sbjct: 179 IR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 350 EANLPGVCTRISKFVPWVLDTGDSGG 375
G T + + W+ D G
Sbjct: 233 RDGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 105 bits (261), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 112/215 (52%), Gaps = 25/215 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 81 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 138
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 139 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 198
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ G
Sbjct: 199 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 252
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
I+SWG GC G T + + W+ D G
Sbjct: 253 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 287
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 105 bits (261), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 112/215 (52%), Gaps = 25/215 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 82 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 139
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 140 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 199
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ G
Sbjct: 200 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 253
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
I+SWG GC G T + + W+ D G
Sbjct: 254 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 288
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 105 bits (261), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 112/215 (52%), Gaps = 25/215 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 82 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 139
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 140 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 199
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ G
Sbjct: 200 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 253
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
I+SWG GC G T + + W+ D G
Sbjct: 254 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 288
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 105 bits (261), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 71/214 (33%), Positives = 112/214 (52%), Gaps = 25/214 (11%)
Query: 179 SLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVE 236
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 53 NFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 110
Query: 237 FAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSN 286
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 111 FSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVER 170
Query: 287 EKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGI 341
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI
Sbjct: 171 PVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGI 224
Query: 342 ISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
+SWG GC G T + + W+ D G
Sbjct: 225 VSWGEGCDRDGKFGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 104 bits (260), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 112/215 (52%), Gaps = 25/215 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 84 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 141
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 142 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 201
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ G
Sbjct: 202 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 255
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
I+SWG GC G T + + W+ D G
Sbjct: 256 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 290
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 104 bits (260), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 112/215 (52%), Gaps = 25/215 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 88 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 145
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 146 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 205
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ G
Sbjct: 206 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 259
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
I+SWG GC G T + + W+ D G
Sbjct: 260 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 294
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 104 bits (260), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 112/215 (52%), Gaps = 25/215 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 88 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 145
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 146 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 205
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ G
Sbjct: 206 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 259
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
I+SWG GC G T + + W+ D G
Sbjct: 260 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 294
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 104 bits (260), Expect = 9e-23, Method: Compositional matrix adjust.
Identities = 71/214 (33%), Positives = 112/214 (52%), Gaps = 25/214 (11%)
Query: 179 SLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVE 236
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 53 NFTENDLLVRIGKHSRTRYEANI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 110
Query: 237 FAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSN 286
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 111 FSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVER 170
Query: 287 EKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGI 341
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI
Sbjct: 171 PVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGI 224
Query: 342 ISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
+SWG GC G T + + W+ D G
Sbjct: 225 VSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 104 bits (259), Expect = 9e-23, Method: Compositional matrix adjust.
Identities = 79/233 (33%), Positives = 116/233 (49%), Gaps = 35/233 (15%)
Query: 173 STESVNSLLTSQIKIRVGEYDFSKLEE----------PYPYQERGVVKKMVHPKYNFFTY 222
+ V+ L +IR+GE+ S E+ P G+ K ++H KY+
Sbjct: 161 AAHCVHGLQNDLYEIRLGEHRISTEEDCRQQGRKKKCAPPVVNVGIEKHLIHEKYDARHI 220
Query: 223 EYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENAT------VTGWGRLSEGGSLPPVL 276
+D+AL++L V F +I PICLP +D+L E A VTGWG +E GS VL
Sbjct: 221 MHDIALLKLNRSVPFQKHIKPICLPITDEL--KEKAEQISTYFVTGWG-TTENGSSSDVL 277
Query: 277 QKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGG--RDSCQGDSGGPLQVKGKD- 333
+ VP+ C + RA + +C G GG +DSC+GDSGGPLQ +
Sbjct: 278 LQANVPLQPRSACSQAYRRA-----VPLSQLCVG---GGDLQDSCKGDSGGPLQAPAQYL 329
Query: 334 GRY----FLAGIISWG-IGCAEANLPGVCTRISKFVPWVLDTGDSGGPLQVKG 381
G Y GI+S G + C + +LPG+ T + ++V W+ DT S G L+ +G
Sbjct: 330 GEYAPKMVEFGIVSQGVVTCGQISLPGLYTNVGEYVQWITDTMASNGLLESRG 382
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 104 bits (259), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 71/214 (33%), Positives = 112/214 (52%), Gaps = 25/214 (11%)
Query: 179 SLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVE 236
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 218 NFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 275
Query: 237 FAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSN 286
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 276 FSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVER 335
Query: 287 EKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGI 341
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI
Sbjct: 336 PVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGI 389
Query: 342 ISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
+SWG GC G T + + W+ D G
Sbjct: 390 VSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 423
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 104 bits (259), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 70/204 (34%), Positives = 108/204 (52%), Gaps = 25/204 (12%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSNEKCR-SMF 293
CLP + L G VTGWG L E G P VLQ V +PIV C+ S
Sbjct: 119 CLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTR 178
Query: 294 LRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCA 349
+R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI+SWG GC
Sbjct: 179 IR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 350 EANLPGVCTRISKFVPWVLDTGDS 373
G T + + W+ D
Sbjct: 233 RDGKYGFYTHVFRLKKWIQKVIDQ 256
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 104 bits (259), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 70/215 (32%), Positives = 112/215 (52%), Gaps = 25/215 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 52 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 109
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 110 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 169
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+GD+GGP +K + R++ G
Sbjct: 170 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMG 223
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
I+SWG GC G T + + W+ D G
Sbjct: 224 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 104 bits (259), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 70/215 (32%), Positives = 112/215 (52%), Gaps = 25/215 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 101 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 158
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 159 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 218
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+GD+GGP +K + R++ G
Sbjct: 219 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMG 272
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
I+SWG GC G T + + W+ D G
Sbjct: 273 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 307
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 104 bits (259), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 70/215 (32%), Positives = 112/215 (52%), Gaps = 25/215 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 53 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 110
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 111 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 170
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+GD+GGP +K + R++ G
Sbjct: 171 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMG 224
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
I+SWG GC G T + + W+ D G
Sbjct: 225 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 259
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 103 bits (258), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 70/213 (32%), Positives = 111/213 (52%), Gaps = 25/213 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 82 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 139
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 140 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 199
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ G
Sbjct: 200 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 253
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDS 373
I+SWG GC G T + + W+ D
Sbjct: 254 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQ 286
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 103 bits (258), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 71/215 (33%), Positives = 112/215 (52%), Gaps = 25/215 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 52 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 109
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 110 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGPLKETWTANVGKGQPSVLQVVNLPIVE 169
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ G
Sbjct: 170 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 223
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
I+SWG GC G T + + W+ D G
Sbjct: 224 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 103 bits (258), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 70/215 (32%), Positives = 112/215 (52%), Gaps = 25/215 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 83 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 140
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 141 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 200
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+GD+GGP +K + R++ G
Sbjct: 201 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDAGGPFVMKSPFNNRWYQMG 254
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
I+SWG GC G T + + W+ D G
Sbjct: 255 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 289
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 103 bits (258), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 57/164 (34%), Positives = 88/164 (53%), Gaps = 4/164 (2%)
Query: 205 ERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLP-GSDDLLIGENATVTGW 263
+RG+ + +VH KY +++YD++L L +PV + + +CLP S + G+ VTG+
Sbjct: 66 KRGLRRIIVHEKYKHPSHDYDISLAELSSPVPYTNAVHRVCLPDASYEFQPGDVMFVTGF 125
Query: 264 GRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
G L G L++ V ++ C + I+ +CAG G D+CQGDS
Sbjct: 126 GALKNDGYSQNHLRQAQVTLIDATTCNEP---QAYNDAITPRMLCAGSLEGKTDACQGDS 182
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL ++LAGI+SWG CA+ N PGV TR++ W+
Sbjct: 183 GGPLVSSDARDIWYLAGIVSWGDECAKPNKPGVYTRVTALRDWI 226
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 103 bits (258), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 70/204 (34%), Positives = 108/204 (52%), Gaps = 25/204 (12%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYEANI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSNEKCR-SMF 293
CLP + L G VTGWG L E G P VLQ V +PIV C+ S
Sbjct: 119 CLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTR 178
Query: 294 LRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCA 349
+R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI+SWG GC
Sbjct: 179 IR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 350 EANLPGVCTRISKFVPWVLDTGDS 373
G T + + W+ D
Sbjct: 233 RDGKYGFYTHVFRLKKWIQKVIDQ 256
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 103 bits (258), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 70/213 (32%), Positives = 111/213 (52%), Gaps = 25/213 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 84 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 141
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 142 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 201
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ G
Sbjct: 202 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 255
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDS 373
I+SWG GC G T + + W+ D
Sbjct: 256 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQ 288
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 103 bits (257), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 70/204 (34%), Positives = 108/204 (52%), Gaps = 25/204 (12%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 91 VRIGKHSRTRYEANI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 148
Query: 245 CLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSNEKCR-SMF 293
CLP + L G VTGWG L E G P VLQ V +PIV C+ S
Sbjct: 149 CLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTR 208
Query: 294 LRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCA 349
+R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI+SWG GC
Sbjct: 209 IR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 262
Query: 350 EANLPGVCTRISKFVPWVLDTGDS 373
G T + + W+ D
Sbjct: 263 RDGKYGFYTHVFRLKKWIQKVIDQ 286
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 103 bits (257), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 70/206 (33%), Positives = 109/206 (52%), Gaps = 25/206 (12%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ +HP+YN+ + ++AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRNIALMKLKKPVAFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSNEKCR-SMF 293
CLP + L G VTGWG L E G P VLQ V +PIV C+ S
Sbjct: 119 CLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTR 178
Query: 294 LRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCA 349
+R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI+SWG GC
Sbjct: 179 IR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCD 232
Query: 350 EANLPGVCTRISKFVPWVLDTGDSGG 375
G T + + W+ D G
Sbjct: 233 RDGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 103 bits (257), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 60/188 (31%), Positives = 93/188 (49%), Gaps = 13/188 (6%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S +++R+GE+ E Y V + HP Y+ + D+ L++L P +
Sbjct: 44 SVLRVRLGEHHIRVNEGTEQYISSSSVIR--HPNYSSYNINNDIMLIKLTKPATLNQYVH 101
Query: 243 PICLPGSDDLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFI 302
+ LP ++ TV+GWG + LQ +++PI+S+ C + + I
Sbjct: 102 AVALP-TECAADATMCTVSGWGNTMSSVADGDKLQCLSLPILSHADCANSYPG-----MI 155
Query: 303 SDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISK 362
+ CAG+ GG+DSCQGDSGGP+ G L G++SWG GCAE + PGV ++
Sbjct: 156 TQSMFCAGYLEGGKDSCQGDSGGPVVCNG-----VLQGVVSWGYGCAERDHPGVYAKVCV 210
Query: 363 FVPWVLDT 370
WV DT
Sbjct: 211 LSGWVRDT 218
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 68/198 (34%), Positives = 103/198 (52%), Gaps = 26/198 (13%)
Query: 186 KIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYN---------FFTYEY--DLALVRLETP 234
K+ +G+ + K +EP Q R V K + HP +N F Y+Y DL L+RL P
Sbjct: 48 KVWLGKNNLFK-DEPSA-QHRFVSKAIPHPGFNMSLMRKHIRFLEYDYSNDLMLLRLSKP 105
Query: 235 VEFAPNIVPICLPGSDDLLIGENATVTGWGRLSEGG-SLPPVLQKVTVPIVSNEKCRSMF 293
+ + PI LP +++ +G +GWG ++ L V + ++ NE C
Sbjct: 106 ADITDTVKPITLP-TEEPKLGSTCLASGWGSITPTKFQFTDDLYCVNLKLLPNEDCAKAH 164
Query: 294 LRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWG-IGCAEAN 352
+ E ++D +CAG +GG+D+C+GDSGGPL G L GI SWG C E +
Sbjct: 165 I-----EKVTDAMLCAGEMDGGKDTCKGDSGGPLICDG-----VLQGITSWGHTPCGEPD 214
Query: 353 LPGVCTRISKFVPWVLDT 370
+PGV T+++KF W+ DT
Sbjct: 215 MPGVYTKLNKFTSWIKDT 232
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 70/215 (32%), Positives = 111/215 (51%), Gaps = 25/215 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 52 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 109
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 110 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 169
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+ DSGGP +K + R++ G
Sbjct: 170 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEADSGGPFVMKSPFNNRWYQMG 223
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
I+SWG GC G T + + W+ D G
Sbjct: 224 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 70/214 (32%), Positives = 112/214 (52%), Gaps = 25/214 (11%)
Query: 179 SLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVE 236
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 53 NFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVA 110
Query: 237 FAPNIVPICLPGSDD----LLIGENATVTGWGRLSEGGSL------PPVLQKVTVPIVSN 286
F+ I P+CLP + L G VTGWG L E + P VLQ V +PIV
Sbjct: 111 FSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVER 170
Query: 287 EKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGI 341
C+ S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI
Sbjct: 171 PVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGI 224
Query: 342 ISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
+SWG GC G T + + W+ D G
Sbjct: 225 VSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 103 bits (256), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 69/205 (33%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ VHP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYERNV--EKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSEGGSL------PPVLQKVTVPIVSNEKCRSMFL 294
CLP L G VTGWG L E + P VLQ V +PIV C+
Sbjct: 119 CLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCK---- 174
Query: 295 RAGRYEFISDIFMCAGF---DNGGRDSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCAE 350
A I+D CAGF D D+C+GDSGGP +K + R++ GI+SWG GC
Sbjct: 175 -ASTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDR 233
Query: 351 ANLPGVCTRISKFVPWVLDTGDSGG 375
G T + + W+ D G
Sbjct: 234 KGKYGFYTHVFRLKAWIQKVIDQFG 258
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 102 bits (255), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 69/209 (33%), Positives = 110/209 (52%), Gaps = 22/209 (10%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 52 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 109
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCR- 290
F+ I P+CLP + L G VTGWG L P VLQ V +PIV C+
Sbjct: 110 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLK---GQPSVLQVVNLPIVERPVCKD 166
Query: 291 SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGI 346
S +R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI+SWG
Sbjct: 167 STRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGE 220
Query: 347 GCAEANLPGVCTRISKFVPWVLDTGDSGG 375
GC G T + + W+ D G
Sbjct: 221 GCDRDGKYGFYTHVFRLKKWIQKVIDQFG 249
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 102 bits (253), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 70/215 (32%), Positives = 111/215 (51%), Gaps = 25/215 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 52 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 109
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 110 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 169
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CAG+ D G R D+C+ DSGGP +K + R++ G
Sbjct: 170 RPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEPDSGGPFVMKSPFNNRWYQMG 223
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
I+SWG GC G T + + W+ D G
Sbjct: 224 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 101 bits (252), Expect = 7e-22, Method: Compositional matrix adjust.
Identities = 65/194 (33%), Positives = 105/194 (54%), Gaps = 14/194 (7%)
Query: 182 TSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFT-YEYDLALVRLETPVEFAPN 240
S + IR+G +L Y V +H Y ++ D+AL++L V N
Sbjct: 48 ASALDIRMGT--LKRLSPHYTQAWSEAV--FIHEGYTHDAGFDNDIALIKLNNKVVINSN 103
Query: 241 IVPICLPGSDD---LLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAG 297
I PICLP + + + T +GWG L++ G L L V +PIV ++KC + + +
Sbjct: 104 ITPICLPRKEAESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPP 162
Query: 298 --RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQ-VKGKDGRYFLAGIISWG-IGCAEANL 353
R +++ +CAG ++GG+DSC+GDSGG L + + R+F+ GI+SWG + C EA
Sbjct: 163 YPRGSVTANM-LCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQ 221
Query: 354 PGVCTRISKFVPWV 367
GV T++ ++PW+
Sbjct: 222 YGVYTKVINYIPWI 235
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 101 bits (252), Expect = 8e-22, Method: Compositional matrix adjust.
Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ VHP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYERNV--EKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSEGGSL------PPVLQKVTVPIVSNEKCRSMFL 294
CLP L G VTGWG L E + P VLQ V +PIV C+
Sbjct: 119 CLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCK---- 174
Query: 295 RAGRYEFISDIFMCAGF---DNGGRDSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCAE 350
A I+D CAGF D D+C+GD+GGP +K + R++ GI+SWG GC
Sbjct: 175 -ASTRIRITDNMFCAGFKVNDTKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDR 233
Query: 351 ANLPGVCTRISKFVPWVLDTGDSGG 375
G T + + W+ D G
Sbjct: 234 KGKYGFYTHVFRLKRWIQKVIDQFG 258
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 101 bits (251), Expect = 8e-22, Method: Compositional matrix adjust.
Identities = 65/206 (31%), Positives = 109/206 (52%), Gaps = 18/206 (8%)
Query: 178 NSLLTSQIKIRVGEYDFSKLE---------EPYPYQERGVVKKMVHPKYNFFT-YEYDLA 227
N +LT+ + ++D S L+ P+ Y + +H Y ++ D+A
Sbjct: 193 NWVLTAAHAVYEQKHDASALDIRMGTLKRLSPH-YTQAWSEAVFIHEGYTHDAGFDNDIA 251
Query: 228 LVRLETPVEFAPNIVPICLPGSDD---LLIGENATVTGWGRLSEGGSLPPVLQKVTVPIV 284
L++L V NI PICLP + + + T +GWG L++ G L L V +PIV
Sbjct: 252 LIKLNNKVVINSNITPICLPRKEAESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIV 310
Query: 285 SNEKCRSMFLRAGRYE-FISDIFMCAGFDNGGRDSCQGDSGGPLQ-VKGKDGRYFLAGII 342
++KC + + + ++ +CAG ++GG+DSC+GDSGG L + + R+F+ GI+
Sbjct: 311 DHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIV 370
Query: 343 SWG-IGCAEANLPGVCTRISKFVPWV 367
SWG + C EA GV T++ ++PW+
Sbjct: 371 SWGSMNCGEAGQYGVYTKVINYIPWI 396
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 101 bits (251), Expect = 9e-22, Method: Compositional matrix adjust.
Identities = 69/213 (32%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 178 NSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPV 235
+ + + +R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV
Sbjct: 56 KNFTENDLLVRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPV 113
Query: 236 EFAPNIVPICLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVS 285
F+ I P+CLP + L G VTGWG L E G P VLQ V +PIV
Sbjct: 114 AFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVE 173
Query: 286 NEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAG 340
C+ S +R I+D CA + D G R D+C+GDSGGP +K + R++ G
Sbjct: 174 RPVCKDSTRIR------ITDNMFCAYYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMG 227
Query: 341 IISWGIGCAEANLPGVCTRISKFVPWVLDTGDS 373
I+SWG GC G T + + W+ D
Sbjct: 228 IVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQ 260
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 65/194 (33%), Positives = 106/194 (54%), Gaps = 14/194 (7%)
Query: 182 TSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFT-YEYDLALVRLETPVEFAPN 240
S + IR+G K P+ Y + +H Y ++ D+AL++L V N
Sbjct: 134 ASALDIRMGTL---KRLSPH-YTQAWSEAVFIHEGYTHDAGFDNDIALIKLNNKVVINSN 189
Query: 241 IVPICLPGSDD---LLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAG 297
I PICLP + + + T +GWG L++ G L L V +PIV ++KC + + +
Sbjct: 190 ITPICLPRKEAESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPP 248
Query: 298 --RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQ-VKGKDGRYFLAGIISWG-IGCAEANL 353
R +++ +CAG ++GG+DSC+GDSGG L + + R+F+ GI+SWG + C EA
Sbjct: 249 YPRGSVTANM-LCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQ 307
Query: 354 PGVCTRISKFVPWV 367
GV T++ ++PW+
Sbjct: 308 YGVYTKVINYIPWI 321
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 66/188 (35%), Positives = 94/188 (50%), Gaps = 15/188 (7%)
Query: 185 IKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPI 244
++R+G Y S + E +GV K + HP Y+ + DL L++L + ++ PI
Sbjct: 48 FRVRLGHYSLSPVYESGQQMFQGV-KSIPHPGYSHPGHSNDLMLIKLNRRIRPTKDVRPI 106
Query: 245 CLPGSDDLLIGENATVTGWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFIS 303
+ S G V+GWG S P VLQ + + ++S ++C + R I
Sbjct: 107 NV-SSHCPSAGTKCLVSGWGTTKSPQVHFPKVLQCLNISVLSQKRCEDAYPRQ-----ID 160
Query: 304 DIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWG-IGCAEANLPGVCTRISK 362
D CAG D GRDSCQGDSGGP+ G L G++SWG CA N PGV T + K
Sbjct: 161 DTMFCAG-DKAGRDSCQGDSGGPVVCNGS-----LQGLVSWGDYPCARPNRPGVYTNLCK 214
Query: 363 FVPWVLDT 370
F W+ +T
Sbjct: 215 FTKWIQET 222
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 65/193 (33%), Positives = 102/193 (52%), Gaps = 13/193 (6%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFT-YEYDLALVRLETPVEFAPN-- 240
+ + +G++ F++ + Q G+ K + + Y+ F ++DL L+RL+ +
Sbjct: 50 SVSVVLGQHFFNRTTDVT--QTFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRS 107
Query: 241 --IVPICLPGSDDLL-IGENATVTGWGRLSEGGS-LPPVLQKVTVPIVSNEKCRSMFLRA 296
+ PICLP G + GWG L E S L++ VP+V++ KC S +
Sbjct: 108 QFVQPICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYG 167
Query: 297 GRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGV 356
IS +CAG+ + D+CQGDSGGPL + K+G +L GIISWG GC + PGV
Sbjct: 168 AD---ISPNMLCAGYFDCKSDACQGDSGGPLACE-KNGVAYLYGIISWGDGCGRLHKPGV 223
Query: 357 CTRISKFVPWVLD 369
TR++ +V W+ D
Sbjct: 224 YTRVANYVDWIND 236
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 65/193 (33%), Positives = 102/193 (52%), Gaps = 13/193 (6%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFT-YEYDLALVRLETPVEFAPN-- 240
+ + +G++ F++ + Q G+ K + + Y+ F ++DL L+RL+ +
Sbjct: 50 SVSVVLGQHFFNRTTDVT--QTFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRS 107
Query: 241 --IVPICLPGSDDLL-IGENATVTGWGRLSEGGS-LPPVLQKVTVPIVSNEKCRSMFLRA 296
+ PICLP G + GWG L E S L++ VP+V++ KC S +
Sbjct: 108 QFVQPICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYG 167
Query: 297 GRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGV 356
IS +CAG+ + D+CQGDSGGPL + K+G +L GIISWG GC + PGV
Sbjct: 168 AD---ISPNMLCAGYFDCKSDACQGDSGGPLACE-KNGVAYLYGIISWGDGCGRLHKPGV 223
Query: 357 CTRISKFVPWVLD 369
TR++ +V W+ D
Sbjct: 224 YTRVANYVDWIND 236
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 100 bits (250), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 64/194 (32%), Positives = 105/194 (54%), Gaps = 14/194 (7%)
Query: 182 TSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFT-YEYDLALVRLETPVEFAPN 240
S + IR+G +L Y V +H Y ++ D+AL++L V N
Sbjct: 48 ASALDIRMGT--LKRLSPHYTQAWSEAV--FIHEGYTHDAGFDNDIALIKLNNKVVINSN 103
Query: 241 IVPICLPGSDD---LLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAG 297
I PICLP + + + T +GWG L++ G L L V +PIV ++KC + + +
Sbjct: 104 ITPICLPRKEAESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPP 162
Query: 298 --RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQ-VKGKDGRYFLAGIISWG-IGCAEANL 353
R +++ +CAG ++GG+DSC+GD+GG L + + R+F+ GI+SWG + C EA
Sbjct: 163 YPRGSVTANM-LCAGLESGGKDSCRGDAGGALVFLDSETERWFVGGIVSWGSMNCGEAGQ 221
Query: 354 PGVCTRISKFVPWV 367
GV T++ ++PW+
Sbjct: 222 YGVYTKVINYIPWI 235
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 100 bits (249), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 70/206 (33%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSNEKCR-SMF 293
CLP + L G VTGWG L E G P VLQ V +PIV C+ S
Sbjct: 119 CLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTR 178
Query: 294 LRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCA 349
+R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI+S G GC
Sbjct: 179 IR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCD 232
Query: 350 EANLPGVCTRISKFVPWVLDTGDSGG 375
G T + + W+ D G
Sbjct: 233 RDGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 100 bits (249), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 65/192 (33%), Positives = 102/192 (53%), Gaps = 13/192 (6%)
Query: 185 IKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFT-YEYDLALVRLETPVEFAPN--- 240
+ + +G++ F++ + Q G+ K + + Y+ F ++DL L+RL+ +
Sbjct: 86 VSVVLGQHFFNRTTDVT--QTFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQ 143
Query: 241 -IVPICLPGSDDLL-IGENATVTGWGRLSEGGS-LPPVLQKVTVPIVSNEKCRSMFLRAG 297
+ PICLP G + GWG L E S L++ VP+V++ KC S +
Sbjct: 144 FVQPICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGA 203
Query: 298 RYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVC 357
IS +CAG+ + D+CQGDSGGPL + K+G +L GIISWG GC + PGV
Sbjct: 204 D---ISPNMLCAGYFDCKSDACQGDSGGPLACE-KNGVAYLYGIISWGDGCGRLHKPGVY 259
Query: 358 TRISKFVPWVLD 369
TR++ +V W+ D
Sbjct: 260 TRVANYVDWIND 271
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 100 bits (248), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 69/204 (33%), Positives = 107/204 (52%), Gaps = 25/204 (12%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSNEKCR-SMF 293
CLP + L G VTGWG L E G P VLQ V +PIV C+ S
Sbjct: 119 CLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTR 178
Query: 294 LRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCA 349
+R I+D CAG+ D G R D+C+GDSGGP +K + R++ GI+S G GC
Sbjct: 179 IR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCD 232
Query: 350 EANLPGVCTRISKFVPWVLDTGDS 373
G T + + W+ D
Sbjct: 233 RDGKYGFYTHVFRLKKWIQKVIDQ 256
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 99.0 bits (245), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 69/206 (33%), Positives = 107/206 (51%), Gaps = 25/206 (12%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSE------GGSLPPVLQKVTVPIVSNEKCR-SMF 293
CLP + L G VTGWG L E G P VLQ V +PIV C+ S
Sbjct: 119 CLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTR 178
Query: 294 LRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCA 349
+R I+D CAG+ D G R D+ +GDSGGP +K + R++ GI+SWG G
Sbjct: 179 IR------ITDNMFCAGYKPDEGKRGDAAEGDSGGPFVMKSPFNNRWYQMGIVSWGEGAD 232
Query: 350 EANLPGVCTRISKFVPWVLDTGDSGG 375
G T + + W+ D G
Sbjct: 233 RDGKYGFYTHVFRLKKWIQKVIDQFG 258
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 98.2 bits (243), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 23/205 (11%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ VHP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYERNV--EKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSEGGSL------PPVLQKVTVPIVSNEKCRSMFL 294
CLP L G VTGWG L E + P VLQ V +PIV C
Sbjct: 119 CLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVC----- 173
Query: 295 RAGRYEFISDIFMCAGF---DNGGRDSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCAE 350
+A I+D CAGF D D+C+GDSGGP +K + R++ GI+S G GC
Sbjct: 174 KASTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDR 233
Query: 351 ANLPGVCTRISKFVPWVLDTGDSGG 375
G T + + W+ D G
Sbjct: 234 KGKYGFYTHVFRLKRWIQKVIDQFG 258
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 97.8 bits (242), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 57/178 (32%), Positives = 92/178 (51%), Gaps = 9/178 (5%)
Query: 195 SKLEEPYPYQERGVVKKMVHPKY---NFFTYEYDLALVRLETPVEFAPNIVPICLPGSDD 251
+ +EE + + VHP Y + +E D+AL+ LE V PN++PICLP +D
Sbjct: 61 TNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPDNDT 120
Query: 252 LL-IGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAG 310
+G V+G+G + E + L+ V +P+ + + C + R + S CAG
Sbjct: 121 FYDLGLMGYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAG 178
Query: 311 FDNGGRDSCQGDSGGPLQVKGKD-GRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
+ +D+CQGDSGG V+ + R+ GI+SWGIGC+ G T++ +V W+
Sbjct: 179 HPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTKVLNYVDWI 234
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 65/200 (32%), Positives = 105/200 (52%), Gaps = 9/200 (4%)
Query: 170 DDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALV 229
+D + + L S KI +G++ +L Q GV +HP+Y+ T+E D+ALV
Sbjct: 206 EDPTLRDSDLLSPSDFKIILGKH--WRLRSDENEQHLGVKHTTLHPQYDPNTFENDVALV 263
Query: 230 RL-ETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEK 288
L E+PV A ++PICLP G V+GWG+ P L ++ +PIV +
Sbjct: 264 ELLESPVLNA-FVMPICLPEGPQQE-GAMVIVSGWGK-QFLQRFPETLMEIEIPIVDHST 320
Query: 289 CRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKD-GRYFLAGIISWGIG 347
C+ + A + ++ +CAG GG+D+C GDSGGP+ ++ G+++L G +SWG
Sbjct: 321 CQKAY--APLKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGDD 378
Query: 348 CAEANLPGVCTRISKFVPWV 367
C + + GV + I W+
Sbjct: 379 CGKKDRYGVYSYIHHNKDWI 398
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 58/157 (36%), Positives = 77/157 (49%), Gaps = 10/157 (6%)
Query: 209 VKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSE 268
K + P + TY D AL++L P+ P + TV GWG E
Sbjct: 73 TKVLQAPGFTKETYGKDWALIKLAQPIN-----QPTLKIATTTAYNQGTFTVAGWGANRE 127
Query: 269 GGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGF-DNGGRDSCQGDSGGPL 327
GGS L K VP VS+ CRS + + +++ +CAG+ D GG D+CQGDSGGP+
Sbjct: 128 GGSQQRYLLKANVPFVSDAACRS----SSSFILVANEMICAGYPDTGGVDTCQGDSGGPM 183
Query: 328 QVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFV 364
K + GI+SWG GCA PGV T +S F
Sbjct: 184 FRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFA 220
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 57/178 (32%), Positives = 92/178 (51%), Gaps = 9/178 (5%)
Query: 195 SKLEEPYPYQERGVVKKMVHPKY---NFFTYEYDLALVRLETPVEFAPNIVPICLPGSDD 251
+ +EE + + VHP Y + +E D+AL+ LE V PN++PICLP +D
Sbjct: 150 TNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPDNDT 209
Query: 252 LL-IGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAG 310
+G V+G+G + E + L+ V +P+ + + C + R + S CAG
Sbjct: 210 FYDLGLMGYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAG 267
Query: 311 FDNGGRDSCQGDSGGPLQVKGKD-GRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
+ +D+CQGDSGG V+ + R+ GI+SWGIGC+ G T++ +V W+
Sbjct: 268 HPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTKVLNYVDWI 323
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 97.4 bits (241), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 57/178 (32%), Positives = 92/178 (51%), Gaps = 9/178 (5%)
Query: 195 SKLEEPYPYQERGVVKKMVHPKY---NFFTYEYDLALVRLETPVEFAPNIVPICLPGSDD 251
+ +EE + + VHP Y + +E D+AL+ LE V PN++PICLP +D
Sbjct: 218 TNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPDNDT 277
Query: 252 LL-IGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAG 310
+G V+G+G + E + L+ V +P+ + + C + R + S CAG
Sbjct: 278 FYDLGLMGYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAG 335
Query: 311 FDNGGRDSCQGDSGGPLQVKGKD-GRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
+ +D+CQGDSGG V+ + R+ GI+SWGIGC+ G T++ +V W+
Sbjct: 336 HPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTKVLNYVDWI 391
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 96.7 bits (239), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 9/199 (4%)
Query: 171 DFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVR 230
D + + L S KI +G++ +L Q GV +HP+Y+ T+E D+ALV
Sbjct: 52 DPTLRDSDLLSPSDFKIILGKH--WRLRSDENEQHLGVKHTTLHPQYDPNTFENDVALVE 109
Query: 231 L-ETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKC 289
L E+PV A ++PICLP G V+GWG+ P L ++ +PIV + C
Sbjct: 110 LLESPVLNA-FVMPICLPEGPQQE-GAMVIVSGWGKQFLQ-RFPETLMEIEIPIVDHSTC 166
Query: 290 RSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKD-GRYFLAGIISWGIGC 348
+ + A + ++ +CAG GG+D+C GDSGGP+ ++ G+++L G +SWG C
Sbjct: 167 QKAY--APLKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGDDC 224
Query: 349 AEANLPGVCTRISKFVPWV 367
+ + GV + I W+
Sbjct: 225 GKKDRYGVYSYIHHNKDWI 243
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 96.3 bits (238), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 56/178 (31%), Positives = 92/178 (51%), Gaps = 9/178 (5%)
Query: 195 SKLEEPYPYQERGVVKKMVHPKY---NFFTYEYDLALVRLETPVEFAPNIVPICLPGSDD 251
+ +EE + + VHP Y + +E D+AL+ LE V PN++PICLP +D
Sbjct: 150 TNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLPDNDT 209
Query: 252 LL-IGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAG 310
+G V+G+G + E + L+ V +P+ + + C + R + S CAG
Sbjct: 210 FYDLGLMGYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAG 267
Query: 311 FDNGGRDSCQGDSGGPLQVKGKD-GRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
+ +D+CQGD+GG V+ + R+ GI+SWGIGC+ G T++ +V W+
Sbjct: 268 HPSLKQDACQGDAGGVFAVRDPNTDRWVATGIVSWGIGCSRGY--GFYTKVLNYVDWI 323
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 95.9 bits (237), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 59/188 (31%), Positives = 101/188 (53%), Gaps = 17/188 (9%)
Query: 185 IKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPI 244
+++ +G+++ + E ++ VV+ ++HP Y+ +++ D+ L+RL P + + I P
Sbjct: 47 LQVFLGKHNLRQRESSQ--EQSSVVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQP- 103
Query: 245 CLPGSDDLLIGENAT-VTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFIS 303
LP D + + GWG+ ++G P +Q + +VS E+C + G+ I+
Sbjct: 104 -LPLERDCSANTTSCHILGWGKTADG-DFPDTIQCAYIHLVSREECEHAY--PGQ---IT 156
Query: 304 DIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWG-IGCAEANLPGVCTRISK 362
+CAG + G+DSCQGDSGGPL V G L G++SWG I C PGV T + +
Sbjct: 157 QNMLCAGDEKYGKDSCQGDSGGPL-VCGD----HLRGLVSWGNIPCGSKEKPGVYTNVCR 211
Query: 363 FVPWVLDT 370
+ W+ T
Sbjct: 212 YTNWIQKT 219
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 95.5 bits (236), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ ++ K+ +HP+YN+ + D+AL++L+ P+E + I P+
Sbjct: 61 VRIGKHSRTRYERKV--EKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSEGGSL------PPVLQKVTVPIVSNEKCRSMFL 294
CLP L G VTGWG E + P VLQ V +P+V C
Sbjct: 119 CLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVC----- 173
Query: 295 RAGRYEFISDIFMCAGFDNG-GR--DSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCAE 350
+A I+D CAG+ G G+ D+C+GDSGGP +K + R++ GI+SWG GC
Sbjct: 174 KASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDR 233
Query: 351 ANLPGVCTRISKFVPWVLDTGDSGG 375
G T + + W+ D G
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVIDRLG 258
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 95.1 bits (235), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 66/206 (32%), Positives = 106/206 (51%), Gaps = 25/206 (12%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ ++ K+ +HP+YN+ + D+AL++L+ P+E + I P+
Sbjct: 110 VRIGKHSRTRYERKV--EKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPV 167
Query: 245 CLPGSDD----LLIGENATVTGWGRLSEGGSL------PPVLQKVTVPIVSNEKCR-SMF 293
CLP L G VTGWG E + P VLQ V +P+V C+ S
Sbjct: 168 CLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTR 227
Query: 294 LRAGRYEFISDIFMCAGFDNG-GR--DSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCA 349
+R I+D CAG+ G G+ D+C+GDSGGP +K + R++ GI+SWG GC
Sbjct: 228 IR------ITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCD 281
Query: 350 EANLPGVCTRISKFVPWVLDTGDSGG 375
G T + + W+ D G
Sbjct: 282 RDGKYGFYTHVFRLKKWIQKVIDRLG 307
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 94.7 bits (234), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ ++ K+ +HP+YN+ + D+AL++L+ P+E + I P+
Sbjct: 61 VRIGKHSRTRYERKV--EKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSEGGSL------PPVLQKVTVPIVSNEKCRSMFL 294
CLP L G VTGWG E + P VLQ V +P+V C
Sbjct: 119 CLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVC----- 173
Query: 295 RAGRYEFISDIFMCAGFDNG-GR--DSCQGDSGGPLQVKGK-DGRYFLAGIISWGIGCAE 350
+A I+D CAG+ G G+ D+C+GDSGGP +K + R++ GI+SWG GC
Sbjct: 174 KASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDR 233
Query: 351 ANLPGVCTRISKFVPWVLDTGD 372
G T + + W+ D
Sbjct: 234 DGKYGFYTHVFRLKKWIQKVID 255
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 58/159 (36%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 209 VKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSE 268
K + P YN D AL++L P+ P + TV GWG E
Sbjct: 68 TKVLQAPGYN--GTGKDWALIKLAQPIN-----QPTLKIATTTAYNQGTFTVAGWGANRE 120
Query: 269 GGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQ 328
GGS L K VP VS+ CRS + E +++ +CAG+D GG D+CQGDSGGP+
Sbjct: 121 GGSQQRYLLKANVPFVSDAACRSAYGN----ELVANEEICAGYDTGGVDTCQGDSGGPMF 176
Query: 329 VKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
K + GI+SWG GCA GV T +S F +
Sbjct: 177 RKDNADEWIQVGIVSWGEGCARKGKYGVYTEVSTFASAI 215
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 94.0 bits (232), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 59/157 (37%), Positives = 76/157 (48%), Gaps = 12/157 (7%)
Query: 209 VKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSE 268
K + P YN D AL++L P+ P + TV GWG E
Sbjct: 68 TKVLQAPGYN--GTGKDWALIKLAQPIN-----QPTLKIATTTAYNQGTFTVAGWGANRE 120
Query: 269 GGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGF-DNGGRDSCQGDSGGPL 327
GGS L K VP VS+ CRS + E +++ +CAG+ D GG D+CQGDSGGP+
Sbjct: 121 GGSQQRYLLKANVPFVSDAACRSAYGN----ELVANEEICAGYPDTGGVDTCQGDSGGPM 176
Query: 328 QVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFV 364
K + GI+SWG GCA PGV T +S F
Sbjct: 177 FRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFA 213
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 59/157 (37%), Positives = 76/157 (48%), Gaps = 12/157 (7%)
Query: 209 VKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSE 268
K + P YN D AL++L P+ P + TV GWG E
Sbjct: 68 TKVLQAPGYN--GTGKDWALIKLAQPIN-----QPTLKIATTTAYNQGTFTVAGWGANRE 120
Query: 269 GGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGF-DNGGRDSCQGDSGGPL 327
GGS L K VP VS+ CRS + E +++ +CAG+ D GG D+CQGDSGGP+
Sbjct: 121 GGSQQRYLLKANVPFVSDAACRSAYGN----ELVANEEICAGYPDTGGVDTCQGDSGGPM 176
Query: 328 QVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFV 364
K + GI+SWG GCA PGV T +S F
Sbjct: 177 FRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFA 213
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 93.6 bits (231), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 63/194 (32%), Positives = 92/194 (47%), Gaps = 18/194 (9%)
Query: 186 KIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNF--FTYEYDLALVRLETPVEFAPNIVP 243
++ +GEYD S L+ VHP +N D+ALV+L + +
Sbjct: 65 QVVLGEYDRSVLQGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQL 124
Query: 244 ICLPGSDDLLIGENAT-VTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF- 301
LP + D+L E ++GWGRL GG LP LQ+ +P+V E C +Y++
Sbjct: 125 ANLPPAGDILPNEAPCYISGWGRLYTGGPLPDKLQEALLPVVDYEHCS-------QYDWW 177
Query: 302 ---ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISW--GIGCAEANLPGV 356
+ +CAG D R C GDSGGPL DG + + G+ S+ GC P V
Sbjct: 178 GITVKKTMVCAGGDT--RSGCDGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTV 235
Query: 357 CTRISKFVPWVLDT 370
TR+S F+ W+ +T
Sbjct: 236 FTRVSAFIDWINET 249
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 93.2 bits (230), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 54/179 (30%), Positives = 87/179 (48%), Gaps = 12/179 (6%)
Query: 194 FSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLL 253
F + E +P+ + H + Y +DL L+RL P + + V + +++
Sbjct: 65 FVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPE 124
Query: 254 IGENATVTGWGRLS-EGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFD 312
+G +GWG + E S P LQ V + I+ N++C+ ++ ++D +C G
Sbjct: 125 VGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQK-----VTDFMLCVGHL 179
Query: 313 NGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWG-IGCAEANLPGVCTRISKFVPWVLDT 370
GG+D+C GDSGGPL G L G+ SWG + C N P V R+ +V W+ DT
Sbjct: 180 EGGKDTCVGDSGGPLMCDG-----VLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDT 233
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 55/159 (34%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 209 VKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSE 268
K + P + TY D AL++L P+ P + TV GWG E
Sbjct: 68 TKVLQAPGFTKETYGKDWALIKLAQPIN-----QPTLKIATTTAYNQGTFTVAGWGANRE 122
Query: 269 GGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQ 328
GGS L K VP VS+ CRS + + +++ +CAG+D D+CQGDSGGP+
Sbjct: 123 GGSQQRYLLKANVPFVSDAACRS----SSSFILVANEMICAGYDTKQEDTCQGDSGGPMF 178
Query: 329 VKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
K + GI+SWG GCA GV T +S F +
Sbjct: 179 RKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTFASAI 217
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 92.8 bits (229), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 55/159 (34%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 209 VKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSE 268
K + P + TY D AL++L P+ P + TV GWG E
Sbjct: 73 TKVLQAPGFTKETYGKDWALIKLAQPIN-----QPTLKIATTTAYNQGTFTVAGWGANRE 127
Query: 269 GGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQ 328
GGS L K VP VS+ CRS + + +++ +CAG+D D+CQGDSGGP+
Sbjct: 128 GGSQQRYLLKANVPFVSDAACRS----SSSFILVANEMICAGYDTKQEDTCQGDSGGPMF 183
Query: 329 VKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
K + GI+SWG GCA GV T +S F +
Sbjct: 184 RKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTFASAI 222
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 92.8 bits (229), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 59/157 (37%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 209 VKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSE 268
K + P YN D AL++L P+ P + TV GWG E
Sbjct: 68 TKVLQAPGYN--GTGKDWALIKLAQPIN-----QPTLKIATTTAYNQGTFTVAGWGANRE 120
Query: 269 GGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGF-DNGGRDSCQGDSGGPL 327
GGS L K VP VS+ CRS + E +++ +CAG+ D GG D CQGDSGGP+
Sbjct: 121 GGSQQRYLLKANVPFVSDAACRSAYGN----ELVANEEICAGYPDTGGVDPCQGDSGGPM 176
Query: 328 QVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFV 364
K + GI+SWG GCA PGV T +S F
Sbjct: 177 FRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFA 213
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 63/190 (33%), Positives = 87/190 (45%), Gaps = 10/190 (5%)
Query: 186 KIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNF--FTYEYDLALVRLETPVEFAPNIVP 243
++ +GEYD S LE VHP +N D+ALV+L + +
Sbjct: 52 QVVLGEYDRSVLEGSEQVIPINAGDLFVHPLWNSNCVACGNDIALVKLSRSAQLGDKVQL 111
Query: 244 ICLPGSDDLLIGEN-ATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFI 302
LP + D+L E ++GWGRL GG LP LQ+ +P V E C +
Sbjct: 112 ANLPPAGDILPNEAPCYISGWGRLYTGGPLPDKLQQALLPTVDYEHCSQWDWWG---ITV 168
Query: 303 SDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISW--GIGCAEANLPGVCTRI 360
+CAG D R C GDSGGPL DG + + G+ S+ GC P V TR+
Sbjct: 169 KKTMVCAGGDT--RSGCNGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRV 226
Query: 361 SKFVPWVLDT 370
S F+ W+ +T
Sbjct: 227 SAFIDWIDET 236
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 92.4 bits (228), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 62/189 (32%), Positives = 95/189 (50%), Gaps = 8/189 (4%)
Query: 182 TSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNI 241
T ++ VG+ + ++E+ GV VH ++N D+AL++L VE + I
Sbjct: 50 TRTYRVAVGKNNL-EVEDEEGSLFVGVDTIHVHKRWNALLLRNDIALIKLAEHVELSDTI 108
Query: 242 VPICLPGSDDLLIGEN-ATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYE 300
CLP D LL + VTGWGRL G + LQ+ P+V + C + R
Sbjct: 109 QVACLPEKDSLLPKDYPCYVTGWGRLWTNGPIADKLQQGLQPVVDHATCSRIDWWGFR-- 166
Query: 301 FISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGI--GCAEANLPGVCT 358
+ +CAG D G +C GDSGGPL + ++G + + GI+S+G GC P V T
Sbjct: 167 -VKKTMVCAGGD-GVISACNGDSGGPLNCQLENGSWEVFGIVSFGSRRGCNTRKKPVVYT 224
Query: 359 RISKFVPWV 367
R+S ++ W+
Sbjct: 225 RVSAYIDWI 233
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 92.0 bits (227), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 62/188 (32%), Positives = 98/188 (52%), Gaps = 13/188 (6%)
Query: 186 KIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNF--FTYEYDLALVRLETPVEFAPNIVP 243
++ +G + S EP + V K +VH +N + D+AL++L +PV I
Sbjct: 54 RVVLGRHSLST-NEPGSLAVK-VSKLVVHQDWNSNQLSNGNDIALLKLASPVSLTDKIQL 111
Query: 244 ICLPGSDDLLIGENAT-VTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRY-EF 301
CLP + +L VTGWGRL G+ P +LQ+ + +V C + G +
Sbjct: 112 GCLPAAGTILPNNYVCYVTGWGRLQTNGASPDILQQGQLLVVDYATCS----KPGWWGST 167
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWG--IGCAEANLPGVCTR 359
+ +CAG D G SC GDSGGPL +G +G++ + GI+S+G +GC + P V TR
Sbjct: 168 VKTNMICAGGD-GIISSCNGDSGGPLNCQGANGQWQVHGIVSFGSSLGCNYYHKPSVFTR 226
Query: 360 ISKFVPWV 367
+S ++ W+
Sbjct: 227 VSNYIDWI 234
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 92.0 bits (227), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 56/176 (31%), Positives = 94/176 (53%), Gaps = 23/176 (13%)
Query: 212 MVHPKYNFFT-------YEYDLALVRLETPVEFAPNIVPICLPGSD---DLLIGENATVT 261
+HP + ++ D+ALVRL+ PV+ P + PICLPG+ +L+ G+ ++
Sbjct: 154 FIHPGWKLLAVPEGRTNFDNDIALVRLKDPVKMGPTVSPICLPGTSSDYNLMDGDLGLIS 213
Query: 262 GWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLR-----AGRYEFISDIFMCAGFDNGGR 316
GWGR +E L+ +P+ KC+ + + A Y F ++ +CAG + G
Sbjct: 214 GWGR-TEKRDRAVRLKAARLPVAPLRKCKEVKVEKPTADAEAYVFTPNM-ICAGGEK-GM 270
Query: 317 DSCQGDSGGPLQVKGKDG--RYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDT 370
DSC+GDSGG V+ + +++ AG++SWG C G+ TR+ +V W++ T
Sbjct: 271 DSCKGDSGGAFAVQDPNDKTKFYAAGLVSWGPQCGTY---GLYTRVKNYVDWIMKT 323
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 92.0 bits (227), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 56/164 (34%), Positives = 89/164 (54%), Gaps = 13/164 (7%)
Query: 208 VVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLS 267
VV+ ++HP Y+ +++ D+ L+RL P + + I P+ L D + + GWG+ +
Sbjct: 69 VVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLE-RDCSAQTTSCHILGWGKTA 127
Query: 268 EGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPL 327
+G P +Q + +VS E+C + G+ I+ +CAG + G+DSCQGDSGGPL
Sbjct: 128 DG-DFPDTIQCAYIHLVSREECEHAY--PGQ---ITQNMLCAGDEKYGKDSCQGDSGGPL 181
Query: 328 QVKGKDGRYFLAGIISWG-IGCAEANLPGVCTRISKFVPWVLDT 370
V G L G++SWG I C PGV T + ++ W+ T
Sbjct: 182 -VCGD----HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKT 220
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 56/164 (34%), Positives = 89/164 (54%), Gaps = 13/164 (7%)
Query: 208 VVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLS 267
VV+ ++HP Y+ +++ D+ L+RL P + + I P+ L D + + GWG+ +
Sbjct: 68 VVRAVIHPDYDAASHDQDIMLLRLARPAKLSELIQPLPLE-RDCSAQTTSCHILGWGKTA 126
Query: 268 EGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPL 327
+G P +Q + +VS E+C + G+ I+ +CAG + G+DSCQGDSGGPL
Sbjct: 127 DG-DFPDTIQCAYIHLVSREECEHAY--PGQ---ITQNMLCAGDEKYGKDSCQGDSGGPL 180
Query: 328 QVKGKDGRYFLAGIISWG-IGCAEANLPGVCTRISKFVPWVLDT 370
V G L G++SWG I C PGV T + ++ W+ T
Sbjct: 181 -VCGD----HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKT 219
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 91.3 bits (225), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 23/233 (9%)
Query: 147 PYVKPLKESLGRPVNVYSNNEKVDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQER 206
P+ +P + +L + + V D + + +R+G++ ++P QE
Sbjct: 9 PHSQPWQAALFQGERLICGGVLVGDRWVLTAAHCKKQKYSVRLGDHSLQSRDQPE--QEI 66
Query: 207 GVVKKMVHPKYNFFT---YEYDLALVRLETPVEFAPNIVPICLPGSDDLL--IGENATVT 261
V + + HP YN + +D+ L+RL+ + P+ L +L +G+ ++
Sbjct: 67 QVAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDKVKPVQLA---NLCPKVGQKCIIS 123
Query: 262 GWGRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQ 320
GWG + S + P L V I S KC + G+ I++ +CAG NG D+CQ
Sbjct: 124 GWGTVTSPQENFPNTLNCAEVKIYSQNKCERAY--PGK---ITEGMVCAGSSNGA-DTCQ 177
Query: 321 GDSGGPLQVKGKDGRYFLAGIISWGIG-CAEANLPGVCTRISKFVPWVLDTGD 372
GDSGGPL G L GI SWG C + PGV T+I ++ W+ T D
Sbjct: 178 GDSGGPLVCDG-----MLQGITSWGSDPCGKPEKPGVYTKICRYTTWIKKTMD 225
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
Length = 241
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 177 VNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEY--DLALVRLETP 234
V+ +L + I++ G + S Q V +H Y T Y D+A++ L T
Sbjct: 46 VDGVLPNNIRVIAGLWQQSDTSGT---QTANVDSYTMHENYGAGTASYSNDIAILHLATS 102
Query: 235 VEFAPNIVPICLPGSDDL-LIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMF 293
+ NI LP +++ G ++GWGR +LP +LQK ++P+++ +C +
Sbjct: 103 ISLGGNIQAAVLPANNNNDYAGTTCVISGWGRTDGTNNLPDILQKSSIPVITTAQCTAAM 162
Query: 294 LRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISW----GIGCA 349
+ G I D +C G +C GDSGGPL DG + G+ SW G+G
Sbjct: 163 VGVGGAN-IWDNHICVQDPAGNTGACNGDSGGPLNC--PDGGTRVVGVTSWVVSSGLGAC 219
Query: 350 EANLPGVCTRISKFVPWVLD 369
+ P V TR+S ++ W+ D
Sbjct: 220 LPDYPSVYTRVSAYLGWIGD 239
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 90.9 bits (224), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 60/164 (36%), Positives = 82/164 (50%), Gaps = 8/164 (4%)
Query: 207 GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENAT-VTGWGR 265
GV VH K+N F D+AL++L VE I CLP LL + VTGWGR
Sbjct: 87 GVDTIFVHEKWNSFLVRNDIALIKLAETVELGDTIQVACLPSEGSLLPQDYPCFVTGWGR 146
Query: 266 LSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
L G + LQ+ P+V C R + + +CAG D G +C GDSGG
Sbjct: 147 LYTNGPIAAELQQGLQPVVDYATCSQ---RDWWGTTVKETMVCAGGD-GVISACNGDSGG 202
Query: 326 PLQVKGKDGRYFLAGIISWGIG--CAEANLPGVCTRISKFVPWV 367
PL + DG++ + GI+S+G G C P V TR+S ++ W+
Sbjct: 203 PLNCQA-DGQWDVRGIVSFGSGLSCNTFKKPTVFTRVSAYIDWI 245
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 90.5 bits (223), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 57/187 (30%), Positives = 92/187 (49%), Gaps = 16/187 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQER-GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
++++ +G + S +P P + V++ + HP Y T ++DL L++L P +
Sbjct: 50 KVQVLLGAHSLS---QPEPSKRLYDVLRAVPHPDYQPDTIDHDLLLLQLSEKATLGPAVR 106
Query: 243 PICLPGSD-DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P+ D D+ G V GWG ++ G P LQ V +P++ C G
Sbjct: 107 PLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDG---A 163
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG-CAEANLPGVCTRI 360
I++ MCA ++ RDSC+GDSGGPL G L G++SWG C PG+ TR+
Sbjct: 164 ITERLMCA--ESNRRDSCKGDSGGPLVCGG-----VLEGVVSWGSRVCGNRKKPGIYTRV 216
Query: 361 SKFVPWV 367
+ + W+
Sbjct: 217 ASYAAWI 223
>pdb|1EPT|C Chain C, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
pdb|1AKS|B Chain B, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
Length = 98
Score = 89.0 bits (219), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 45/104 (43%), Positives = 62/104 (59%), Gaps = 10/104 (9%)
Query: 267 SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGP 326
S G S P +LQ + P++SN C+S + I+ +C GF GG+DSCQGDSGGP
Sbjct: 1 SSGSSYPSLLQCLKAPVLSNSSCKSSYPGQ-----ITGNMICVGFLQGGKDSCQGDSGGP 55
Query: 327 LQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDT 370
+ G+ L GI+SWG GCA+ N PGV T++ +V W+ T
Sbjct: 56 VVCNGQ-----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQT 94
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 88.6 bits (218), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 12/164 (7%)
Query: 212 MVHPKY--NFFTYEYDLALVRLETP----VEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
++H Y + + D+AL+++ + + + I ICLP +D G + +TG+G
Sbjct: 82 ILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG 141
Query: 265 RLSEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
+ + L P L+ V ++S+ +C+ ++ +CA DSCQGDS
Sbjct: 142 KEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSE---VTTKMLCAADPQWKTDSCQGDS 198
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL V GR L GI+SWG GCA + PGV TR+S F+PW+
Sbjct: 199 GGPL-VCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWI 241
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 88.6 bits (218), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 12/164 (7%)
Query: 212 MVHPKY--NFFTYEYDLALVRLETP----VEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
++H Y + + D+AL+++ + + + I ICLP +D G + +TG+G
Sbjct: 82 ILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG 141
Query: 265 RLSEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
+ + L P L+ V ++S+ +C+ ++ +CA DSCQGDS
Sbjct: 142 KEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSE---VTTKMLCAADPQWKTDSCQGDS 198
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL V GR L GI+SWG GCA + PGV TR+S F+PW+
Sbjct: 199 GGPL-VCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWI 241
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 88.6 bits (218), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 12/164 (7%)
Query: 212 MVHPKY--NFFTYEYDLALVRLETP----VEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
++H Y + + D+AL+++ + + + I ICLP +D G + +TG+G
Sbjct: 82 ILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG 141
Query: 265 RLSEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
+ + L P L+ V ++S+ +C+ ++ +CA DSCQGDS
Sbjct: 142 KENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE---VTTKMLCAADPQWKTDSCQGDS 198
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL V GR L GI+SWG GCA + PGV TR+S F+PW+
Sbjct: 199 GGPL-VCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWI 241
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 88.6 bits (218), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 12/164 (7%)
Query: 212 MVHPKY--NFFTYEYDLALVRLETP----VEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
++H Y + + D+AL+++ + + + I ICLP +D G + +TG+G
Sbjct: 105 ILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG 164
Query: 265 RLSEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
+ + L P L+ V ++S+ +C+ ++ +CA DSCQGDS
Sbjct: 165 KENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE---VTTKMLCAADPQWKTDSCQGDS 221
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL V GR L GI+SWG GCA + PGV TR+S F+PW+
Sbjct: 222 GGPL-VCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWI 264
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 88.2 bits (217), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 12/164 (7%)
Query: 212 MVHPKY--NFFTYEYDLALVRLETP----VEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
++H Y + + D+AL+++ + + + I ICLP +D G + +TG+G
Sbjct: 82 ILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG 141
Query: 265 RLSEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
+ + L P L+ V ++S+ +C+ ++ +CA DSCQGDS
Sbjct: 142 KENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE---VTTKMLCAADPQWKTDSCQGDS 198
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL V GR L GI+SWG GCA + PGV TR+S F+PW+
Sbjct: 199 GGPL-VCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWI 241
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 88.2 bits (217), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 12/164 (7%)
Query: 212 MVHPKY--NFFTYEYDLALVRLETP----VEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
++H Y + + D+AL+++ + + + I ICLP +D G + +TG+G
Sbjct: 82 ILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG 141
Query: 265 RLSEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
+ + L P L+ V ++S+ +C+ ++ +CA DSCQGDS
Sbjct: 142 KENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE---VTTKMLCAADPQWKTDSCQGDS 198
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL V GR L GI+SWG GCA + PGV TR+S F+PW+
Sbjct: 199 GGPL-VCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWI 241
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 88.2 bits (217), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 59/158 (37%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 213 VHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSEGG-S 271
VH YN F D+A++RL PV I + LP S D+ +G T TGWG S+
Sbjct: 75 VHENYNSFVISNDIAVIRLPVPVTLTAAIATVGLP-STDVGVGTVVTPTGWGLPSDSALG 133
Query: 272 LPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKG 331
+ VL++V VPI+SN C ++ Y ++D +C GG+ +C GDSGGPL G
Sbjct: 134 ISDVLRQVDVPIMSNADCDAV------YGIVTDGNICID-STGGKGTCNGDSGGPLNYNG 186
Query: 332 KDGRYFLAGIISWG--IGCAEANLPGVCTRISKFVPWV 367
GI S+G GC EA P TR++ F+ W+
Sbjct: 187 -----LTYGITSFGAAAGC-EAGYPDAFTRVTYFLDWI 218
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 88.2 bits (217), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 55/164 (33%), Positives = 85/164 (51%), Gaps = 12/164 (7%)
Query: 212 MVHPKY--NFFTYEYDLALVRLETP----VEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
++H Y + + D+AL+++ + + + I ICLP +D G + +TG+G
Sbjct: 82 ILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG 141
Query: 265 RLSEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
+ L P L+ V ++S+ +C+ ++ +CA DSCQGDS
Sbjct: 142 KEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE---VTTKMLCAADPQWKTDSCQGDS 198
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL V GR L GI+SWG GCA + PGV TR+S F+PW+
Sbjct: 199 GGPL-VCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWI 241
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 87.8 bits (216), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 54/164 (32%), Positives = 86/164 (52%), Gaps = 12/164 (7%)
Query: 212 MVHPKY--NFFTYEYDLALVRLETP----VEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
++H Y + + D+AL+++ + + + I ICLP +D G + +TG+G
Sbjct: 82 ILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFG 141
Query: 265 RLSEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
+ + L P L+ V ++S+ +C+ ++ +CA D+CQGDS
Sbjct: 142 KEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSE---VTTKMLCAADPQWKTDACQGDS 198
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL V GR L GI+SWG GCA + PGV TR+S F+PW+
Sbjct: 199 GGPL-VCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWI 241
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 90/185 (48%), Gaps = 18/185 (9%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
+++K+ VG S+ + Y ++ +V+ Y+ F D+ALV L P++F +
Sbjct: 50 NRLKVHVGTNYLSESGDVYDVED-----AVVNKNYDDFLLRNDVALVHLTNPIKFNDLVQ 104
Query: 243 PICLPGSDDLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFI 302
PI L +D+ L T+TGWG GG+ P LQ++ + + ++C R +
Sbjct: 105 PIKLSTNDEDLESNPCTLTGWGSTRLGGNTPNALQEIELIVHPQKQCERDQWR------V 158
Query: 303 SDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISK 362
D +C G +C GDSGGPL G GI+S+G CA P V TR+S
Sbjct: 159 IDSHICT-LTKRGEGACHGDSGGPLVANGAQ-----IGIVSFGSPCALGE-PDVYTRVSS 211
Query: 363 FVPWV 367
FV W+
Sbjct: 212 FVSWI 216
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 87.0 bits (214), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 20/205 (9%)
Query: 179 SLLTSQIKIRVGE-YDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETP--- 234
S L Q+K+ +G Y EE ++ V K +VH +++ TY D+AL++L++
Sbjct: 65 SYLPDQLKVVLGRTYRVKPGEEEQTFK---VKKYIVHKEFDDDTYNNDIALLQLKSDSPQ 121
Query: 235 -VEFAPNIVPICLPGSD-DLLIGENATVTGWGRLSEGGSL-PPVLQKVTVPIVSNEKCRS 291
+ + ++ ICLP ++ L ++G+G+ L++ V + + +C
Sbjct: 122 CAQESDSVRAICLPEANLQLPDWTECELSGYGKHKSSSPFYSEQLKEGHVRLYPSSRCAP 181
Query: 292 MFLRAGRYEFISDIFMCAGFDNGG------RDSCQGDSGGPLQVKGKDGRYFLAGIISWG 345
FL + +++ +CAG G D+CQGDSGGPL V D L GIISWG
Sbjct: 182 KFLFN---KTVTNNMLCAGDTRSGEIYPNVHDACQGDSGGPL-VCMNDNHMTLLGIISWG 237
Query: 346 IGCAEANLPGVCTRISKFVPWVLDT 370
+GC E ++PGV T+++ ++ W+ D
Sbjct: 238 VGCGEKDVPGVYTKVTNYLGWIRDN 262
>pdb|1UHB|B Chain B, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 98
Score = 86.7 bits (213), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 44/104 (42%), Positives = 62/104 (59%), Gaps = 10/104 (9%)
Query: 267 SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGP 326
S G S P +LQ + P++S+ C+S + I+ +C GF GG+DSCQGDSGGP
Sbjct: 1 SSGSSYPSLLQCLKAPVLSDSSCKSSYPGQ-----ITGNMICVGFLEGGKDSCQGDSGGP 55
Query: 327 LQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDT 370
+ G+ L GI+SWG GCA+ N PGV T++ +V W+ T
Sbjct: 56 VVCNGQ-----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQT 94
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 54/169 (31%), Positives = 84/169 (49%), Gaps = 13/169 (7%)
Query: 204 QERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGW 263
Q K HP Y+ T+ DL LV+L + + + + LP + G TV+GW
Sbjct: 62 QRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEP-PGTTCTVSGW 120
Query: 264 GRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGD 322
G S + P L V V ++S + C ++ + + + +CAG + +++C GD
Sbjct: 121 GTTTSPDVTFPSDLMCVDVKLISPQDCTKVY-----KDLLENSMLCAGIPDSKKNACNGD 175
Query: 323 SGGPLQVKGKDGRYFLAGIISWG-IGCAEANLPGVCTRISKFVPWVLDT 370
SGGPL +G L G++SWG C + N PGV T++ KF W+ DT
Sbjct: 176 SGGPLVCRGT-----LQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDT 219
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 70/237 (29%), Positives = 108/237 (45%), Gaps = 32/237 (13%)
Query: 153 KESLGRPVNVYSNNEKVDDFSTESVNSLLTS------QIKIRVGEYDFSKLEEPYPYQER 206
K S V VY E + N +LT+ Q ++ +G+ + EEP Q R
Sbjct: 9 KNSQPWQVAVYYQKEHICGGVLLDRNWVLTAAHCYVDQYEVWLGKNKLFQ-EEPS-AQHR 66
Query: 207 GVVKKMVHPKYNF-----------FTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIG 255
V K HP +N + DL L+RL P + + PI LP + + G
Sbjct: 67 LVSKSFPHPGFNMSLLMLQTIPPGADFSDDLMLLRLSKPADITDVVKPIALP-TKEPKPG 125
Query: 256 ENATVTGWGRLSEG-GSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNG 314
+GWG ++ P LQ V + ++ NE C ++L+ ++D+ +CAG G
Sbjct: 126 SKCLASGWGSITPTRWQKPDDLQCVFITLLPNENCAKVYLQK-----VTDVMLCAGEMGG 180
Query: 315 GRDSCQGDSGGPLQVKGKDGRYFLAGIISWG-IGCAEANLPGVCTRISKFVPWVLDT 370
G+D+C+ DSGGPL G L G S+G + C + +P + T + KF W+ DT
Sbjct: 181 GKDTCRDDSGGPLICDG-----ILQGTTSYGPVPCGKPGVPAIYTNLIKFNSWIKDT 232
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 86.3 bits (212), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 54/169 (31%), Positives = 84/169 (49%), Gaps = 13/169 (7%)
Query: 204 QERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGW 263
Q K HP Y+ T+ DL LV+L + + + + LP + G TV+GW
Sbjct: 62 QRIKASKSFRHPGYSTQTHVNDLMLVKLNSQARLSSMVKKVRLPSRCEP-PGTTCTVSGW 120
Query: 264 GRL-SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGD 322
G S + P L V V ++S + C ++ + + + +CAG + +++C GD
Sbjct: 121 GTTTSPDVTFPSDLMCVDVKLISPQDCTKVY-----KDLLENSMLCAGIPDSKKNACNGD 175
Query: 323 SGGPLQVKGKDGRYFLAGIISWG-IGCAEANLPGVCTRISKFVPWVLDT 370
SGGPL +G L G++SWG C + N PGV T++ KF W+ DT
Sbjct: 176 SGGPLVCRGT-----LQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDT 219
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 60/187 (32%), Positives = 91/187 (48%), Gaps = 12/187 (6%)
Query: 186 KIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNF--FTYEYDLALVRLETPVEFAPNIVP 243
++ VGE++ ++ + Y GV K +VHP +N YD+AL+RL V +
Sbjct: 54 RVVVGEHNLNQNDGTEQY--VGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQL 111
Query: 244 ICLPGSDDLLIGEN-ATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFI 302
LP + +L + +TGWG G L LQ+ +P V C S +
Sbjct: 112 GVLPRAGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWG---STV 168
Query: 303 SDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISW--GIGCAEANLPGVCTRI 360
+ +CAG D G R CQGDSGGPL +G+Y + G+ S+ +GC P V TR+
Sbjct: 169 KNSMVCAGGD-GVRSGCQGDSGGPLHCL-VNGQYAVHGVTSFVSRLGCNVTRKPTVFTRV 226
Query: 361 SKFVPWV 367
S ++ W+
Sbjct: 227 SAYISWI 233
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 85.5 bits (210), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 26/202 (12%)
Query: 182 TSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFF-----------TYEYDLALVR 230
+ ++ +G+ +F LE+ Q R V K + HP +N Y DL L+R
Sbjct: 47 NDKYQVWLGKNNF--LEDEPSDQHRLVSKAIPHPDFNMSLLNEHTPQPEDDYSNDLMLLR 104
Query: 231 LETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSE-GGSLPPVLQKVTVPIVSNEKC 289
L P + + PI LP +++ +G +GWG + P LQ V + ++ NE C
Sbjct: 105 LSKPADITDVVKPITLP-TEEPKLGSTCLASGWGSTTPIKFKYPDDLQCVNLKLLPNEDC 163
Query: 290 RSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG-C 348
++D +CAG +GG +C+ DSGGPL G L GI SWG C
Sbjct: 164 DKAHEMK-----VTDAMLCAGEMDGGSYTCEHDSGGPLICDG-----ILQGITSWGPEPC 213
Query: 349 AEANLPGVCTRISKFVPWVLDT 370
E P V T++ KF W+ +T
Sbjct: 214 GEPTEPSVYTKLIKFSSWIRET 235
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 85.1 bits (209), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 54/164 (32%), Positives = 85/164 (51%), Gaps = 12/164 (7%)
Query: 212 MVHPKY--NFFTYEYDLALVRLETP----VEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
++H Y + + D+AL+++ + + + I I LP +D G + +TG+G
Sbjct: 82 ILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG 141
Query: 265 RLSEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
+ + L P L+ V ++S+ +C+ ++ +CA DSCQGDS
Sbjct: 142 KENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE---VTTKMLCAADPQWKTDSCQGDS 198
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL V GR L GI+SWG GCA + PGV TR+S F+PW+
Sbjct: 199 GGPL-VCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWI 241
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 85.1 bits (209), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 60/187 (32%), Positives = 90/187 (48%), Gaps = 12/187 (6%)
Query: 186 KIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNF--FTYEYDLALVRLETPVEFAPNIVP 243
++ VGE++ ++ Y GV K +VHP +N YD+AL+RL V +
Sbjct: 54 RVVVGEHNLNQNNGTEQY--VGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQL 111
Query: 244 ICLPGSDDLLIGEN-ATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFI 302
LP + +L + +TGWG G L LQ+ +P V C S +
Sbjct: 112 GVLPRAGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWG---STV 168
Query: 303 SDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISW--GIGCAEANLPGVCTRI 360
+ +CAG D G R CQGDSGGPL +G+Y + G+ S+ +GC P V TR+
Sbjct: 169 KNSMVCAGGD-GVRSGCQGDSGGPLHCL-VNGQYAVHGVTSFVSRLGCNVTRKPTVFTRV 226
Query: 361 SKFVPWV 367
S ++ W+
Sbjct: 227 SAYISWI 233
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 85.1 bits (209), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 54/164 (32%), Positives = 85/164 (51%), Gaps = 12/164 (7%)
Query: 212 MVHPKY--NFFTYEYDLALVRLETP----VEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
++H Y + + D+AL+++ + + + I I LP +D G + +TG+G
Sbjct: 82 ILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG 141
Query: 265 RLSEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
+ + L P L+ V ++S+ +C+ ++ +CA DSCQGDS
Sbjct: 142 KENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE---VTTKMLCAADPQWKTDSCQGDS 198
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL V GR L GI+SWG GCA + PGV TR+S F+PW+
Sbjct: 199 GGPL-VCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWI 241
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 85.1 bits (209), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 12/164 (7%)
Query: 212 MVHPKY--NFFTYEYDLALVRLETP----VEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
++H Y + + D+AL+++ + + + I I LP +D G + +TG+G
Sbjct: 82 ILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG 141
Query: 265 RLSEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
+ L P L+ V ++S+ +C+ ++ +CA DSCQGDS
Sbjct: 142 KEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE---VTTKMLCAADPQWKTDSCQGDS 198
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL V GR L GI+SWG GCA + PGV TR+S F+PW+
Sbjct: 199 GGPL-VCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWI 241
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 12/164 (7%)
Query: 212 MVHPKY--NFFTYEYDLALVRLETP----VEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
++H Y + + D+AL+++ + + + I I LP +D G + +TG+G
Sbjct: 82 ILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG 141
Query: 265 RLSEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
+ L P L+ V ++S+ +C+ ++ +CA DSCQGDS
Sbjct: 142 KEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE---VTTKMLCAADPQWKTDSCQGDS 198
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL V GR L GI+SWG GCA + PGV TR+S F+PW+
Sbjct: 199 GGPL-VCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWI 241
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 54/164 (32%), Positives = 85/164 (51%), Gaps = 12/164 (7%)
Query: 212 MVHPKY--NFFTYEYDLALVRLETP----VEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
++H Y + + D+AL+++ + + + I I LP +D G + +TG+G
Sbjct: 82 ILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFG 141
Query: 265 RLSEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
+ + L P L+ V ++S+ +C+ ++ +CA DSCQGDS
Sbjct: 142 KENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE---VTTKMLCAADPQWKTDSCQGDS 198
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL V GR L GI+SWG GCA + PGV TR+S F+PW+
Sbjct: 199 GGPL-VCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWI 241
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 84.7 bits (208), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 54/164 (32%), Positives = 85/164 (51%), Gaps = 12/164 (7%)
Query: 212 MVHPKY--NFFTYEYDLALVRLETP----VEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
++H Y + + D+AL+++ + + + I I LP +D G + +TG+G
Sbjct: 97 ILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFG 156
Query: 265 RLSEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
+ + L P L+ V ++S+ +C+ ++ +CA DSCQGDS
Sbjct: 157 KENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE---VTTKMLCAADPQWKTDSCQGDS 213
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL V GR L GI+SWG GCA + PGV TR+S F+PW+
Sbjct: 214 GGPL-VCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWI 256
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 84.7 bits (208), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 54/164 (32%), Positives = 85/164 (51%), Gaps = 12/164 (7%)
Query: 212 MVHPKY--NFFTYEYDLALVRLETP----VEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
++H Y + + D+AL+++ + + + I I LP +D G + +TG+G
Sbjct: 82 ILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTISLPSMYNDPQFGTSCEITGFG 141
Query: 265 RLSEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
+ + L P L+ V ++S+ +C+ ++ +CA DSCQGDS
Sbjct: 142 KENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE---VTTKMLCAADPQWKTDSCQGDS 198
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL V GR L GI+SWG GCA + PGV TR+S F+PW+
Sbjct: 199 GGPL-VCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWI 241
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 84.3 bits (207), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 60/187 (32%), Positives = 90/187 (48%), Gaps = 12/187 (6%)
Query: 186 KIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNF--FTYEYDLALVRLETPVEFAPNIVP 243
++ VGE++ ++ Y GV K +VHP +N YD+AL+RL V +
Sbjct: 54 RVVVGEHNLNQNNGTEQY--VGVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQL 111
Query: 244 ICLPGSDDLLIGEN-ATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFI 302
LP + +L + +TGWG G L LQ+ +P V C S +
Sbjct: 112 GVLPRAGTILRNNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWG---STV 168
Query: 303 SDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISW--GIGCAEANLPGVCTRI 360
+ +CAG D G R CQGDSGGPL +G+Y + G+ S+ +GC P V TR+
Sbjct: 169 KNSMVCAGGD-GVRSGCQGDSGGPLHCL-VNGQYAVHGVTSFVSRLGCNVTRKPTVFTRV 226
Query: 361 SKFVPWV 367
S ++ W+
Sbjct: 227 SAYISWI 233
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 84.0 bits (206), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 53/164 (32%), Positives = 84/164 (51%), Gaps = 12/164 (7%)
Query: 212 MVHPKY--NFFTYEYDLALVRLETP----VEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
++H Y + + D+AL+++ + + + I I LP +D G + +TG+G
Sbjct: 82 ILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFG 141
Query: 265 RLSEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDS 323
+ L P L+ V ++S+ +C+ ++ +CA DSCQGD+
Sbjct: 142 KEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE---VTTKMLCAADPQWKTDSCQGDA 198
Query: 324 GGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
GGPL V GR L GI+SWG GCA + PGV TR+S F+PW+
Sbjct: 199 GGPL-VCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWI 241
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 82.4 bits (202), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQER-GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
++++ +G + S +P P + V++ + HP T ++DL L++L P +
Sbjct: 50 KVQVLLGAHSLS---QPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVR 106
Query: 243 PICLPGSD-DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P+ D D+ G V GWG ++ G P LQ V +P++ C G
Sbjct: 107 PLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDG---A 163
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG-CAEANLPGVCTRI 360
I++ MCA ++ RDSC+GDSGGPL G L G+++ G C PG+ TR+
Sbjct: 164 ITERLMCA--ESNRRDSCKGDSGGPLVCGG-----VLEGVVTSGSAVCGNRKKPGIYTRV 216
Query: 361 SKFVPWV 367
+ + W+
Sbjct: 217 ASYAAWI 223
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQER-GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
++++ +G + S +P P + V++ + HP T ++DL L++L P +
Sbjct: 50 KVQVLLGAHSLS---QPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVR 106
Query: 243 PICLPGSD-DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P+ D D+ G V GWG ++ G P LQ V +P++ C G
Sbjct: 107 PLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDG---A 163
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG-CAEANLPGVCTRI 360
I++ MCA ++ RDSC+GDSGGPL G L G+++ G C PG+ TR+
Sbjct: 164 ITERLMCA--ESNRRDSCKGDSGGPLVCGG-----VLEGVVTSGSRVCGNRKKPGIYTRV 216
Query: 361 SKFVPWV 367
+ + W+
Sbjct: 217 ASYAAWI 223
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 81.6 bits (200), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQER-GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
++++ +G + S +P P + V++ + HP T ++DL L++L P +
Sbjct: 57 KVQVLLGAHSLS---QPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVR 113
Query: 243 PICLPGSD-DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P+ D D+ G V GWG ++ G P LQ V +P++ C G
Sbjct: 114 PLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDG---A 170
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG-CAEANLPGVCTRI 360
I++ MCA ++ RDSC+GDSGGPL G L G+++ G C PG+ TR+
Sbjct: 171 ITERLMCA--ESNRRDSCKGDSGGPLVCGG-----VLEGVVTSGSRVCGNRKKPGIYTRV 223
Query: 361 SKFVPWV 367
+ + W+
Sbjct: 224 ASYAAWI 230
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 81.3 bits (199), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 56/187 (29%), Positives = 88/187 (47%), Gaps = 13/187 (6%)
Query: 186 KIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNF--FTYEYDLALVRLETPVEFAPNIVP 243
++ +GE++ + E Q V +H +N YD+AL+RL T +
Sbjct: 54 RVVLGEHNLNTNEGKE--QIMTVNSVFIHSGWNSDDVAGGYDIALLRLNTQASLNSAVQL 111
Query: 244 ICLPGSDDLLIGEN-ATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFI 302
LP S+ +L N +TGWG+ S GG L L++ +P V + C S +
Sbjct: 112 AALPPSNQILPNNNPCYITGWGKTSTGGPLSDSLKQAWLPSVDHATCSSSGWWG---STV 168
Query: 303 SDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISW--GIGCAEANLPGVCTRI 360
+CAG G C GDSGGPL + +G Y++ G+ S+ GC + P V TR+
Sbjct: 169 KTTMVCAG--GGANSGCNGDSGGPLNCQ-VNGSYYVHGVTSFVSSSGCNASKKPTVFTRV 225
Query: 361 SKFVPWV 367
S ++ W+
Sbjct: 226 SAYISWM 232
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 81.3 bits (199), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 61/191 (31%), Positives = 90/191 (47%), Gaps = 15/191 (7%)
Query: 181 LTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPN 240
L S I + +G ++ +E Q V + + HP YN T D+ L++L +
Sbjct: 46 LGSSINVTLGAHNI--MERERTQQVIPVRRPIPHPDYNDETLANDIMLLKLTRKADITDK 103
Query: 241 IVPICLPGS-DDLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRY 299
+ PI LP S ++ G +V GWGRL LQ+V + + S EKC + F
Sbjct: 104 VSPINLPRSLAEVKPGMMCSVAGWGRLGVNMPSTDKLQEVDLEVQSEEKCIARF-----K 158
Query: 300 EFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTR 359
+I +CAG + ++S GDSGGPL G GI+S+G + P V TR
Sbjct: 159 NYIPFTQICAGDPSKRKNSFSGDSGGPLVCNG-----VAQGIVSYGRN--DGTTPDVYTR 211
Query: 360 ISKFVPWVLDT 370
IS F+ W+ T
Sbjct: 212 ISSFLSWIHST 222
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 80.9 bits (198), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 55/187 (29%), Positives = 89/187 (47%), Gaps = 16/187 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQER-GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
++++ +G + S +P P + V++ + HP T ++DL L++L P +
Sbjct: 50 KVQVLLGAHSLS---QPEPSKRLYDVLRAVPHPDSRPDTIDHDLLLLQLSEKATLGPAVR 106
Query: 243 PICLPGSD-DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P+ D D+ G V GWG +S G P LQ V +P++ C G
Sbjct: 107 PLPWQRVDRDVEPGTLCDVAGWGIVSHAGRRPDRLQHVLLPVLDRATCNRRTHHDG---A 163
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG-CAEANLPGVCTRI 360
I+ MCA ++ RDSC+GDSGGPL G L G+++ G C PG+ TR+
Sbjct: 164 ITQRMMCA--ESNRRDSCKGDSGGPLVCGG-----VLEGVVTSGSRVCGNRKKPGIYTRV 216
Query: 361 SKFVPWV 367
+ + W+
Sbjct: 217 ASYAAWI 223
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 12/165 (7%)
Query: 208 VVKKMVHPKYNFFTYEYDLALVRLETPVEFA----PNIVPICLPGSDDLLI-GENATVTG 262
V + + H YN TY+ D+AL+ ++ P +P C+P S L + V+G
Sbjct: 394 VDRIIFHENYNAGTYQNDIALIEMKKDGNKKDCELPRSIPACVPWSPYLFQPNDTCIVSG 453
Query: 263 WGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGD 322
WGR + + LQ V ++SN C + F CAG +G D+C+GD
Sbjct: 454 WGREKDNERVFS-LQWGEVKLISN--CSKFYGN----RFYEKEMECAGTYDGSIDACKGD 506
Query: 323 SGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
SGGPL + ++ G++SWG C + PGV T+++ + W+
Sbjct: 507 SGGPLVCMDANNVTYVWGVVSWGENCGKPEFPGVYTKVANYFDWI 551
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 80.5 bits (197), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 53/187 (28%), Positives = 90/187 (48%), Gaps = 16/187 (8%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQER-GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
++++ +G + S +P P + V++ + HP T ++DL L++L P +
Sbjct: 50 KVQVLLGAHSLS---QPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVR 106
Query: 243 PICLPGSD-DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P+ D D+ G V GWG ++ G P LQ V +P++ C G
Sbjct: 107 PLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDG---A 163
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG-CAEANLPGVCTRI 360
I++ MCA ++ RDSC+GD+GGPL G L G+++ G C PG+ TR+
Sbjct: 164 ITERLMCA--ESNRRDSCKGDAGGPLVCGG-----VLEGVVTSGSRVCGNRKKPGIYTRV 216
Query: 361 SKFVPWV 367
+ + W+
Sbjct: 217 ASYAAWI 223
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 79.7 bits (195), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 180 LLTSQIKIRVGEYDFSKLEEPYPY--------QERGVVKKMVHPKYNFFTYEYDLALVRL 231
LLT+ +R+G + +K ++ P QE + K + HP + D+ L++L
Sbjct: 138 LLTTAKNLRLGHKNDTKAKDIAPTLRLYVGKKQEVEIEKVIFHPDNSTV----DIGLIKL 193
Query: 232 ETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRS 291
+ V ++PICLP D + +G V+GWGR + + L+ V +P+ EKC
Sbjct: 194 KQKVPVNERVMPICLPSKDYVNVGLVGYVSGWGR-NANLNFTEHLKYVMLPVADQEKCVQ 252
Query: 292 MFLRA------------GRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGK-DGRYFL 338
+ + G +++ CAG D+C GD+G V K D ++
Sbjct: 253 YYEGSTVPEKKTPKSPVGVQPILNEHTFCAGLSKYQEDTCYGDAGSAFAVHDKDDDTWYA 312
Query: 339 AGIISWGIGCAEANLPGVCTRISKFVPWVLDT 370
AGI+S+ C A GV R++ + W+ T
Sbjct: 313 AGILSFDKSCRTAEY-GVYVRVTSILDWIQTT 343
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 79.3 bits (194), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 57/189 (30%), Positives = 95/189 (50%), Gaps = 14/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S+I++ +G ++ + E+ Q VVK + HP YN T D+ L++L++ + + +
Sbjct: 49 SKIQVTLGAHNIKEQEKMQ--QIIPVVKIIPHPAYNSKTISNDIMLLKLKSKAKRSSAVK 106
Query: 243 PICLPGSD-DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P+ LP + + G+ V GWG+L G LQ+V + + ++KC S + F
Sbjct: 107 PLNLPRRNVKVKPGDVCYVAGWGKLGPMGKYSDTLQEVELTVQEDQKCESYL----KNYF 162
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
+CAG R S +GDSGGPL K AGI+S+G + + P T++S
Sbjct: 163 DKANEICAGDPKIKRASFRGDSGGPLVCKK-----VAAGIVSYGQN--DGSTPRAFTKVS 215
Query: 362 KFVPWVLDT 370
F+ W+ T
Sbjct: 216 TFLSWIKKT 224
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 170 DDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMV-HPKYNFFTYEYDLAL 228
DDF + + +S I + +G ++ ++E P Q+ VK+ + HP YN + D+ L
Sbjct: 36 DDFVLTAAHCWGSS-INVTLGAHN---IKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIML 91
Query: 229 VRLETPVEFAPNIVPICLPGSD-DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNE 287
++LE + + P+ LP + + G+ +V GWG+ + G LQ+V + + +
Sbjct: 92 LQLERKAKRTRAVQPLRLPSNKAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDR 151
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
KC S R+ + S I +C G + S +GDSGGPL GI+S+G
Sbjct: 152 KCESDL----RHYYDSTIELCVGDPEIKKTSFKGDSGGPLVCNK-----VAQGIVSYGRN 202
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
P CT++S FV W+ T
Sbjct: 203 --NGMPPRACTKVSSFVHWIKKT 223
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 79.3 bits (194), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 170 DDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMV-HPKYNFFTYEYDLAL 228
DDF + + +S I + +G ++ ++E P Q+ VK+ + HP YN + D+ L
Sbjct: 36 DDFVLTAAHCWGSS-INVTLGAHN---IKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIML 91
Query: 229 VRLETPVEFAPNIVPICLPGSD-DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNE 287
++LE + + P+ LP + + G+ +V GWG+ + G LQ+V + + +
Sbjct: 92 LQLERKAKRTRAVQPLRLPSNKAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDR 151
Query: 288 KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG 347
KC S R+ + S I +C G + S +GDSGGPL GI+S+G
Sbjct: 152 KCESDL----RHYYDSTIELCVGDPEIKKTSFKGDSGGPLVCNK-----VAQGIVSYGRN 202
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
P CT++S FV W+ T
Sbjct: 203 --NGMPPRACTKVSSFVHWIKKT 223
>pdb|2JET|C Chain C, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 99
Score = 79.0 bits (193), Expect = 4e-15, Method: Composition-based stats.
Identities = 43/95 (45%), Positives = 56/95 (58%), Gaps = 8/95 (8%)
Query: 273 PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGK 332
P LQ+ +PIVS C+ + I+D+ CAG G DSC GDSGGPL V K
Sbjct: 6 PEKLQQAALPIVSEADCKKSWGSK-----ITDVMTCAG--ASGVDSCMGDSGGPL-VCQK 57
Query: 333 DGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
DG + LAGI+SWG G + PGV +R++ +PWV
Sbjct: 58 DGVWTLAGIVSWGSGVCSTSTPGVYSRVTALMPWV 92
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 14/152 (9%)
Query: 218 NFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRL-SEGGSLPPVL 276
N ++ D+ L+RL PV + +I P+ LP S+ +G + GWG + S +LP V
Sbjct: 78 NDTIWDKDIMLIRLNRPVRNSAHIAPLSLP-SNPPSVGSVCRIMGWGTITSPNATLPDVP 136
Query: 277 QKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRY 336
+ I+ C++ Y+ ++ +CAG GG+D+C+GDSGGPL G+
Sbjct: 137 HCANINILDYAVCQAA------YKGLAATTLCAGILEGGKDTCKGDSGGPLICNGQ---- 186
Query: 337 FLAGIISWGIG-CAEANLPGVCTRISKFVPWV 367
GI+S G CA+ PG+ T++ + W+
Sbjct: 187 -FQGILSVGGNPCAQPRKPGIYTKVFDYTDWI 217
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 22/187 (11%)
Query: 185 IKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPI 244
I + +G ++ + EE +Q+ V+K+ HPKYN T +D+ L++L+ + +
Sbjct: 51 ITVTLGAHNIT--EEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTL 108
Query: 245 CLPGSDDLL-IGENATVTGWGRLSEGGSLPP---VLQKVTVPIVSNEKCRSMFLRAGRYE 300
P + + G V GWGR G L P LQ+V + ++ + C +
Sbjct: 109 PFPSQKNFVPPGRMCRVAGWGRT---GVLKPGSDTLQEVKLRLMDPQACSHF------RD 159
Query: 301 FISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRI 360
F ++ +C G + + +GDSGGPL G GI+S+G ++A P V TRI
Sbjct: 160 FDHNLQLCVGNPRKTKSAFKGDSGGPLLCAGA-----AQGIVSYGR--SDAKPPAVFTRI 212
Query: 361 SKFVPWV 367
S + PW+
Sbjct: 213 SHYQPWI 219
>pdb|2KAI|B Chain B, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|B Chain B, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|Y Chain Y, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|B Chain B, Kallikrein Complexed With Hirustasin
pdb|1HIA|Y Chain Y, Kallikrein Complexed With Hirustasin
Length = 152
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 15/153 (9%)
Query: 222 YEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSEGGS---LPPVLQK 278
Y +DL L+RL++P + + + LP + L G +GWG + G P +Q
Sbjct: 6 YSHDLMLLRLQSPAKITDAVKVLELPTQEPEL-GSTCEASGWGSIEPGPDDFEFPDEIQC 64
Query: 279 VTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFL 338
V + ++ N C + +++ +CAG+ GG+D+C GDSGGPL G
Sbjct: 65 VQLTLLQNTFCAD-----AHPDKVTESMLCAGYLPGGKDTCMGDSGGPLICNG-----MW 114
Query: 339 AGIISWG-IGCAEANLPGVCTRISKFVPWVLDT 370
GI SWG C AN P + T++ ++ W+ DT
Sbjct: 115 QGITSWGHTPCGSANKPSIYTKLIFYLDWIDDT 147
>pdb|1KDQ|B Chain B, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 99
Score = 77.0 bits (188), Expect = 2e-14, Method: Composition-based stats.
Identities = 42/95 (44%), Positives = 55/95 (57%), Gaps = 8/95 (8%)
Query: 273 PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGK 332
P LQ+ +PIVS C+ + I+D+ CAG G DSC GDSGGPL V K
Sbjct: 6 PEKLQQAALPIVSEADCKKSWGSK-----ITDVMTCAG--ASGVDSCMGDSGGPL-VCQK 57
Query: 333 DGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
DG + LAGI+SWG G + P V +R++ +PWV
Sbjct: 58 DGVWTLAGIVSWGSGVCSTSTPAVYSRVTALMPWV 92
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 26/199 (13%)
Query: 182 TSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKY-----------NFFTYEYDLALVR 230
++ ++ +G + K +EP+ Q R V + HP Y + DL L+
Sbjct: 42 SNNYQVLLGRNNLFK-DEPFA-QRRLVRQSFRHPDYIPLIVTNDTEQPVHDHSNDLMLLH 99
Query: 231 LETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSEGGSL-PPVLQKVTVPIVSNEKC 289
L P + + I LP + + +G +GWG + + LQ V + ++SNEKC
Sbjct: 100 LSEPADITGGVKVIDLP-TKEPKVGSTCLASGWGSTNPSEMVVSHDLQCVNIHLLSNEKC 158
Query: 290 RSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG-C 348
+ + ++D+ +CAG GG+D+C GDSGGPL G L GI S G C
Sbjct: 159 IETY-----KDNVTDVMLCAGEMEGGKDTCAGDSGGPLICDG-----VLQGITSGGATPC 208
Query: 349 AEANLPGVCTRISKFVPWV 367
A+ P + ++ KF W+
Sbjct: 209 AKPKTPAIYAKLIKFTSWI 227
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 70/232 (30%), Positives = 106/232 (45%), Gaps = 21/232 (9%)
Query: 146 RPYVKPLKESLGRPVNVYSNNEKVDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQE 205
RPY+ L SL R + + D+ + + L + ++ +G + ++ EEP Q
Sbjct: 12 RPYMVLL--SLDRKT-ICAGALIAKDWVLTAAHCNLNKRSQVILGAHSITR-EEPTK-QI 66
Query: 206 RGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
V K+ +P Y+ T E DL L++L + + + LP DD+ G V GWG
Sbjct: 67 MLVKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGDDVKPGTMCQVAGWG 126
Query: 265 RLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFM---CAGFDNGGRDSCQG 321
R S L++V + I+ + C Y F I M CAG GGRDSC G
Sbjct: 127 RTHNSASWSDTLREVNITIIDRKVCND----RNHYNFNPVIGMNMVCAGSLRGGRDSCNG 182
Query: 322 DSGGPLQVKGKDGRYFLAGIISWGI--GCAEANLPGVCTRIS-KFVPWVLDT 370
DSG PL +G G+ S+G+ C + PGV +S K + W++ T
Sbjct: 183 DSGSPLLCEG-----VFRGVTSFGLENKCGDPRGPGVYILLSKKHLNWIIMT 229
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 76.3 bits (186), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 22/187 (11%)
Query: 185 IKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPI 244
I + +G ++ + EE +Q+ V+K+ HPKYN T +D+ L++L+ + +
Sbjct: 51 ITVTLGAHNIT--EEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTL 108
Query: 245 CLPGSDDLL-IGENATVTGWGRLSEGGSLPP---VLQKVTVPIVSNEKCRSMFLRAGRYE 300
P + + G V GWGR G L P LQ+V + ++ + C +
Sbjct: 109 PFPSQFNFVPPGRMCRVAGWGRT---GVLKPGSDTLQEVKLRLMDPQACSHF------RD 159
Query: 301 FISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRI 360
F ++ +C G + + +GDSGGPL G GI+S+G ++A P V TRI
Sbjct: 160 FDHNLQLCVGNPRKTKSAFKGDSGGPLLCAGA-----AQGIVSYGR--SDAKPPAVFTRI 212
Query: 361 SKFVPWV 367
S + PW+
Sbjct: 213 SHYQPWI 219
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 76.3 bits (186), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 22/187 (11%)
Query: 185 IKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPI 244
I + +G ++ + EE +Q+ V+K+ HPKYN T +D+ L++L+ + +
Sbjct: 51 ITVTLGAHNIT--EEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTL 108
Query: 245 CLPGSDDLL-IGENATVTGWGRLSEGGSLPP---VLQKVTVPIVSNEKCRSMFLRAGRYE 300
P + + G V GWGR G L P LQ+V + ++ + C +
Sbjct: 109 PFPSQFNFVPPGRMCRVAGWGRT---GVLKPGSDTLQEVKLRLMDPQACSHF------RD 159
Query: 301 FISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRI 360
F ++ +C G + + +GDSGGPL G GI+S+G ++A P V TRI
Sbjct: 160 FDHNLQLCVGNPRKTKSAFKGDSGGPLLCAG-----VAQGIVSYGR--SDAKPPAVFTRI 212
Query: 361 SKFVPWV 367
S + PW+
Sbjct: 213 SHYRPWI 219
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 70/232 (30%), Positives = 106/232 (45%), Gaps = 21/232 (9%)
Query: 146 RPYVKPLKESLGRPVNVYSNNEKVDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQE 205
RPY+ L SL R + + D+ + + L + ++ +G + ++ EEP Q
Sbjct: 12 RPYMVLL--SLDRKT-ICAGALIAKDWVLTAAHCNLNKRSQVILGAHSITR-EEPTK-QI 66
Query: 206 RGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGS-DDLLIGENATVTGWG 264
V K+ +P Y+ T E DL L++L + + + LP DD+ G V GWG
Sbjct: 67 MLVKKEFPYPCYDPATREGDLKLLQLTEKAKINKYVTILHLPKKGDDVKPGTMCQVAGWG 126
Query: 265 RLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFM---CAGFDNGGRDSCQG 321
R S L++V + I+ + C Y F I M CAG GGRDSC G
Sbjct: 127 RTHNSASWSDTLREVEITIIDRKVCND----RNHYNFNPVIGMNMVCAGSLRGGRDSCNG 182
Query: 322 DSGGPLQVKGKDGRYFLAGIISWGI--GCAEANLPGVCTRIS-KFVPWVLDT 370
DSG PL +G G+ S+G+ C + PGV +S K + W++ T
Sbjct: 183 DSGSPLLCEG-----VFRGVTSFGLENKCGDPRGPGVYILLSKKHLNWIIMT 229
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 22/187 (11%)
Query: 185 IKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPI 244
I + +G ++ + EE +Q+ V+K+ HPKYN T +D+ L++L+ + +
Sbjct: 51 ITVTLGAHNIT--EEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTL 108
Query: 245 CLPGSDDLL-IGENATVTGWGRLSEGGSLPP---VLQKVTVPIVSNEKCRSMFLRAGRYE 300
P + + G V GWGR G L P LQ+V + ++ + C +
Sbjct: 109 PFPSQFNFVPPGRMCRVAGWGRT---GVLKPGSDTLQEVKLRLMDPQACSHF------RD 159
Query: 301 FISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRI 360
F ++ +C G + + +GDSGGPL G GI+S+G ++A P V TRI
Sbjct: 160 FDHNLQLCVGNPRKTKSAFKGDSGGPLLCAG-----VAQGIVSYGR--SDAKPPAVFTRI 212
Query: 361 SKFVPWV 367
S + PW+
Sbjct: 213 SHYRPWI 219
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 75.9 bits (185), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 22/187 (11%)
Query: 185 IKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPI 244
I + +G ++ + EE +Q+ V+K+ HPKYN T +D+ L++L+ + +
Sbjct: 53 ITVTLGAHNIT--EEEDTWQKLEVIKQFRHPKYNTSTLHHDIMLLKLKEKASLTLAVGTL 110
Query: 245 CLPGSDDLL-IGENATVTGWGRLSEGGSLPP---VLQKVTVPIVSNEKCRSMFLRAGRYE 300
P + + G V GWGR G L P LQ+V + ++ + C +
Sbjct: 111 PFPSQFNFVPPGRMCRVAGWGRT---GVLKPGSDTLQEVKLRLMDPQACSHF------RD 161
Query: 301 FISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRI 360
F ++ +C G + + +GDSGGPL G GI+S+G ++A P V TRI
Sbjct: 162 FDHNLQLCVGNPRKTKSAFKGDSGGPLLCAG-----VAQGIVSYGR--SDAKPPAVFTRI 214
Query: 361 SKFVPWV 367
S + PW+
Sbjct: 215 SHYRPWI 221
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 50/146 (34%), Positives = 76/146 (52%), Gaps = 10/146 (6%)
Query: 225 DLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSEGGSLPP--VLQKVTVP 282
D+ LV+L+T + ++ + + L G VTGWG ++ SL P L++VTV
Sbjct: 92 DIMLVKLQTAAKLNKHVKMLHIRSKTSLRSGTKCKVTGWG-ATDPDSLRPSDTLREVTVT 150
Query: 283 IVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGII 342
++S + C S G FI+ +CAG G +DSC+GD+GGPL KG I+
Sbjct: 151 VLSRKLCNSQSYYNGD-PFITKDMVCAGDAKGQKDSCKGDAGGPLICKG-----VFHAIV 204
Query: 343 SWGIGCAEANLPGVCTRIS-KFVPWV 367
S G C A PG+ T ++ K+ W+
Sbjct: 205 SGGHECGVATKPGIYTLLTKKYQTWI 230
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 75.5 bits (184), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 49/153 (32%), Positives = 81/153 (52%), Gaps = 12/153 (7%)
Query: 218 NFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLS-EGGSLPPVL 276
N+ ++ D+ L+RL++PV+ + +I P S +G + GWGR+S G+ P V
Sbjct: 81 NYTLWDKDIMLIRLDSPVKNSKHIAPF-SLPSSPPSVGSVCRIMGWGRISPTEGTYPDVP 139
Query: 277 QKVTVPIVSNEKCRSMFLRAGRYEF-ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGR 335
V + ++ E CR+ + +E + +CAG GG+D+C+GDSGGPL G+
Sbjct: 140 HCVNINLLEYEMCRAPY---PEFELPATSRTLCAGILEGGKDTCKGDSGGPLICNGQ--- 193
Query: 336 YFLAGIISWGIG-CAEANLPGVCTRISKFVPWV 367
GI SWG CA+ + P T++ + W+
Sbjct: 194 --FQGIASWGDDPCAQPHKPAAYTKVFDHLDWI 224
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 75.1 bits (183), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 14/225 (6%)
Query: 147 PYVKPLKESLGRPVNVYSNNEKVDDFSTESVNSLLTSQIKIRVGEYDFSKLEEPYPYQER 206
P+ +P + +L ++ + V S + I +G + +EP
Sbjct: 9 PHSQPWQAALVMENELFCSGVLVHPQWVLSAAHCFQNSYTIGLGLHSLEADQEPGSQMVE 68
Query: 207 GVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRL 266
+ + HP+YN DL L++L+ V + I I + S G + V+GWG L
Sbjct: 69 ASLS-VRHPEYNRPLLANDLMLIKLDESVSESDTIRSISI-ASQCPTAGNSCLVSGWGLL 126
Query: 267 SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGP 326
+ G +P VLQ V V +VS E C ++ CAG +DSC GDSGGP
Sbjct: 127 ANG-RMPTVLQCVNVSVVSEEVCSKLY-----DPLYHPSMFCAGGGQDQKDSCNGDSGGP 180
Query: 327 LQVKGKDGRYFLAGIISWGIG-CAEANLPGVCTRISKFVPWVLDT 370
L G +L G++S+G C + +PGV T + KF W+ T
Sbjct: 181 LICNG-----YLQGLVSFGKAPCGQVGVPGVYTNLCKFTEWIEKT 220
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 75.1 bits (183), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 58/186 (31%), Positives = 90/186 (48%), Gaps = 18/186 (9%)
Query: 184 QIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAP--NI 241
+I + +G +D K E Q+ V K+++H YN +D+ L++LE VE P N+
Sbjct: 50 EITVILGAHDVRKRESTQ--QKIKVEKQIIHESYNSVPNLHDIMLLKLEKKVELTPAVNV 107
Query: 242 VPICLPGSDDLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
VP+ P SD + G GWG+ L++V + I+ + C + R Y+F
Sbjct: 108 VPLPSP-SDFIHPGAMCWAAGWGKTGVRDPTSYTLREVELRIMDEKAC--VDYRYYEYKF 164
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
+C G R + GDSGGPL G GI+S+ G +A P + TR+S
Sbjct: 165 ----QVCVGSPTTLRAAFMGDSGGPLLCAG-----VAHGIVSY--GHPDAKPPAIFTRVS 213
Query: 362 KFVPWV 367
+VPW+
Sbjct: 214 TYVPWI 219
Score = 36.6 bits (83), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 27/47 (57%), Gaps = 7/47 (14%)
Query: 371 GDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 417
GDSGGPL G GI+S+G +A P + TR+S +VPW+
Sbjct: 180 GDSGGPLLCAG-----VAHGIVSYG--HPDAKPPAIFTRVSTYVPWI 219
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 53/174 (30%), Positives = 83/174 (47%), Gaps = 17/174 (9%)
Query: 200 PYPYQERGVVK-KMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENA 258
P+P + ++K + + P + +DL L+RL P E + + LP + L G
Sbjct: 73 PHPLYDMSLLKNRFLRPGDD---SSHDLMLLRLSEPAELTDAVKVMDLPTQEPAL-GTTC 128
Query: 259 TVTGWGRLS-EGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRD 317
+GWG + E P LQ V + ++SN+ C + + ++ +CAG GG+
Sbjct: 129 YASGWGSIEPEEFLTPKKLQCVDLHVISNDVCAQVHPQK-----VTKFMLCAGRWTGGKS 183
Query: 318 SCQGDSGGPLQVKGKDGRYFLAGIISWGIG-CAEANLPGVCTRISKFVPWVLDT 370
+C GDSGGPL G L GI SWG CA P + T++ + W+ DT
Sbjct: 184 TCSGDSGGPLVCNG-----VLQGITSWGSEPCALPERPSLYTKVVHYRKWIKDT 232
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 60/227 (26%)
Query: 204 QERGVVKKMVHPKYNFFTYEYDLALVRLETP----VEFAPNIVPICLPGSD-DLLIGENA 258
Q+ V K +VH +++ TY+ D+AL++L++ + + + +CLP +D L
Sbjct: 88 QKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCLPPADLQLPDWTEC 147
Query: 259 TVTGWGRLSEGGSLPPV----LQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNG 314
++G+G+ +L P L++ V + + +C S L ++D +CAG
Sbjct: 148 ELSGYGKHE---ALSPFYSERLKEAHVRLYPSSRCTSQHLLN---RTVTDNMLCAG---- 197
Query: 315 GRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDTGDSG 374
SGGP +ANL C GDSG
Sbjct: 198 -----DTRSGGP-----------------------QANLHDACQ------------GDSG 217
Query: 375 GPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDTV 421
GPL V DGR L GIISWG+GC + ++PGV T+++ ++ W+ D +
Sbjct: 218 GPL-VCLNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNM 263
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 73.9 bits (180), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 60/227 (26%)
Query: 204 QERGVVKKMVHPKYNFFTYEYDLALVRLETP----VEFAPNIVPICLPGSD-DLLIGENA 258
Q+ V K +VH +++ TY+ D+AL++L++ + + + +CLP +D L
Sbjct: 75 QKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCLPPADLQLPDWTEC 134
Query: 259 TVTGWGRLSEGGSLPPV----LQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNG 314
++G+G+ +L P L++ V + + +C S L ++D +CAG
Sbjct: 135 ELSGYGKHE---ALSPFYSERLKEAHVRLYPSSRCTSQHLLN---RTVTDNMLCAG---- 184
Query: 315 GRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDTGDSG 374
SGGP +ANL C GDSG
Sbjct: 185 -----DTRSGGP-----------------------QANLHDACQ------------GDSG 204
Query: 375 GPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDTV 421
GPL V DGR L GIISWG+GC + ++PGV T+++ ++ W+ D +
Sbjct: 205 GPL-VCLNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNM 250
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 72.8 bits (177), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 15/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I + +G ++ + E + V + + HP YN + D+ L++LE ++ +
Sbjct: 48 SSINVTLGAHNIKEQERTQQFIP--VKRPIPHPAYNPKNFSNDIMLLQLERKAKWTTAVR 105
Query: 243 PICLPGSD-DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P+ LP S + G+ +V GWG +S +L LQ+V + + + +C +F G Y
Sbjct: 106 PLRLPSSKAQVKPGQLCSVAGWGYVSM-STLATTLQEVLLTVQKDCQCERLF--HGNYSR 162
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
++I C G + +GDSGGPL K GI+S+ G + PGV ++S
Sbjct: 163 ATEI--CVGDPKKTQTGFKGDSGGPLVCKD-----VAQGILSY--GNKKGTPPGVYIKVS 213
Query: 362 KFVPWVLDT 370
F+PW+ T
Sbjct: 214 HFLPWIKRT 222
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 52/190 (27%), Positives = 92/190 (48%), Gaps = 18/190 (9%)
Query: 182 TSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFF-TYEYDLALVRLETPVEFAPN 240
++ ++++G + L E Q R +K + P N + D+ L++L+ P+ + +
Sbjct: 43 STNFQMQLGVHSKKVLNEDE--QTRNPKEKFICPNKNMSEVLDKDIMLIKLDKPISNSKH 100
Query: 241 IVPICLPGSDDLLIGENATVTGWGRLS-EGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRY 299
I P+ LP S+ +G + GWG ++ + P V + +V E C+ G Y
Sbjct: 101 IAPLSLP-SNPPSVGSVCRIMGWGSITIPNETYPDVPYCANINLVDYEVCQ------GAY 153
Query: 300 EFI-SDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGI-GCAEANLPGVC 357
+ + +CAG GG+D+C GDSGGPL G+ GI+S+G C + PG+
Sbjct: 154 NGLPAKTTLCAGVLEGGKDTCVGDSGGPLICNGQ-----FQGIVSYGAHSCGQGPKPGIY 208
Query: 358 TRISKFVPWV 367
T + + W+
Sbjct: 209 TNVFDYTDWI 218
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 71.2 bits (173), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 12/146 (8%)
Query: 223 EYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSEGGSLPPVLQKVTVP 282
+ D+ L+RL PV ++ +I P+ LP S +G + GWG++S + P V +
Sbjct: 86 DKDIMLIRLRRPVTYSTHIAPVSLP-SRSRGVGSRCRIMGWGKISTT-TYPDVPHCTNIF 143
Query: 283 IVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGII 342
IV ++ C ++ + +CAG GGRD+C GDSGGPL G+ + GI+
Sbjct: 144 IVKHKWCEPLY----PWVPADSRTLCAGILKGGRDTCHGDSGGPLICNGE-----MHGIV 194
Query: 343 SWGIG-CAEANLPGVCTRISKFVPWV 367
+ G C + P V T++ + W+
Sbjct: 195 AGGSEPCGQHLKPAVYTKVFDYNNWI 220
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 71.2 bits (173), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 51/157 (32%), Positives = 83/157 (52%), Gaps = 9/157 (5%)
Query: 214 HPKYNFF-TYEYDLALVRLETPVEFAPNIVPICLPGSDDLLI-GENATVTGWGRLSEGGS 271
HP+Y E DLAL++L+ V+ + I P+ LP ++ G ++ GWG +GG
Sbjct: 74 HPRYKPVPALENDLALLQLDGKVKPSRTIRPLALPSKRQVVAAGTRCSMAGWGLTHQGGR 133
Query: 272 LPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKG 331
L VL+++ + ++ C + G +S +C D+ + C+GDSGGPL V G
Sbjct: 134 LSRVLRELDLQVLDTRMCNNSRFWNGS---LSPSMVCLAADSKDQAPCKGDSGGPL-VCG 189
Query: 332 KDGRYFLAGIISWGIG-CAEANLPGVCTRISKFVPWV 367
K GR LAG++S+ C + P V T ++ +V W+
Sbjct: 190 K-GR-VLAGVLSFSSRVCTDIFKPPVATAVAPYVSWI 224
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 53/189 (28%), Positives = 92/189 (48%), Gaps = 15/189 (7%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I + +G ++ + E + V + + HP YN + ++ L++LE ++ +
Sbjct: 48 SSINVTLGAHNIKEQERTQQFIP--VKRPIPHPAYNPKNFSNNIMLLQLERKAKWTTAVR 105
Query: 243 PICLPGSD-DLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P+ LP S + G+ +V GWG +S +L LQ+V + + + +C +F G Y
Sbjct: 106 PLRLPSSKAQVKPGQLCSVAGWGYVSM-STLATTLQEVLLTVQKDCQCERLF--HGNYSR 162
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
++I C G + +GDSGGPL K GI+S+ G + PGV ++S
Sbjct: 163 ATEI--CVGDPKKTQTGFKGDSGGPLVCKD-----VAQGILSY--GNKKGTPPGVYIKVS 213
Query: 362 KFVPWVLDT 370
F+PW+ T
Sbjct: 214 HFLPWIKRT 222
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 70.5 bits (171), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 54/187 (28%), Positives = 87/187 (46%), Gaps = 14/187 (7%)
Query: 185 IKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPI 244
+ + +G ++ EE Q V K + HP YN D+ L++L + + P+
Sbjct: 51 MTVTLGAHNIKAKEETQ--QIIPVAKAIPHPDYNPDDRSNDIMLLKLVRNAKRTRAVRPL 108
Query: 245 CLPGSDDLLI-GENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFIS 303
LP + + G+ V GWG+++ G P L +V + + ++ C S F + Y +
Sbjct: 109 NLPRRNAHVKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSS--YNRAN 166
Query: 304 DIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKF 363
+I C G S +GDSGGPL K AGI+S+G + + P V TR+ F
Sbjct: 167 EI--CVGDSKIKGASFRGDSGGPLVCK-----RAAAGIVSYGQ--TDGSAPQVFTRVLSF 217
Query: 364 VPWVLDT 370
V W+ T
Sbjct: 218 VSWIKKT 224
>pdb|1MTN|C Chain C, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|G Chain G, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|C Chain C, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|H Chain H, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|C Chain C, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|H Chain H, Bovine Chymotrypsin Complexed To Bpti
pdb|1VGC|C Chain C, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|C Chain C, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|C Chain C, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|C Chain C, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|C Chain C, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|C Chain C, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|E Chain E, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|F Chain F, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|C Chain C, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|G Chain G, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|C Chain C, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|G Chain G, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|G Chain G, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|G Chain G, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|G Chain G, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|G Chain G, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|G Chain G, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|G Chain G, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|G Chain G, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|C Chain C, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|G Chain G, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|C Chain C, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|G Chain G, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|C Chain C, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|G Chain G, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|G Chain G, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|C Chain C, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|C Chain C, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|C Chain C, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|C Chain C, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|C Chain C, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
Length = 97
Score = 69.7 bits (169), Expect = 3e-12, Method: Composition-based stats.
Identities = 39/98 (39%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 273 PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGK 332
P LQ+ ++P++SN C+ + I D +CAG G SC GDSGGPL K K
Sbjct: 4 PDRLQQASLPLLSNTNCKKYWGTK-----IKDAMICAG--ASGVSSCMGDSGGPLVCK-K 55
Query: 333 DGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDT 370
+G + L GI+SWG + PGV R++ V WV T
Sbjct: 56 NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQT 93
Score = 49.3 bits (116), Expect = 4e-06, Method: Composition-based stats.
Identities = 24/51 (47%), Positives = 31/51 (60%), Gaps = 1/51 (1%)
Query: 371 GDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDTV 421
GDSGGPL K K+G + L GI+SWG + PGV R++ V WV T+
Sbjct: 45 GDSGGPLVCK-KNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL 94
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 9/157 (5%)
Query: 214 HPKYNFF-TYEYDLALVRLETPVEFAPNIVPICLPGSDDLLI-GENATVTGWGRLSEGGS 271
HP+Y E +LAL++L+ V+ + I P+ LP ++ G ++ GWG +GG
Sbjct: 74 HPRYKPVPALENNLALLQLDGKVKPSRTIRPLALPSKRQVVAAGTRCSMAGWGLTHQGGR 133
Query: 272 LPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKG 331
L VL+++ + ++ C + G +S +C D+ + C+GDSGGPL V G
Sbjct: 134 LSRVLRELDLQVLDTRMCNNSRFWNGS---LSPSMVCLAADSKDQAPCKGDSGGPL-VCG 189
Query: 332 KDGRYFLAGIISWGIG-CAEANLPGVCTRISKFVPWV 367
K GR LAG++S+ C + P V T ++ +V W+
Sbjct: 190 K-GR-VLAGVLSFSSRVCTDIFKPPVATAVAPYVSWI 224
>pdb|1AFQ|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|3RU4|E Chain E, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 96
Score = 69.3 bits (168), Expect = 4e-12, Method: Composition-based stats.
Identities = 39/98 (39%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 273 PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGK 332
P LQ+ ++P++SN C+ + I D +CAG G SC GDSGGPL K K
Sbjct: 3 PDRLQQASLPLLSNTNCKKYWGTK-----IKDAMICAG--ASGVSSCMGDSGGPLVCK-K 54
Query: 333 DGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDT 370
+G + L GI+SWG + PGV R++ V WV T
Sbjct: 55 NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQT 92
Score = 48.9 bits (115), Expect = 5e-06, Method: Composition-based stats.
Identities = 24/51 (47%), Positives = 31/51 (60%), Gaps = 1/51 (1%)
Query: 371 GDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDTV 421
GDSGGPL K K+G + L GI+SWG + PGV R++ V WV T+
Sbjct: 44 GDSGGPLVCK-KNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL 93
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 12/164 (7%)
Query: 208 VVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLI-GENATVTGWGRL 266
V K + HP YN D+ L++L + + P+ LP + + G+ V GWG++
Sbjct: 72 VAKAIPHPDYNPDDRSNDIMLLKLVRNAKRTRAVRPLNLPRRNAHVKPGDECYVAGWGKV 131
Query: 267 SEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGP 326
+ G P L +V + + ++ C S F + Y ++I C G S + DSGGP
Sbjct: 132 TPDGEFPKTLHEVKLTVQKDQVCESQFQSS--YNRANEI--CVGDSKIKGASFEEDSGGP 187
Query: 327 LQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDT 370
L K AGI+S+G + + P V TR+ FV W+ T
Sbjct: 188 LVCK-----RAAAGIVSYGQ--TDGSAPQVFTRVLSFVSWIKKT 224
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 64.7 bits (156), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 20/163 (12%)
Query: 215 PKYNFFT--------YEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRL 266
PK FF + D+ L++L++ V + +I P+ S +G + GWG+
Sbjct: 68 PKEKFFCPNRKKDDEVDKDIMLIKLDSSVSNSEHIAPL-SLPSSPPSVGSVCRIMGWGKT 126
Query: 267 SEGGSL-PPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
+ P V + I+ + CR+ + + +++ +CAG GGRD+C DSGG
Sbjct: 127 IPTKEIYPDVPHCANINILDHAVCRTAY----SWRQVANTTLCAGILQGGRDTCHFDSGG 182
Query: 326 PLQVKGKDGRYFLAGIISWGIG-CAEANLPGVCTRISKFVPWV 367
PL G GI+SWG C + PGV T++ ++ W+
Sbjct: 183 PLICNG-----IFQGIVSWGGHPCGQPGEPGVYTKVFDYLDWI 220
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 16/192 (8%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I + +G ++ + E Q + + HP+YN T + D+ L++L V N+
Sbjct: 48 SNINVTLGAHNIQRRENTQ--QHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVN 105
Query: 243 PICLPGSDD-LLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P+ LP + + L G TV GWGR+S L++V + + + +C +F G Y+
Sbjct: 106 PVALPRAQEGLRPGTLCTVAGWGRVSMRRGT-DTLREVQLRVQRDRQCLRIF---GSYDP 161
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I C G + + +GDSGGPL GI+S+G P V TR+S
Sbjct: 162 RRQI--CVGDRRERKAAFKGDSGGPLLCNN-----VAHGIVSYGKSSGVP--PEVFTRVS 212
Query: 362 KFVPWVLDTGDS 373
F+PW+ T S
Sbjct: 213 SFLPWIRTTMRS 224
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 16/192 (8%)
Query: 183 SQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIV 242
S I + +G ++ + E Q + + HP+YN T + D+ L++L V N+
Sbjct: 48 SNINVTLGAHNIQRRENTQ--QHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVN 105
Query: 243 PICLPGSDD-LLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEF 301
P+ LP + + L G TV GWGR+S L++V + + + +C +F G Y+
Sbjct: 106 PVALPRAQEGLRPGTLCTVAGWGRVSMRRGT-DTLREVQLRVQRDRQCLRIF---GSYDP 161
Query: 302 ISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
I C G + + +GDSGGPL GI+S+G + P V TR+S
Sbjct: 162 RRQI--CVGDRRERKAAFKGDSGGPLLCNN-----VAHGIVSYGK--SSGVPPEVFTRVS 212
Query: 362 KFVPWVLDTGDS 373
F+PW+ T S
Sbjct: 213 SFLPWIRTTMRS 224
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 62.4 bits (150), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 50/190 (26%), Positives = 92/190 (48%), Gaps = 17/190 (8%)
Query: 182 TSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHP-KYNFFTYEYDLALVRLETPVEFAPN 240
++ ++++G + L E Q R +K + P K N + D+ L++L+ P+ + +
Sbjct: 44 STNFQMQLGVHSKKVLNEDE--QTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKH 101
Query: 241 IVPICLPGSDDLLIGENATVTGWGRLSE-GGSLPPVLQKVTVPIVSNEKCRSMFLRAGRY 299
I P+ S +G + GWG ++ + P V + ++ + C+ AG
Sbjct: 102 IAPL-SLPSSPPSVGSVCRIMGWGSITPVKETFPDVPYCANINLLDHAVCQ-----AGYP 155
Query: 300 EFISDI-FMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG-CAEANLPGVC 357
E +++ +CAG GG+D+C GDSGGPL G+ GI+S+G C + PG+
Sbjct: 156 ELLAEYRTLCAGIVQGGKDTCGGDSGGPLICNGQ-----FQGIVSYGAHPCGQGPKPGIY 210
Query: 358 TRISKFVPWV 367
T + + W+
Sbjct: 211 TNVFDYTDWI 220
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 62.0 bits (149), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 50/190 (26%), Positives = 92/190 (48%), Gaps = 17/190 (8%)
Query: 182 TSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHP-KYNFFTYEYDLALVRLETPVEFAPN 240
++ ++++G + L E Q R +K + P K N + D+ L++L+ P+ + +
Sbjct: 44 STDFQMQLGVHSKKVLNEDE--QTRNPKEKFICPNKNNNEVLDKDIMLIKLDKPISNSKH 101
Query: 241 IVPICLPGSDDLLIGENATVTGWGRLSE-GGSLPPVLQKVTVPIVSNEKCRSMFLRAGRY 299
I P+ S +G + GWG ++ + P V + ++ + C+ AG
Sbjct: 102 IAPL-SLPSSPPSVGSVCRIMGWGSITPVKETFPDVPYCANINLLDHAVCQ-----AGYP 155
Query: 300 EFISDI-FMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG-CAEANLPGVC 357
E +++ +CAG GG+D+C GDSGGPL G+ GI+S+G C + PG+
Sbjct: 156 ELLAEYRTLCAGIVQGGKDTCGGDSGGPLICNGQ-----FQGIVSYGAHPCGQGPKPGIY 210
Query: 358 TRISKFVPWV 367
T + + W+
Sbjct: 211 TNVFDYTDWI 220
>pdb|2HNT|F Chain F, Crystallographic Structure Of Human Gamma-Thrombin
pdb|1BHX|F Chain F, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|C Chain C, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
Length = 105
Score = 61.6 bits (148), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 41/108 (37%), Positives = 56/108 (51%), Gaps = 11/108 (10%)
Query: 273 PPVLQKVTVPIVSNEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQ 328
P VLQ V +PIV C+ S +R I+D CAG+ D G R D+C+GDSGGP
Sbjct: 3 PSVLQVVNLPIVERPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFV 56
Query: 329 VKGK-DGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
+K + R++ GI+SWG GC G T + + W+ D G
Sbjct: 57 MKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG 104
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 18/52 (34%), Positives = 27/52 (51%), Gaps = 1/52 (1%)
Query: 371 GDSGGPLQVKGK-DGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDTV 421
GDSGGP +K + R++ GI+SWG GC G T + + W+ +
Sbjct: 49 GDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 100
>pdb|2PKS|C Chain C, Thrombin In Complex With Inhibitor
pdb|3PO1|C Chain C, Thrombin In Complex With Benzothiazole Guanidine
Length = 102
Score = 61.2 bits (147), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 39/100 (39%), Positives = 54/100 (54%), Gaps = 11/100 (11%)
Query: 273 PPVLQKVTVPIVSNEKCR-SMFLRAGRYEFISDIFMCAGF--DNGGR-DSCQGDSGGPLQ 328
P VLQ V +PIV C+ S +R I+D CAG+ D G R D+C+GDSGGP
Sbjct: 3 PSVLQVVNLPIVERPVCKDSTRIR------ITDNMFCAGYKPDEGKRGDACEGDSGGPFV 56
Query: 329 VKGK-DGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 367
+K + R++ GI+SWG GC G T + + W+
Sbjct: 57 MKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWI 96
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 18/52 (34%), Positives = 27/52 (51%), Gaps = 1/52 (1%)
Query: 371 GDSGGPLQVKGK-DGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDTV 421
GDSGGP +K + R++ GI+SWG GC G T + + W+ +
Sbjct: 49 GDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 100
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 26/203 (12%)
Query: 181 LTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYN-----------FFTYEYDLALV 229
++ +I +G ++ SK E+ + + V + P+++ + +DL L+
Sbjct: 43 MSDDYQIWLGRHNLSKDEDTAQFHQ--VSDSFLDPQFDLSLLKKKYLRPYDDISHDLMLL 100
Query: 230 RLETPVEFAPNIVPICLPGSDDLLIGENATVTGWGRLSEGGSLPP-VLQKVTVPIVSNEK 288
RL P + + LP + L G +GWG +S + LQ V + + SNEK
Sbjct: 101 RLAQPARITDAVKILDLPTQEPKL-GSTCYTSGWGLISTFTNRGSGTLQCVELRLQSNEK 159
Query: 289 CRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG- 347
C + E +++ +CA + C GDSGG L G GI SWG
Sbjct: 160 CARAYP-----EKMTEFVLCATHRDDSGSICLGDSGGALICDG-----VFQGITSWGYSE 209
Query: 348 CAEANLPGVCTRISKFVPWVLDT 370
CA+ N V T++ W+ +T
Sbjct: 210 CADFNDNFVFTKVMPHKKWIKET 232
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 21/173 (12%)
Query: 203 YQERGVVKK---MVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSDDLLIG-EN- 257
Y+ VV + H +N TY D+AL+++ VE+ NI PI LP ++L EN
Sbjct: 63 YEGEAVVNSERIISHSMFNPDTYLNDVALIKIPH-VEYTDNIQPIRLPSGEELNNKFENI 121
Query: 258 -ATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGR 316
ATV+GWG + + +LQ ++ N++C + I + +C G + G+
Sbjct: 122 WATVSGWG---QSNTDTVILQYTYNLVIDNDRCAQEYPPG----IIVESTIC-GDTSDGK 173
Query: 317 DSCQGDSGGPLQVKGKDGRYFLAGIISW--GIGCAEANLPGVCTRISKFVPWV 367
C GDSGGP + K+ L G++S+ G GC E+ P +R++ ++ W+
Sbjct: 174 SPCFGDSGGPFVLSDKN---LLIGVVSFVSGAGC-ESGKPVGFSRVTSYMDWI 222
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 59.3 bits (142), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/195 (29%), Positives = 95/195 (48%), Gaps = 27/195 (13%)
Query: 182 TSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHP-KYNFFTYEYDLALVRLETPVEFAPN 240
+ ++++G + L E Q R +K + P K N + D+ L++L++ V + +
Sbjct: 44 NTNFQMKLGVHSKKVLNEDE--QTRNPKEKFICPNKKNDEVLDKDIMLIKLDSRVSNSEH 101
Query: 241 IVPICLPGSDDLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFL------ 294
IVP+ S +G + GWG S+ P+ KVT P V C + L
Sbjct: 102 IVPL-SLPSSPPSVGSVCHIMGWG------SITPI--KVTYPDVP--YCAYINLLDDAVC 150
Query: 295 RAGRYEFISDI-FMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG-CAEAN 352
+AG E +++ +CAG GG+D+C GDSGGPL G+ GI+S+G C +
Sbjct: 151 QAGYPELLTEYRTLCAGILEGGKDTCGGDSGGPLICNGQ-----FQGIVSFGAHPCGQGL 205
Query: 353 LPGVCTRISKFVPWV 367
PGV T++ + W+
Sbjct: 206 KPGVYTKVFDYNHWI 220
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 55/195 (28%), Positives = 85/195 (43%), Gaps = 26/195 (13%)
Query: 175 ESVNSLLTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETP 234
S+ LL + K +V E + KLE V K+ HPKY+ D+ L++L+
Sbjct: 49 RSITVLLGAHNK-KVKEDTWQKLE---------VEKQFPHPKYDDRLVLNDIMLLKLKEK 98
Query: 235 VEFAPNI--VPICLPGSDDLLIGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSM 292
+ +PI S+ + G GWGR + LQ+V + I+ + C+
Sbjct: 99 ANLTLGVGTLPISA-KSNSIPPGRVCRAVGWGRTNVNEPPSDTLQEVKMRILDPQACKHF 157
Query: 293 FLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEAN 352
+F + +C G R+ +GDSGGPL G GI S+ + A+
Sbjct: 158 ------EDFHQEPQLCVGNPKKIRNVYKGDSGGPLLCAG-----IAQGIASYVLRNAKP- 205
Query: 353 LPGVCTRISKFVPWV 367
P V TRIS + PW+
Sbjct: 206 -PSVFTRISHYRPWI 219
>pdb|1BBR|E Chain E, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|E Chain E, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|G Chain G, Thrombin:hirudin 51-65 Complex
pdb|1YCP|M Chain M, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 109
Score = 58.9 bits (141), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 39/108 (36%), Positives = 56/108 (51%), Gaps = 11/108 (10%)
Query: 273 PPVLQKVTVPIVSNEKCR-SMFLRAGRYEFISDIFMCAGFDNG-GR--DSCQGDSGGPLQ 328
P VLQ V +P+V C+ S +R I+D CAG+ G G+ D+C+GDSGGP
Sbjct: 7 PSVLQVVNLPLVERPVCKASTRIR------ITDNMFCAGYKPGEGKRGDACEGDSGGPFV 60
Query: 329 VKGK-DGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDTGDSGG 375
+K + R++ GI+SWG GC G T + + W+ D G
Sbjct: 61 MKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDRLG 108
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 18/52 (34%), Positives = 27/52 (51%), Gaps = 1/52 (1%)
Query: 371 GDSGGPLQVKGK-DGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWVLDTV 421
GDSGGP +K + R++ GI+SWG GC G T + + W+ +
Sbjct: 53 GDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 104
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 56.6 bits (135), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 39/171 (22%)
Query: 212 MVHPKYNFFT---------YEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTG 262
+ HP YN Y+YD+AL++L+ +++ I PICLP ++ T
Sbjct: 88 LFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTT 147
Query: 263 WGRLSEGGSLPPVLQKVTVPIVSNEKC----RSMFLRAGR--------------YEFISD 304
+ + LP Q + VS E+ + ++++ G Y+ + D
Sbjct: 148 TCQQQKEELLPA--QDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKD 205
Query: 305 I-------FMCAGFDNGGRD--SCQGDSGGPLQVKGKDGRYFLAGIISWGI 346
I F+C G + D +C+GDSGGPL V K R+ G+ISWG+
Sbjct: 206 ISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVH-KRSRFIQVGVISWGV 255
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 39/171 (22%)
Query: 212 MVHPKYNFFT---------YEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTG 262
+ HP YN Y+YD+AL++L+ +++ I PICLP ++ T
Sbjct: 287 LFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTT 346
Query: 263 WGRLSEGGSLPPVLQKVTVPIVSNEKC----RSMFLRAGR--------------YEFISD 304
+ + LP Q + VS E+ + ++++ G Y+ + D
Sbjct: 347 TCQQQKEELLPA--QDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKD 404
Query: 305 I-------FMCAGFDNGGRD--SCQGDSGGPLQVKGKDGRYFLAGIISWGI 346
I F+C G + D +C+GDSGGPL V K R+ G+ISWG+
Sbjct: 405 ISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVH-KRSRFIQVGVISWGV 454
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 39/171 (22%)
Query: 212 MVHPKYNFFT---------YEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTG 262
+ HP YN Y+YD+AL++L+ +++ I PICLP ++ T
Sbjct: 295 LFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTT 354
Query: 263 WGRLSEGGSLPPVLQKVTVPIVSNEKC----RSMFLRAGR--------------YEFISD 304
+ + LP Q + VS E+ + ++++ G Y+ + D
Sbjct: 355 TCQQQKEELLPA--QDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKD 412
Query: 305 I-------FMCAGFDNGGRD--SCQGDSGGPLQVKGKDGRYFLAGIISWGI 346
I F+C G + D +C+GDSGGPL V K R+ G+ISWG+
Sbjct: 413 ISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVH-KRSRFIQVGVISWGV 462
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 39/171 (22%)
Query: 212 MVHPKYNFFT---------YEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTG 262
+ HP YN Y+YD+AL++L+ +++ I PICLP ++ T
Sbjct: 520 LFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTT 579
Query: 263 WGRLSEGGSLPPVLQKVTVPIVSNEKC----RSMFLRAGR--------------YEFISD 304
+ + LP Q + VS E+ + ++++ G Y+ + D
Sbjct: 580 TCQQQKEELLPA--QDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKD 637
Query: 305 I-------FMCAGFDNGGRD--SCQGDSGGPLQVKGKDGRYFLAGIISWGI 346
I F+C G + D +C+GDSGGPL V K R+ G+ISWG+
Sbjct: 638 ISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVH-KRSRFIQVGVISWGV 687
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 39/171 (22%)
Query: 212 MVHPKYNFFT---------YEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTG 262
+ HP YN Y+YD+AL++L+ +++ I PICLP ++ T
Sbjct: 539 LFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTT 598
Query: 263 WGRLSEGGSLPPVLQKVTVPIVSNEKC----RSMFLRAGR--------------YEFISD 304
+ + LP Q + VS E+ + ++++ G Y+ + D
Sbjct: 599 TCQQQKEELLPA--QDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKD 656
Query: 305 I-------FMCAGFDNGGRD--SCQGDSGGPLQVKGKDGRYFLAGIISWGI 346
I F+C G + D +C+GDSGGPL V K R+ G+ISWG+
Sbjct: 657 ISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVH-KRSRFIQVGVISWGV 706
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 55.8 bits (133), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 39/171 (22%)
Query: 212 MVHPKYNFFT---------YEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENATVTG 262
+ HP YN Y+YD+AL++L+ +++ I PICLP ++ T
Sbjct: 529 LFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTT 588
Query: 263 WGRLSEGGSLPPVLQKVTVPIVSNEKC----RSMFLRAGR--------------YEFISD 304
+ + LP Q + VS E+ + ++++ G Y+ + D
Sbjct: 589 TCQQQKEELLPA--QDIKALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKD 646
Query: 305 I-------FMCAGFDNGGRD--SCQGDSGGPLQVKGKDGRYFLAGIISWGI 346
I F+C G + D +C+GDSGGPL V K R+ G+ISWG+
Sbjct: 647 ISEVVTPRFLCTGGVSPYADPNTCRGDSGGPLIVH-KRSRFIQVGVISWGV 696
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 6/144 (4%)
Query: 225 DLALVRLETPVEFAPNIVPICLPGSDDLLIGENA-TVTGWGRLSEGGSLPPVLQKVTVPI 283
DL L++L P + I LP + + + +V GWG + + +L+ + I
Sbjct: 84 DLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYGWG-YTGLINYDGLLRVAHLYI 142
Query: 284 VSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIIS 343
+ NEKC G+ +++ +CAG + G C+GD GGPL + R L G+I
Sbjct: 143 MGNEKCSQH--HRGKVT-LNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVL-GVIV 198
Query: 344 WGIGCAEANLPGVCTRISKFVPWV 367
G GCA N PG+ R++ + W+
Sbjct: 199 PGRGCAIPNRPGIFVRVAYYAKWI 222
Score = 36.6 bits (83), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 19/47 (40%), Positives = 26/47 (55%), Gaps = 1/47 (2%)
Query: 371 GDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 417
GD GGPL + R L G+I G GCA N PG+ R++ + W+
Sbjct: 177 GDYGGPLVCEQHKMRMVL-GVIVPGRGCAIPNRPGIFVRVAYYAKWI 222
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 6/144 (4%)
Query: 225 DLALVRLETPVEFAPNIVPICLPGSDDLLIGENA-TVTGWGRLSEGGSLPPVLQKVTVPI 283
DL L++L P + I LP + + + +V GWG + + +L+ + I
Sbjct: 84 DLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYGWG-YTGLINYDGLLRVAHLYI 142
Query: 284 VSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIIS 343
+ NEKC G+ +++ +CAG + G C+GD GGPL + R L G+I
Sbjct: 143 MGNEKCSQH--HRGKVT-LNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVL-GVIV 198
Query: 344 WGIGCAEANLPGVCTRISKFVPWV 367
G GCA N PG+ R++ + W+
Sbjct: 199 PGRGCAIPNRPGIFVRVAYYAKWI 222
Score = 36.6 bits (83), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 19/47 (40%), Positives = 26/47 (55%), Gaps = 1/47 (2%)
Query: 371 GDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 417
GD GGPL + R L G+I G GCA N PG+ R++ + W+
Sbjct: 177 GDYGGPLVCEQHKMRMVL-GVIVPGRGCAIPNRPGIFVRVAYYAKWI 222
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 55.1 bits (131), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 48/188 (25%), Positives = 78/188 (41%), Gaps = 24/188 (12%)
Query: 185 IKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPI 244
+ + +G ++ E P Q+ V ++ Y+ D+ L++L +P + ++ +
Sbjct: 54 VNVVLGAHNVRTQE---PTQQHFSVAQVFLNNYDAENKLNDILLIQLSSPANLSASVATV 110
Query: 245 CLPGSDDLL-IGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFIS 303
LP D + G GWGR+ VLQ++ V +V+ F R
Sbjct: 111 QLPQQDQPVPHGTQCLAMGWGRVGAHDPPAQVLQELNVTVVT------FFCRPHN----- 159
Query: 304 DIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGI-GCAEANLPGVCTRISK 362
+C C GDSGGPL G + GI S+ I GCA P TR++
Sbjct: 160 ---ICTFVPRRKAGICFGDSGGPLICDG-----IIQGIDSFVIWGCATRLFPDFFTRVAL 211
Query: 363 FVPWVLDT 370
+V W+ T
Sbjct: 212 YVDWIRST 219
Score = 33.5 bits (75), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 21/52 (40%), Positives = 28/52 (53%), Gaps = 6/52 (11%)
Query: 371 GDSGGPLQVKGKDGRYFLAGIISWGI-GCAEANLPGVCTRISKFVPWVLDTV 421
GDSGGPL G + GI S+ I GCA P TR++ +V W+ T+
Sbjct: 174 GDSGGPLICDG-----IIQGIDSFVIWGCATRLFPDFFTRVALYVDWIRSTL 220
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 55.1 bits (131), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 44/144 (30%), Positives = 66/144 (45%), Gaps = 8/144 (5%)
Query: 225 DLALVRLETPVEFAPNIVPICLPGSDDLLI-GENATVTGWGRLSEGGSLPPVLQKVTVPI 283
L L++LE V + ICLP ++ G + GWG ++G VL + +
Sbjct: 85 QLVLLKLERSVTLNQRVALICLPPEWYVVPPGTKCEIAGWGE-TKGTGNDTVLNVALLNV 143
Query: 284 VSNEKCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIIS 343
+SN++C GR + + MC +C+GD GGPL + + L GII
Sbjct: 144 ISNQECN--IKHRGR---VRESEMCTEGLLAPVGACEGDYGGPLACFTHNS-WVLEGIII 197
Query: 344 WGIGCAEANLPGVCTRISKFVPWV 367
CA + P V TR+S FV W+
Sbjct: 198 PNRVCARSRWPAVFTRVSVFVDWI 221
Score = 33.9 bits (76), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 25/47 (53%), Gaps = 1/47 (2%)
Query: 371 GDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPWV 417
GD GGPL + + L GII CA + P V TR+S FV W+
Sbjct: 176 GDYGGPLACFTHNS-WVLEGIIIPNRVCARSRWPAVFTRVSVFVDWI 221
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 51.6 bits (122), Expect = 8e-07, Method: Composition-based stats.
Identities = 27/77 (35%), Positives = 40/77 (51%), Gaps = 3/77 (3%)
Query: 190 GEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPG- 248
GE+D EE Q + + +PK+N FT D+ L++L TP +F+ + +CLP
Sbjct: 51 GEFDQGSDEENI--QVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVCLPNV 108
Query: 249 SDDLLIGENATVTGWGR 265
DD G TGWG+
Sbjct: 109 DDDFPPGTVCATTGWGK 125
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 52/88 (59%), Gaps = 8/88 (9%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ +++K+ +HP+YN+ + D+AL++L+ PV F+ I P+
Sbjct: 61 VRIGKHSRTRYERNI--EKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPV 118
Query: 245 CLPGSDD----LLIGENATVTGWGRLSE 268
CLP + L G VTGWG L E
Sbjct: 119 CLPDRETAASLLQAGYKGRVTGWGNLKE 146
>pdb|2HNT|E Chain E, Crystallographic Structure Of Human Gamma-Thrombin
Length = 81
Score = 50.8 bits (120), Expect = 2e-06, Method: Composition-based stats.
Identities = 26/64 (40%), Positives = 37/64 (57%), Gaps = 5/64 (7%)
Query: 210 KKMVHPKYNFF-TYEYDLALVRLETPVEFAPNIVPICLPGSDD----LLIGENATVTGWG 264
K +HP+YN+ + D+AL++L+ PV F+ I P+CLP + L G VTGWG
Sbjct: 10 KIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWG 69
Query: 265 RLSE 268
L E
Sbjct: 70 NLKE 73
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 48.5 bits (114), Expect = 7e-06, Method: Composition-based stats.
Identities = 27/85 (31%), Positives = 40/85 (47%), Gaps = 3/85 (3%)
Query: 181 LTSQIKIRVGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPN 240
+T+ + GE+D E Q+ + K + KYN T D+ L++L T F+
Sbjct: 45 VTTSDVVVAGEFDQGSSSEKI--QKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQT 102
Query: 241 IVPICLP-GSDDLLIGENATVTGWG 264
+ +CLP SDD G TGWG
Sbjct: 103 VSAVCLPSASDDFAAGTTCVTTGWG 127
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 48.1 bits (113), Expect = 1e-05, Method: Composition-based stats.
Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 3/77 (3%)
Query: 190 GEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPG- 248
GE+D EE Q + + +PK+N FT D+ L++L TP +F+ + + LP
Sbjct: 54 GEFDQGSDEENI--QVLKIAQVFKNPKFNMFTVRNDITLLKLATPAQFSETVSAVSLPNV 111
Query: 249 SDDLLIGENATVTGWGR 265
DD G TGWG+
Sbjct: 112 DDDFPPGTVCATTGWGK 128
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 50/88 (56%), Gaps = 8/88 (9%)
Query: 187 IRVGEYDFSKLEEPYPYQERGVVKKM-VHPKYNFF-TYEYDLALVRLETPVEFAPNIVPI 244
+R+G++ ++ E ++ ++ K+ +HP+YN+ + D+AL++L+ P+E + I P+
Sbjct: 61 VRIGKHSRTRYERKV--EKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPV 118
Query: 245 CLP----GSDDLLIGENATVTGWGRLSE 268
CLP + L G VTGWG E
Sbjct: 119 CLPDKQTAAKLLHAGFKGRVTGWGNRRE 146
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 43.5 bits (101), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 45/183 (24%), Positives = 73/183 (39%), Gaps = 28/183 (15%)
Query: 189 VGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPG 248
+G ++ S+ E P ++ V+++ Y+ D+ +++L N+ LP
Sbjct: 55 LGAHNLSRRE---PTRQVFAVQRIFEDGYDPVNLLNDIVILQLNGSATINANVQVAQLPA 111
Query: 249 SDDLL-IGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFM 307
L G GWG L + VLQ++ V +V++ RS R
Sbjct: 112 QGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVR--------- 162
Query: 308 CAGFDNGGRDS--CQGDSGGPLQVKGKDGRYFLAGIISW-GIGCAEANLPGVCTRISKFV 364
GR + C GDSG PL G + GI S+ GCA P +++FV
Sbjct: 163 -------GRQAGVCFGDSGSPLVCNG-----LIHGIASFVRGGCASGLYPDAFAPVAQFV 210
Query: 365 PWV 367
W+
Sbjct: 211 NWI 213
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 45/183 (24%), Positives = 73/183 (39%), Gaps = 28/183 (15%)
Query: 189 VGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPG 248
+G ++ S+ E P ++ V+++ Y+ D+ +++L N+ LP
Sbjct: 55 LGAHNLSRRE---PTRQVFAVQRIFEDGYDPVNLLNDIVILQLNGSATINANVQVAQLPA 111
Query: 249 SDDLL-IGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFM 307
L G GWG L + VLQ++ V +V++ RS R
Sbjct: 112 QGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVR--------- 162
Query: 308 CAGFDNGGRDS--CQGDSGGPLQVKGKDGRYFLAGIISW-GIGCAEANLPGVCTRISKFV 364
GR + C GDSG PL G + GI S+ GCA P +++FV
Sbjct: 163 -------GRQAGVCFGDSGSPLVCNG-----LIHGIASFVRGGCASGLYPDAFAPVAQFV 210
Query: 365 PWV 367
W+
Sbjct: 211 NWI 213
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 45/183 (24%), Positives = 73/183 (39%), Gaps = 28/183 (15%)
Query: 189 VGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPG 248
+G ++ S+ E P ++ V+++ Y+ D+ +++L N+ LP
Sbjct: 55 LGAHNLSRRE---PTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPA 111
Query: 249 SDDLL-IGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFM 307
L G GWG L + VLQ++ V +V++ RS R
Sbjct: 112 QGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVR--------- 162
Query: 308 CAGFDNGGRDS--CQGDSGGPLQVKGKDGRYFLAGIISW-GIGCAEANLPGVCTRISKFV 364
GR + C GDSG PL G + GI S+ GCA P +++FV
Sbjct: 163 -------GRQAGVCFGDSGSPLVCNG-----LIHGIASFVRGGCASGLYPDAFAPVAQFV 210
Query: 365 PWV 367
W+
Sbjct: 211 NWI 213
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 44/190 (23%), Positives = 72/190 (37%), Gaps = 24/190 (12%)
Query: 189 VGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPG 248
+G YD + E ++ + M Y+ DL L++L+ ++ + LP
Sbjct: 55 LGAYDLRRRERQS--RQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPL 112
Query: 249 SDDLL-IGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFM 307
+ + G V GWG GG L + V V + ++CR +
Sbjct: 113 QNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPNNV------------- 159
Query: 308 CAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG-CAEANLPGVCTRISKFVPW 366
C G C GD G PL +G G+ S+ +G C P TR++ F W
Sbjct: 160 CTGVLTRRGGICNGDQGTPLVCEG-----LAHGVASFSLGPCGRG--PDFFTRVALFRDW 212
Query: 367 VLDTGDSGGP 376
+ ++ GP
Sbjct: 213 IDGVLNNPGP 222
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human Leukocyte
Elastase (Pmn Elastase) And The Third Domain Of The
Turkey Ovomucoid Inhibitor
Length = 218
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 45/183 (24%), Positives = 73/183 (39%), Gaps = 28/183 (15%)
Query: 189 VGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPG 248
+G ++ S+ E P ++ V+++ Y+ D+ +++L N+ LP
Sbjct: 55 LGAHNLSRRE---PTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPA 111
Query: 249 SDDLL-IGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFM 307
L G GWG L + VLQ++ V +V++ RS R
Sbjct: 112 QGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVR--------- 162
Query: 308 CAGFDNGGRDS--CQGDSGGPLQVKGKDGRYFLAGIISW-GIGCAEANLPGVCTRISKFV 364
GR + C GDSG PL G + GI S+ GCA P +++FV
Sbjct: 163 -------GRQAGVCFGDSGSPLVCNG-----LIHGIASFVRGGCASGLYPDAFAPVAQFV 210
Query: 365 PWV 367
W+
Sbjct: 211 NWI 213
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 44/190 (23%), Positives = 72/190 (37%), Gaps = 24/190 (12%)
Query: 189 VGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPG 248
+G YD + E ++ + M Y+ DL L++L+ ++ + LP
Sbjct: 55 LGAYDLRRRERQS--RQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPL 112
Query: 249 SDDLL-IGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFM 307
+ + G V GWG GG L + V V + ++CR +
Sbjct: 113 QNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPNNV------------- 159
Query: 308 CAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG-CAEANLPGVCTRISKFVPW 366
C G C GD G PL +G G+ S+ +G C P TR++ F W
Sbjct: 160 CTGVLTRRGGICNGDGGTPLVCEG-----LAHGVASFSLGPCGRG--PDFFTRVALFRDW 212
Query: 367 VLDTGDSGGP 376
+ ++ GP
Sbjct: 213 IDGVLNNPGP 222
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 44/190 (23%), Positives = 72/190 (37%), Gaps = 24/190 (12%)
Query: 189 VGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPG 248
+G YD + E ++ + M Y+ DL L++L+ ++ + LP
Sbjct: 55 LGAYDLRRRERQS--RQTFSISSMSENGYDPQQNLNDLMLLQLDREANLTSSVTILPLPL 112
Query: 249 SDDLL-IGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFM 307
+ + G V GWG GG L + V V + ++CR +
Sbjct: 113 QNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPNNV------------- 159
Query: 308 CAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWGIG-CAEANLPGVCTRISKFVPW 366
C G C GD G PL +G G+ S+ +G C P TR++ F W
Sbjct: 160 CTGVLTRRGGICNGDGGTPLVCEG-----LAHGVASFSLGPCGRG--PDFFTRVALFRDW 212
Query: 367 VLDTGDSGGP 376
+ ++ GP
Sbjct: 213 IDGVLNNPGP 222
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 45/185 (24%), Positives = 77/185 (41%), Gaps = 47/185 (25%)
Query: 208 VVKKMVHPKYNFFT---------YEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENA 258
+ K ++ P ++ F Y D+AL++L V+ + + PICLP + + +
Sbjct: 300 IEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLPCTMEANLALRR 359
Query: 259 TVTGWGRLSEGGSLPPVLQKVTVP--------------------------IVSNEKCRSM 292
R E +L K +VP +VS EK
Sbjct: 360 PQGSTCRDHEN----ELLNKQSVPAHFVALNGSKLNINLKMGVEWTSCAEVVSQEKTMFP 415
Query: 293 FLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWG-----IG 347
L R E ++D F+C+G C+G+SGG + ++ + R+F G++SWG +G
Sbjct: 416 NLTDVR-EVVTDQFLCSGTQED-ESPCKGESGGAVFLERR-FRFFQVGLVSWGLYNPCLG 472
Query: 348 CAEAN 352
A+ N
Sbjct: 473 SADKN 477
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 45/185 (24%), Positives = 77/185 (41%), Gaps = 47/185 (25%)
Query: 208 VVKKMVHPKYNFFT---------YEYDLALVRLETPVEFAPNIVPICLPGSDDLLIGENA 258
+ K ++ P ++ F Y D+AL++L V+ + + PICLP + + +
Sbjct: 292 IEKAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVKMSTHARPICLPCTMEANLALRR 351
Query: 259 TVTGWGRLSEGGSLPPVLQKVTVP--------------------------IVSNEKCRSM 292
R E +L K +VP +VS EK
Sbjct: 352 PQGSTCRDHEN----ELLNKQSVPAHFVALNGSKLNINLKMGVEWTSCAEVVSQEKTMFP 407
Query: 293 FLRAGRYEFISDIFMCAGFDNGGRDSCQGDSGGPLQVKGKDGRYFLAGIISWG-----IG 347
L R E ++D F+C+G C+G+SGG + ++ + R+F G++SWG +G
Sbjct: 408 NLTDVR-EVVTDQFLCSGTQED-ESPCKGESGGAVFLERR-FRFFQVGLVSWGLYNPCLG 464
Query: 348 CAEAN 352
A+ N
Sbjct: 465 SADKN 469
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 41.6 bits (96), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 44/183 (24%), Positives = 72/183 (39%), Gaps = 28/183 (15%)
Query: 189 VGEYDFSKLEEPYPYQERGVVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPG 248
+G ++ S+ E P ++ V+++ Y+ D+ +++L N+ LP
Sbjct: 55 LGAHNLSRRE---PTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPA 111
Query: 249 SDDLL-IGENATVTGWGRLSEGGSLPPVLQKVTVPIVSNEKCRSMFLRAGRYEFISDIFM 307
L G GWG L + VLQ++ V +V++ RS R
Sbjct: 112 QGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVR--------- 162
Query: 308 CAGFDNGGRDS--CQGDSGGPLQVKGKDGRYFLAGIISW-GIGCAEANLPGVCTRISKFV 364
GR + C GD G PL G + GI S+ GCA P +++FV
Sbjct: 163 -------GRQAGVCFGDXGSPLVCNG-----LIHGIASFVRGGCASGLYPDAFAPVAQFV 210
Query: 365 PWV 367
W+
Sbjct: 211 NWI 213
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 40/166 (24%), Positives = 68/166 (40%), Gaps = 22/166 (13%)
Query: 208 VVKKMVHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSD---DLLIGEN-ATVTGW 263
+ VH +Y+ E DL+L+ LE P++ +P+C P D LLI ++GW
Sbjct: 161 ITHVHVHMRYDADAGENDLSLLELEWPIQCPGAGLPVCTPEKDFAEHLLIPRTRGLLSGW 220
Query: 264 GRLSEGGSLPPVLQKVTVPIVSNEKCRSMF---LRAGRYEFISDIFMCAGFDNGGRDSCQ 320
R G L L V +V E+C + + Y S + D
Sbjct: 221 AR--NGTDLGNSLTTRPVTLVEGEECGQVLNVTVTTRTYCERSSVAAMHWMD-------- 270
Query: 321 GDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPW 366
G + + G +FL G++ +A++ V T++S++ W
Sbjct: 271 ----GSVVTREHRGSWFLTGVLGSQPVGGQAHMVLV-TKVSRYSLW 311
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 40/161 (24%), Positives = 67/161 (41%), Gaps = 22/161 (13%)
Query: 213 VHPKYNFFTYEYDLALVRLETPVEFAPNIVPICLPGSD---DLLIGEN-ATVTGWGRLSE 268
VH +Y+ E DL+L+ LE P++ +P+C P D LLI ++GW R
Sbjct: 125 VHMRYDADAGENDLSLLELEWPIQCPGAGLPVCTPEKDFAEHLLIPRTRGLLSGWAR--N 182
Query: 269 GGSLPPVLQKVTVPIVSNEKCRSMF---LRAGRYEFISDIFMCAGFDNGGRDSCQGDSGG 325
G L L V +V E+C + + Y S + D G
Sbjct: 183 GTDLGNSLTTRPVTLVEGEECGQVLNVTVTTRTYCERSSVAAMHWMD------------G 230
Query: 326 PLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRISKFVPW 366
+ + G +FL G++ +A++ V T++S++ W
Sbjct: 231 SVVTREHRGSWFLTGVLGSQPVGGQAHMVLV-TKVSRYSLW 270
>pdb|2DPF|A Chain A, Crystal Structure Of Curculin1 Homodimer
pdb|2DPF|B Chain B, Crystal Structure Of Curculin1 Homodimer
pdb|2DPF|C Chain C, Crystal Structure Of Curculin1 Homodimer
pdb|2DPF|D Chain D, Crystal Structure Of Curculin1 Homodimer
Length = 115
Score = 31.2 bits (69), Expect = 1.0, Method: Composition-based stats.
Identities = 15/44 (34%), Positives = 23/44 (52%), Gaps = 6/44 (13%)
Query: 318 SCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
+C GD+G V KDGR+ + G + W +G P C R++
Sbjct: 77 ACWGDNGKYALVLQKDGRFVIYGPVLWSLG------PNGCRRVN 114
Score = 28.1 bits (61), Expect = 9.5, Method: Composition-based stats.
Identities = 14/41 (34%), Positives = 21/41 (51%), Gaps = 6/41 (14%)
Query: 371 GDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 411
GD+G V KDGR+ + G + W +G P C R++
Sbjct: 80 GDNGKYALVLQKDGRFVIYGPVLWSLG------PNGCRRVN 114
>pdb|2D04|B Chain B, Crystal Structure Of Neoculin, A Sweet Protein With
Taste-Modifying Activity.
pdb|2D04|D Chain D, Crystal Structure Of Neoculin, A Sweet Protein With
Taste-Modifying Activity.
pdb|2D04|F Chain F, Crystal Structure Of Neoculin, A Sweet Protein With
Taste-Modifying Activity.
pdb|2D04|H Chain H, Crystal Structure Of Neoculin, A Sweet Protein With
Taste-Modifying Activity
Length = 114
Score = 31.2 bits (69), Expect = 1.0, Method: Composition-based stats.
Identities = 15/44 (34%), Positives = 23/44 (52%), Gaps = 6/44 (13%)
Query: 318 SCQGDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 361
+C GD+G V KDGR+ + G + W +G P C R++
Sbjct: 76 ACWGDNGKYALVLQKDGRFVIYGPVLWSLG------PNGCRRVN 113
Score = 28.1 bits (61), Expect = 9.8, Method: Composition-based stats.
Identities = 14/41 (34%), Positives = 21/41 (51%), Gaps = 6/41 (14%)
Query: 371 GDSGGPLQVKGKDGRYFLAGIISWGIGCAEANLPGVCTRIS 411
GD+G V KDGR+ + G + W +G P C R++
Sbjct: 79 GDNGKYALVLQKDGRFVIYGPVLWSLG------PNGCRRVN 113
>pdb|3LWX|A Chain A, Crystal Structure Of Na(+)-Translocating Nadh-Quinone
Reductase Subunit C (Yp_001302508.1) From
Parabacteroides Distasonis Atcc 8503 At 1.10 A
Resolution
Length = 199
Score = 30.0 bits (66), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 38/82 (46%), Gaps = 6/82 (7%)
Query: 266 LSEGGSLPPVLQKVTVPIVSNE-KCRSMFLRAGRYEFISDIFMCAGFDNGGRDSCQGDSG 324
S G P + +++ P+ SNE K + +F EF S + G G+D G SG
Sbjct: 116 FSHQGETPGLGAEISKPVFSNEFKGKKIFXSG---EFKSVAVVKPGKSVAGQDYVDGISG 172
Query: 325 GPLQVKGKDGRYF--LAGIISW 344
G + KG D F L+G + +
Sbjct: 173 GTITSKGVDEXLFNSLSGYVKF 194
>pdb|4I8I|A Chain A, Crystal Structure Of A Hypothetical Protein (bacuni_01406)
From Bacteroides Uniformis Atcc 8492 At 1.50 A
Resolution
Length = 271
Score = 29.6 bits (65), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 17/59 (28%), Positives = 28/59 (47%), Gaps = 7/59 (11%)
Query: 23 KINPKPCSVNSVEGRCMFVWECINTDGHHLGMCVDTFM-----FGSCCSHNVTKNEISP 76
KI P ++ + R F+ + N DG+HL + + + F + NVT+N SP
Sbjct: 179 KIIPSGTAIQN--ARTSFIGDHXNRDGYHLDLTIGRYTAACTWFEALTHRNVTENPYSP 235
>pdb|2IMO|A Chain A, Crystal Structure Of Allantoate Amidohydrolase From
Escherichia Coli At Ph 4.6
pdb|2IMO|B Chain B, Crystal Structure Of Allantoate Amidohydrolase From
Escherichia Coli At Ph 4.6
Length = 423
Score = 29.3 bits (64), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 11/27 (40%), Positives = 17/27 (62%)
Query: 23 KINPKPCSVNSVEGRCMFVWECINTDG 49
K+ P+P +VN V G+ F +C +TD
Sbjct: 268 KVEPRPNTVNVVPGKTTFTIDCRHTDA 294
>pdb|1Z2L|A Chain A, Crystal Structure Of Allantoate-Amidohydrolase From E.Coli
K12 In Complex With Substrate Allantoate
pdb|1Z2L|B Chain B, Crystal Structure Of Allantoate-Amidohydrolase From E.Coli
K12 In Complex With Substrate Allantoate
Length = 423
Score = 29.3 bits (64), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 11/27 (40%), Positives = 17/27 (62%)
Query: 23 KINPKPCSVNSVEGRCMFVWECINTDG 49
K+ P+P +VN V G+ F +C +TD
Sbjct: 268 KVEPRPNTVNVVPGKTTFTIDCRHTDA 294
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.320 0.140 0.441
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 12,954,047
Number of Sequences: 62578
Number of extensions: 553718
Number of successful extensions: 2674
Number of sequences better than 100.0: 354
Number of HSP's better than 100.0 without gapping: 336
Number of HSP's successfully gapped in prelim test: 18
Number of HSP's that attempted gapping in prelim test: 1015
Number of HSP's gapped (non-prelim): 696
length of query: 422
length of database: 14,973,337
effective HSP length: 101
effective length of query: 321
effective length of database: 8,652,959
effective search space: 2777599839
effective search space used: 2777599839
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 53 (25.0 bits)